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Within the field of mental health, the issues of quality of life, language production, social 
adjustment, neurocognitive functioning, and symptom presentation are considered 
important components in the assessment and treatment of psychiatric patients, 
especially those with the diagnosis of schizophrenia. These individual domains of 
functioning are critical to understanding the unique functioning of a person with 
schizophrenia. A primary focus of mental health services is the general ability of a 
person with schizophrenia to function adequately within the community. Domains such 
as those tapped by the variables in the present study impact the ability of a person to 
interact and relate to other people. In addition, these are areas that can be informally 
assessed after brief contact with another person, and they may provide information 
regarding effective interventions for the individual.
The present study assessed the variables of symptom presentation, subjective and 
objective quality of life, social adjustment, communication failures, as manifested in 
unclear references, and neurocognitive abilities. Results demonstrated that participants 
were exhibiting relatively few psychiatric symptoms and were functioning adequately in 
their social adjustment, although they evidenced some impairment in measures of 
neurocognitive abilities. Specific relationships among variables of interest are described.
Overall, despite having a diagnosis of a severe and persistent mental illness, the 
majority of the participants reported that they were generally satisfied with their lives.
The most important finding of this study is that quality of life can be best predicted by the 
absence of high levels of depressive symptomatology, better overall social functioning, 
and by observations of language production to identify the frequency with which persons 
with schizophrenia use words in such a way that the intended meaning is not clear; 
surprisingly, ambiguous word references are associated with higher quality of life. The 
ultimate goal for working with persons with schizophrenia should be to increase the 
individual’s overall ability to function adequately within the community in the hopes of 
improving their global life satisfaction. Several potential strategies for intervention are 
discussed.
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Functioning in Schizophrenia 1
Functioning in Schizophrenia and Schizoaffective Disorder:
Quality of Life, Symptom Presentation, Language Production, 
and Neurocognitive Abilities 
Within the field of mental health, the issues of quality of life and social adjustment, 
language production, neurocognitive functioning, and symptom presentation are considered 
important components in the assessment and treatment of psychiatric patients, especially those 
with the diagnosis of schizophrenia. This is especially evident in the outpatient treatment that 
many people with schizophrenia now receive and within the context of a move towards managed 
care and a greater emphasis on accountability. A primary focus of case managers and other 
outpatient treatment professionals is the general ability of the person with schizophrenia to 
function adequately within the community. Domains such as those noted above impact the ability 
of a person to interact with and relate to other individuals in the community.
Quality of life refers to the well-being of an individual in relation to objective factors, such 
as type of living situation, income, and number of social contacts, and also subjective evaluations 
of personal satisfaction with those factors; it is a positive indicator of well-being, as opposed to 
only measuring the absence of debilitating or unpleasant symptoms (Frisch, 1994; Lehman,
1996). Language production refers to the manner in which an individual communicates with 
others, and it often focuses on errors that result in a decrease in effective communication that are 
associated with psychopathology (Andreasen, 1979a, 1979b). Neurocognitive ability refers to the 
manner in which the brain functions and how this functioning is exhibited behaviorally, often 
through performance on cognitive assessments (Lezak, 1995). Social adjustment describes the 
functioning of an individual in social situations and within his or her community (Weissman, 1975). 
Evaluation of symptom presentation is important in the understanding of an individual's 
experiences, especially in light of the fact that psychiatric symptoms can impact overall 
functioning, as well as performance in areas such as neurocognitive abilities and language 
production.
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This study examined variables that are relevant to both researchers as well as to 
professionals and caseworkers who interact with persons with schizophrenia and related 
disorders on a regular basis. The variables are ones that other individuals, such as clinicians and 
caseworkers, are able to assess informally and have been demonstrated to be areas of great 
importance for functioning within the community. The present study evaluated variables of 
symptom presentation, quality of life (both subjective and objective), social adjustment, language 
production (specifically communication disturbances manifested through unclear references), and 
neurocognitive functioning (evaluated in the domains of attention/concentration, verbal memory, 
verbal fluency, higher cognitive functioning, and general mental abilities), to determine 
relationships among these domains of variables and to discover patterns predictive of outcome, ft 
is apparent that the manner in which an individual functions, whether exhibited through symptoms, 
language, or neurocognitive abilities, can greatly impact his or her interactions with others, 
general social adjustment, and overall quality of life. Thus, it is important to understand the 
relationships among these variables in order better to understand the disease process, to provide 
adequate care to individuals with schizophrenia, and to assist in the improvement of their life 
situations.
This paper initially discusses issues related to the disorder of schizophrenia, including 
history of the illness, diagnostic and classification issues, common symptoms and their 
presentation, course, and outcome. The variables of interest for this study are then described in 
more detail. Quality of life, both in its current and its historical use, as well as relevant research, is 
explained. Social adjustment and its similarity to quality of life are described. Aspects of language 
production commonly seen in patients with schizophrenia are discussed in terms of common 
errors, theoretical underpinnings of these deviances, and strategies to measure such errors. 
Common patterns in the neurocognitive functioning of persons with schizophrenia are explored, 
while their relations to long-term outcome and specific tests for measuring performance are 
explained. Literature related to these different domains individually and relationships between
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
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them is explored, after which the hypotheses, methods, and results for the present study are 
presented and discussed.
Introduction to Schizophrenia
Schizophrenia is a disorder involving disorganization of thought, serious difficulty 
distinguishing reality from fantasy, frequent delusions and hallucinations, and abnormalities in 
emotional expression, interpersonal relationships, attention, motivation, and drive (Andreasen, 
Arndt, Alliger, Miller, & Flaum, 1995). It is characterized by psychotic symptoms, such as 
hallucinations and delusions, as well as disorder of thought, as the defining features. It is also 
considered to be a heterogeneous disorder with an often-changing presentation, causing 
researchers to have trouble determining etiology, treatment, and even classification for individual 
patients (Andreasen & Carpenter, 1993; Malla, 1995a; 1995b). Schizophrenia is regarded by 
many to be a chronic, recurring disorder that is likely to affect multiple systems in the brain 
(Andreasen, et al., 1995; Malla, 1995a; Schultz & Andreasen, 1999).
The Diagnostic and Statistical Manual for Mental Disorders, Fourth Edition, Text Revision 
(DSM-IV-TR-, American Psychiatric Association, 2000) presents diagnostic criteria for 
schizophrenia requiring that two or more active characteristic symptoms be present for at least 
one month, and signs of the disorder to be present for at least six months. The characteristic 
symptoms consist of delusions, hallucinations, disorganized speech, grossly disorganized or 
catatonic behavior, and negative symptoms. In addition, there needs to be a decreased level of 
functioning in one or more major life areas, such as employment, education, interpersonal 
relations, or self-care. There is general agreement that a diagnosis of schizophrenia can only be 
given to an individual who has at least several of the diagnostically relevant symptoms (DSM-IV- 
TR, 2000; Strauss, Carpenter, & Bartko, 1974). However, this allows for a variety of presentations 
within the disorder of schizophrenia and has resulted in an acceptance of the idea that 
schizophrenia probably involves multiple dysfunctions rather than one unitary process.
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A disorder that is related to schizophrenia is schizoaffective disorder, in which a individual 
experiences an uninterrupted period of illness during which he or she also experiences a major 
depressive, manic, or mixed episode concurrent with the symptoms of schizophrenia (DSM-IV- 
TR, 2000). Specifically, the individual must experience one of a number of the symptoms of 
schizophrenia for the majority of the time during a one-month period. These symptoms are 
delusions, hallucinations, disorganized speech, grossly disorganized or catatonic behavior, and 
negative symptoms. In addition, during the same period of illness, delusions or hallucinations must 
have been present for at least two weeks in the absence of an affective disturbance.
The diagnosis of schizoaffective disorder is commonly given to those patients who have 
both affective and schizophrenic symptoms, but who do not clearly fit into the diagnostic 
categories of schizophrenia or bipolar disorder (Lapens6e, 1992). After a review of the literature, 
Lapens6e concluded that schizoaffective disorder appears to be a heterogeneous construct, 
which includes patients with a variety of presentations and predispositions to the disorder. It 
seems that schizoaffective disorder may be more similar to schizophrenia with a depressive 
component, although the debate is far from over, and this may depend to a great extent on the 
criteria used to define the disorder.
The diagnosis of schizophrenia is made in approximately .5 to 1.5% of the population in 
the United States, which has one of the highest reported rates for schizophrenia in the world 
(DSM-IV-TR, 2000). Explanations for the cross-national differences in prevalence of 
schizophrenia vary, but issues such as industrialization, life expectancies, or diagnostic practices 
and customs, which differ from other countries, may play a part (Torrey, 1987). The breadth of the 
prevalence range for schizophrenia is most often accounted for in terms of the variety of 
methodology (e.g., specific operational definitions, rural vs. urban populations, community vs. 
hospitalized populations) employed in different research that has studied prevalence rates of 
schizophrenia.
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The onset for the disorder usually occurs in early adulthood, but it can develop at any 
age, and it has been seen in children as young as five years old. Males tend to develop 
schizophrenia earlier than females, often between the ages of 18 and 24 years, whereas females 
generally develop this disorder after age 25 (Larsen, McGlashan, & Moe, 1996; Moriarty, et al., 
2001). A variety of factors have been associated with the development of schizophrenia, such as 
genetic vulnerability, season of birth effects, and, pregnancy and birth complications, although 
research has been inconclusive and none of these factors have been unequivocally demonstrated 
to be causal (Eaton, 1991; HSfner & an der Heiden, 1997). Specific information about the 
prevalence of schizoaffective disorder is not available, even after a review of the literature, but it 
appears that this diagnosis is made less frequently than that of schizophrenia (DSM-IV-TR, 2000), 
which appears to be, in part, due to the diagnostic systems and criteria that are used to define the 
disorder (Lapens6e, 1992).
Once diagnosed with schizophrenia, patients are further classified into subtypes based 
upon the predominant symptomatology at the time of the current evaluation. According to the 
DSM-IV-TR (2000), a specific exclusion order should be followed to determine an individual 
patient’s subtype. Catatonic subtype is assigned if prominent catatonic symptoms are present, 
regardless of the presence of other symptoms. Disorganized subtype is assigned if disorganized 
speech and behavior and flat or inappropriate affect are present, unless catatonic features are 
also present, which then indicates the catatonic subtype. Next, the paranoid type is considered if 
delusions or hallucinations are prevalent and if the catatonic and disorganized subtypes have 
been eliminated as alternatives. The subtype of undifferentiated schizophrenia is assigned if the 
patient shows signs and symptoms of schizophrenia but does not meet the criteria for the other 
subtypes. Finally, a patient is categorized as residual type if s/he presents with continuing 
evidence of the disturbance, but no longer meets criteria for active-phase symptoms. Although a 
common practice in some research, an analysis of the subtypes of schizophrenia was not 
undertaken as part of the current research.
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These subtypes are supposed to have high predictive validity, help therapists select 
specific treatment and predict individual outcome, and provide researchers with homogeneous 
groups. However, the utility of these subtypes has been questioned by many professionals due to 
the heterogeneity of the disorder (Fenton, 1996). Some researchers have presented a variety of 
alternative conceptualizations for subtypes or syndromes of schizophrenia. These are discussed 
in the next section.
Symptom Classifications
An awareness of the importance of symptoms has been present in the study of 
schizophrenia since Kraepelin first defined Dementia Praecox in 1898. Kraepelin focused on the 
description of symptomatology and acknowledged that symptoms related to a “weakness-state" 
illness existed. As early as 1914, Berze (Sass, 1989) recognized two broad types of symptoms in 
schizophrenia, which included those that were excesses or distortions in functioning and those 
that were deficits or decreases in functioning. A similar distinction was later conceptualized based 
on a typology of neurological symptoms specifically described by J. Hughlings-Jackson in 1889 
(Sass). Hughlings-Jackson referred to a “double condition” in insanity, which included both 
positive and negative components. Using epilepsy as his model, he referred to the negative 
components as a “loss of control permitting" the body to do something, and the positive 
components as “increased automatic action” resulting from activity in the lower portions of the 
nervous system which arise as involuntary behavior. Translating this to present work within 
psychiatry, these are commonly known as negative and positive symptoms, respectively, and are 
considered to represent independent dimensions of pathology. The distinction between positive 
and negative aspects of any condition in general, which are independent of each other, dates 
back to J. R. Reynolds in 1858, although in relation to schizophrenia this distinction is generally 
attributed to Hughlings-Jackson (Berrios, 1985).
Positive symptoms consist of hallucinations, delusions, formal thought disorder, and 
bizarre or disorganized behavior, all representing functions that are in excess of the reality and
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behaviors of most people. Negative symptoms consist of alogia, affective flattening or 
inappropriate affect, anhedonia, asociality, avolition, apathy, and attentional impairment 
(Andreasen, et al., 1995; Andreasen & Olsen 1982; Malla, 1995b), although others have found 
through factor analysis that inappropriate affect does not correlate highly with other negative 
symptoms and have concluded that it should not be included in the construct (e.g., Kibel, Laffont,
& Liddle, 1993; Peralta & Cuesta, 1995; Schuldberg, Quinlan, Morgenstem & Glazer, 1990).
Care needs to be taken when considering the cause of negative symptoms, and if they 
are actually a result of schizophrenia. The appearance of negative symptoms could be due to 
depression or dysphoria, from which many schizophrenia patients may suffer, and should be 
differentiated from true negative symptoms (DSM-IV-TR, 2000; Kibel, Laffont, & Liddle, 1993;
Malla 1995a, 1995b), or as a result of an impoverished environment and a lack of social 
stimulation, especially when the patient is hospitalized or extremely withdrawn (Owens & 
Johnstone, 1980). There is also the suggestion that negative symptoms may be sequelae of 
neurological insult. Additional discussion of depressive symptoms can be found in the affective 
disturbances portion under the heading “clinical findings in schizophrenia" in this paper.
This dichotomy of symptoms has been utilized to subtype patients into classes of positive 
and negative schizophrenias (Andreasen, Flaum, Swayze, Tyrrell, & Amdt, 1990; Andreasen 8i 
Olsen 1982; Malla, 1995a; Rosen, et al., 1984). This can be useful for description and to provide 
information about individual patients for clinicians. Patients diagnosed with positive, or Type I 
(Crow, 1987), schizophrenia are generally characterized by prominent positive symptoms, normal 
brain structure, relatively good response to neuroleptic medications, fairly good premorbid 
adjustment, and an underlying neurochemical mechanism for the disorder probably related to the 
dopamine system (see also Crow, Johnstone, Longden, & Owen, 1978). Those patients 
characterized by negative, or Type II, schizophrenia usually present with prominent negative 
symptoms, structural brain abnormalities, impaired cognitive functioning, poor response to
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treatment and poor premorbid adjustment. Crow also indicated that the two classifications 
represent overlapping syndromes and not discrete illnesses.
It was originally thought that positive and negative symptoms were inversely related 
(Andreasen & Olsen, 1982), but it has been shown that this is not always the case, as symptoms 
on the two dimensions can co-occur (Liddle & Barnes, 1990; Liddle, Barnes, Morris, & Haque, 
1989). Ratings of the two types of symptoms are not always negatively correlated. In some 
patients, both positive and negative symptoms are present, causing the subtype of ‘‘mixed” 
schizophrenia to be assigned. In a portion of these patients, as positive symptoms increase over 
time, negative symptoms also tend to increase, although there is no relation between the number 
of positive symptoms and the severity of the negative symptoms. This has been especially evident 
in the most severely disturbed of individuals with schizophrenia (Rosen, et al., 1984). Instead of 
meeting criteria for both positive and negative symptoms, some patients who do not meet criteria 
for either positive or negative schizophrenia are also given the subtype of mixed schizophrenia 
according to this classification system (Andreasen & Olsen; Malla 1995a). This latter classification 
is not considered useful or informative to clinicians.
Alternatives to the positive and negative schizophrenia classification system have been 
introduced by a number of authors. An early enhancement of the positive-negative symptom 
classification was presented by Strauss, Carpenter and Bartko (1974), who suggested that three 
categories of symptoms be considered in the process of schizophrenia rather than the previous 
two. These three categories are positive symptoms (disorders of content of thought and 
perception, types of form of thought such as distractibility, and behaviors such as catatonic motor 
disorders), negative symptoms (blunting of affect, apathy, and types of formal thought disorder 
such as blocking), and disordered personal relationships. The authors posited that the separation 
of symptoms into these three categories lends support to a multiprocess conception of 
schizophrenia in which more than one symptom process may be present in the presentation of the 
disorder.
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Another variation has been proposed by some current researchers who have suggested 
that again three syndromes of schizophrenia be considered (Liddle & Bames, 1990; Liddle, 
Bames, Moms & Haque, 1989; Malla, 1995a, 1995b). These are not to be thought of as subtypes, 
but instead are hypothesized to be different sets of symptoms that may or may not coexist in the 
same patients, with these sets potentially having different responses to specific interventions, 
such as different types of neuroleptic medications. These dimensions are reality distortion or 
psychoticism (delusions and hallucinations are prominent), psychomotor poverty (deficits such as 
poverty of speech, decrease in spontaneous movements, and blunted affect) and disorganization 
(poverty of content, inappropriate affect, and formal thought disorder). Symptoms within each 
dimension have been found to vary in severity together, and symptoms across dimensions show 
lesser congruent variation. In creating these dimensions, the positive symptoms were split into two 
separate syndromes, reality distortion and disorganization, while negative symptoms were 
maintained, except for the transfer of inappropriate affect to the disorganized dimension. Similar 
results have been found by other groups who classify the symptoms of schizophrenia into the 
categories of psychotic symptoms, disorganization (together make up the positive symptom 
dimension) and negative symptoms (Andreasen, et al., 1995). Overtime, these three symptom 
categories have been found to change along with one another, however in a completely 
independent manner from the others (Arndt, Andreasen, Flaum, Miller, & Nopoulos, 1995). 
Typically, the two positive symptom dimensions, psychoticism and disorganization, tended to 
improve much more over time, while the negative symptoms tended to improve much less or even 
worsen over time, although this is now controversial as some studies suggest that negative 
symptoms do improve over time (Quinlan, Schuldberg, Morgenstem & Glazer, 1995) or at least 
remain relatively constant (Herbener & Harrow, 2001). Interestingly, changes in the dimensions of 
psychoticism and disorganization are also not correlated with one another, indicating that these 
two dimensions are separate and independent from one another (Arndt, et al.)
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Additional research has indicated that four or more distinct types of symptoms may be 
present in schizophrenia. The analysis of one research group (Schuldberg, et al., 1990) revealed 
symptom factors of positive symptoms, negative symptoms, attentional impairment, and formal 
thought disorder. Two additional factors, bizarreness and avolition-apathy, emerged as possibly 
separate symptom categories as well. An item-level factor analysis of individual items on two 
symptom measures in another study (Toomey et al., 1997) resulted in two negative symptom 
factors of diminished expression and disordered relating, two positive symptom factors of bizarre 
delusions and auditory hallucinations, and a disorganization factor. This different research 
indicates that additional attention should be given to more detailed classifications of symptoms 
and the variety of syndromes they reveal.
The issue of symptom presentation and the positive-negative distinction was included in 
this project by studying both total symptom presentation (by using the Brief Psychiatric Rating 
Scale; BPRS; Overall & Gorham, 1962) and by discriminating those symptoms that load most 
predominantly on the positive symptom dimension from those that load most predominantly on the 
negative symptom dimension, as identified by Ventura, Nuechterlein, Subotnik, Gutkind, and 
Gilbert (2000). In addition, factors such as manic and depressive affect were also considered. 
These factors will be addressed in more detail in the methods section of this paper.
Clinical Findings in Schizophrenia
Perceptual and cognitive disturbances. As noted above, disturbances in thinking and 
language are usually considered the primary pathognomic feature of schizophrenia (see also 
Bleuler, 1950; Meehl, 1989). Problems in the form of thought are referred to as “thought disorder" 
or “formal thought disorder.” This is differentiated from problems involving the content of thought, 
which include delusions and possibly hallucinations. Thought disorder is usually inferred from the 
patient’s language production, for it is assumed that disorganized thought, if severe enough, will 
substantially impair effective communication. The term “thought disorder” is used somewhat 
loosely to refer to both disturbances of language and communication. Andreasen (1979a) defined
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a set of specific terms for disturbances in language behavior and production -  based on a number 
of clinical descriptions in the literature - that are still applicable today and include both deficits and 
excesses in communicative behaviors. These categories are discussed in greater detail in the 
language section.
Language disturbances can be very pervasive and affect a wide range of types of 
communication, although patients with schizophrenia are often not aware that their language 
production is abnormal and may become frustrated when trying to communicate with others who 
do not understand them (Amador & David, 1998). Other persons with schizophrenia sometimes 
seem oblivious or “not to care" about being hard to understand. In general, subjects with 
schizophrenia may have little insight into their disturbance. Language and communication 
disturbances are discussed in greater detail in the language section of this paper, and form the 
basis of one of the predominant areas of research in this study.
Psychotic symptoms of hallucinations and delusions are also symptomatic of 
schizophrenia, even though they may also occur as part of other disorders. Hallucinations are 
perceptions that are experienced as originating in the outside world or within one’s own body, yet 
do not involve an external stimulus to any of the sense organs. These experiences nevertheless 
seem to the patient to be true perceptions and are experienced by a reported 70% of persons with 
schizophrenia (Mueser, Bellack, & Brady, 1990).
Delusions involve disturbances in the end products of logical thinking rather than in 
perception or the formal processes of thinking themselves. Delusions are firmly held ideas, with 
no plausible reason for the beliefs that are untrue and often bizarre, yet are maintained by the 
patient. The “untrueness” or “bizarreness” of the belief must be judged by the clinician or 
researcher based upon the patient's educational and cultural background. A delusion is 
considered to be bizarre if it is clearly implausible, not understandable, or not deriving from normal 
life experiences (DSM-IV-TR, 2000; Spitzer, First, Kendler, & Stein, 1993). Bizarre delusions have
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been estimated to occur in as many as 79% of persons with schizophrenia (Goldman, Hien, Haas, 
Sweeney, & Frances, 1992).
A final cognitive disturbance common in patients with schizophrenia is a lack of insight, 
mentioned above. As many as 97% of schizophrenia patients may believe that they are not ill or 
abnormal, and their hallucinations and delusions are perceived as actual and not imagined 
experiences (Sartorius, Shapiro, & Jablensky, 1974). This lack of insight is found more commonly 
in patients with schizophrenia than with other psychiatric condition, such as bipolar affective 
disorder or schizoaffective disorder (Amador, et al., 1994). As noted above, a lack of insight can 
cause significant difficulties in communication with others for the individual with schizophrenia 
(Amador & David, 1998). These patients usually have normal orientation and memory, although 
they may experience some age disorientation, evidenced by difficulty in providing their own age. 
This lack of insight with intact orientation and memory makes patients with schizophrenia 
extremely difficult to treat, especially because rates of treatment compliance are greatly 
decreased when the patient does not believe s/he is ill (Black & Andreasen, 1994).
Behavioral and motor disturbances. Some people with schizophrenia exhibit both 
behavioral and motor disturbances throughout the course of the illness. At times it is difficult, 
however, to separate true behavior disturbance in schizophrenia from effects of medications 
provided to the individual, and possibly from the effects of chronicity or institutionalization. A 
deterioration in social behavior can also be observed as the individual neglects him/herself and 
his/her surroundings. Social withdrawal and isolation also become prominent for these individuals 
and they may experience a lack of motivation and exhibit a disinterest in planning for the future 
{DSM-IV-TR, 2000; Black & Andreasen, 1994) which result in a paucity of motor behaviors. Such 
disturbances are most often seen in the Disorganized and occasionally in the Residual Types of 
schizophrenia.
A variety of motor disturbances are sometimes seen in persons with schizophrenia. They 
may exhibit uncontrolled and aimless motor activity (excitement) including repeated but non-goal
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directed movement, such as rocking (stereotypy), or regular goal-directed activities appearing to 
have social significance but which are out of context and odd in appearance (mannerisms). 
Catatonic motor behavior may be exhibited, such as extremely decreased reactivity to the 
environment (stupor), allowing one’s body to be posed by another person (waxy flexibility), 
maintaining a rigid posture over an extended period of time (rigidity), or posing in an inappropriate 
and bizarre posture (posturing) while resisting attempts to be moved (negativism). This is most 
often seen in persons given the subtype of Catatonic Schizophrenia or in those with negative 
symptoms (Chandrasena, 1986; DSM-IV-TR, 2000; Gelenberg, 1976).
Impulse control is another behavioral problem exhibited by patients with schizophrenia. 
Some individuals may become quite agitated and exhibit a decrease in judgment and impulse 
control when experiencing active-phase symptoms which increases their risk of suicide or other 
self-harm and demonstrating violent behaviors towards others. Although violence may occur, 
knowing that a patient has schizophrenia does not generally predict violence or dangerousness 
(Swanson, 1994). However, recent research has shown that violence in persons with 
schizophrenia is related to clinical variables, especially an increase in positive symptoms (Arango, 
Barba, Gonzalez-Salvador, & Ordoftez, 1999; Krakowski, Czobor, & Chou, 1999). When a person 
with schizophrenia is violent, the victims are usually family members or friends of the patient. 
These violent behaviors seem to be in response to delusions and hallucinations, or are traceable 
to incorrect dosages of medications (Gottesman, 1991; Junginger, 1996), and violent behavior 
also seems to be associated with a poor prognosis (Karson, & Bigelow, 1987), as patients with a 
history of violence evidenced a greater number of previous hospitalizations.
Affective disturbances. Alterations or decreases in affect can be seen in some individuals 
with schizophrenia, such as those diagnosed with Disorganized or Residual Types, or in patients 
exhibiting negative symptoms. People with affective disturbances tend to exhibit indicators of 
blunted affect, such as indifferent and apathetic responses to others, a lack of empathy, 
decreased intensity of emotional expression, unchanging facial expressions, and poor eye
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contact. A more extreme form of reduced emotion, anhedonia, in which the patient is unable to 
experience or even imagine any form of pleasure, is also seen in some people with schizophrenia. 
Research has revealed that persons with schizophrenia report significantly greater physical and 
social anhedonia, less positive affect, and more negative affect than control subjects, and these 
phenomena have all been found to be stable over time (Blanchard, Mueser, & Bellack, 1998). 
Inappropriate expressions of affect are also common, such as exhibiting a profound silliness or 
discussing a sad or morbid topic with a smile and cheerful manner, and are most often seen in the 
Disorganized subtype. It has been noted that patients with schizophrenia may actually experience 
appropriate emotions despite their outward appearance (Black & Andreasen, 1994). The 
discrepancy, in part, seems to arise from their difficulties in communication and reduced 
expression of affect.
Due to affective disturbances, approximately 60% of schizophrenia patients appear as 
though they have significant depressive symptoms as well (Escamilla, 2001; Kibel, Laffont, & 
Liddle, 1993; Sands & Harrow, 1999; Siris 1991,2000;Taylor, 1992). The separate diagnosis of a 
mood disorder is difficult to make, because the symptoms (e.g., of anhedonia and depression) 
greatly overlap, and because antipsychotic medications can cause what seems to be depression 
(drug-induced akinesia). Care must be taken to determine if a depressive disorder should be 
diagnosed in addition to schizophrenia, or if the depressive symptoms are just manifested through 
other symptoms of schizophrenia. Alternatively, the diagnosis of schizoaffective disorder 
(discussed previously) needs to be considered when a patient presents with both the symptoms of 
schizophrenia and affective disturbance, especially when the mood disorder appears to be an 
episode of major depression or a mixed episode.
Course and Outcome
The paths that patients with schizophrenia patients follow throughout their illness are 
heterogeneous; there is no way to predict the exact course of an individual person with 
schizophrenia, for it varies from patient to patient (McGlashan, 1988; Strauss & Carpenter, 1972).
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However, there are some general patterns observed that are used to describe the course of 
schizophrenia. There are three stages of schizophrenia which patients cycle through (Black & 
Andreasen, 1994). The prodromal stage precedes the active phase of the illness, sometimes by 
many years. It is characterized by a general decline and deterioration in behavior and emotional 
responsiveness. The active phase is when psychotic symptoms, often delusions and 
hallucinations, are predominant. During this phase the patient’s behavior is florid and alarming to 
others and often leads to hospitalization. The residual phase is similar to the prodromal phase and 
equivalent to the experience of the patient subtyped with residual schizophrenia, where active- 
phase symptoms are no longer present, but there is still evidence of a disturbance.
As noted, the course of schizophrenia is variable, and it generally follows one of four 
patterns (Black & Andreasen, 1994; DSM-IV-TR, 2000). The first is of an illness that resolves 
completely with or without treatment and the patient remains stable over time. The second is an 
illness that recurs repeatedly, with a full recovery every time. Each of these patterns is seen very 
infrequently among schizophrenia patients. The third pattern is of an illness that recurs repeatedly, 
but without full recovery, causing a persistent deficit state to develop. The last is of an illness with 
progressive worsening from the onset of the disorder. These last two patterns are most commonly 
found among patients with schizophrenia. The classic course of schizophrenia is one of repeated 
exacerbations and remissions, with a lack of return to baseline functioning following the active 
phase. Research has found that after the first exacerbation of psychotic symptoms, the course of 
schizophrenia tends to remain fairly stable, with the most activity and severity of symptoms early 
on in the illness (Mason, Harrison, Glazebrook, Medley, & Croudace, 1996).
In relation to the positive (Type I) and negative (Type II) syndromes of schizophrenia,
Crow (1987) noted that although either syndrome may be present at any time during the course of 
the illness, the negative syndrome tends to be identified in the patients with more chronic states, 
may be associated with some level of irreversibility, and indicates a limited prospect of 
improvement. Additional research has shown that schizophrenia characterized by primarily
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negative symptoms is associated with a progressive course that often results in permanent 
disability, whereas schizophrenia characterized by primarily positive symptoms are associated 
with a better prognosis (Fenton & McGlashan, 1991; see also Breier, Schreiber, Dyer, & Pickar, 
1991). Arndt et al. (1995) found that negative symptoms tended to remain fairly constant over 
time, whereas positive symptoms were less stable and fluctuated over the course of the illness 
(see also Davidson & McGlashan, 1997)
Some patients experience what is commonly referred to as the “revolving door 
phenomenon.” This is a function of both clinical course, and treatment and clinical management 
practices. These patients have a high frequency of hospital readmissions and discharges, 
commonly thought to be caused by inadequate rehabilitation facilities and a lack of utilization of 
after-care services. These patients also have a tendency towards noncompliance with their 
treatment regimens and also possibly a history of substance abuse, which increases their 
chances of rehospitalization. This revolving door phenomenon previously was thought to be due in 
part to the use of psychiatric hospitals for non-psychiatric purposes, such as holding facilities for 
individuals with a lack of money, no housing, or family problems. This phenomenon is now 
considered to be caused by more frequent exacerbations of the illness influenced by various 
factors described above (Haywood, Kravitz, Grossman, Cavanaugh, Davis, & Lewis, 1995; 
Prendergast, 1995). Patients in circumstances such as these may have a lower quality of life due 
to their numerous hospitalizations and the disruption this occurs in their lives, their refusal of case 
management and other community services, or the lack of available community resources (Geller,
1986).
The symptoms of schizophrenia may change over the course of the illness, but this idea 
is controversial within the literature. Some sources (Black & Andreasen, 1994; DSM-IV-TR, 2000) 
indicate a symptom course of negative symptoms being seen early in the illness, especially during 
the prodromal phase, and positive symptoms being prevalent primarily during the active phase. 
Overall, this can result in a progressive downward course of the disorder. Such a
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
Functioning in Schizophrenia 17
conceptualization has been refuted by some authors, who adhere to the more “classic course” of 
schizophrenia evidencing more negative symptoms over time, or that in general a more variable 
development and course of symptoms may be present in people with schizophrenia (Davidson & 
McGlashan, 1997; Liddle, et al., 1989; Quinlan, et al., 1995). Others have noted that the severity 
of symptoms appear to stabilize after five to ten years of active symptoms (McGlashan, 1988).
The expected outcome or prognosis for persons with schizophrenia today is more 
optimistic than in the past, due in a large part to the development of a variety of antipsychotic 
medications. After a first hospitalization, approximately one-quarter of patients are expected to 
have a good outcome with no subsequent hospitalizations. Another one-fourth is expected to have 
a severe and chronic outcome with continued hospitalization, intellectual and/or social impairment. 
Approximately one-half of persons with schizophrenia are found to have a moderately good 
outcome, with some subsequent hospitalizations and social impairment, but able to function fairly 
well otherwise (Marengo, 1994; see also Mason, et al., 1996). Alternatively, one can consider 
outcome groups in slightly larger categories. Clinical lore asserts that persons with schizophrenia 
fall into three categories, approximately one-third of whom have a good outcome, one-third a poor 
outcome, and one-third experience a moderately good outcome. A more optimistic report has 
supported the considerable heterogeneity in the long-term outcome of individuals with 
schizophrenia, and present that approximately one-half to two-thirds of persons with 
schizophrenia significantly improve or recover from the disorder (Harding, Zubin, & Strauss,
1987).
Indicators of a good prognosis for patients with schizophrenia include an acute onset at a 
later age, having a family history of mood disorder rather than schizophrenia, exhibiting good 
premorbid adjustment and interepisode functioning with minimal residual symptoms, the 
presentation of brief active-phase symptoms with few or no negative symptoms, and having 
normal neurological functioning indicating an absence of brain abnormalities (Davidson & 
McGlashan, 1997; Hdfner, et al., 1998). In addition, increasing evidence has indicated that long-
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term prognosis is greatly improved through early detection of symptoms and intervention with 
medication(s) to relieve the symptoms and assist in the prevention of relapse (Kasper, 1999; 
Robinson, et al., 1999). This apparently tends to curtail the progression of the disorder and 
facilitates better overall functioning.
The present study considered the issue of quality of life (to be discussed below) as an 
outcome measure to be compared to variables of language production, social adjustment, 
symptom presentation, global assessment of functioning, and neurocognitive functioning in order 
to determine predictive patterns and relationships among the variables.
Quality of Life
Quality of life and schizophrenia. As noted above, the outcome for patients with 
schizophrenia is greatly varied. Lehman (1996) stated that one of the various challenges in 
evaluating services for persons with schizophrenia is the development of adequate outcome 
measures that consider a broad range of issues faced by the patients. Many different areas of 
functioning and/or disease aspects can be considered when evaluating the outcome of patients 
with schizophrenia. A construct that includes a number of these areas is Quality of Life, which is 
generally considered to be composed of functional status, burden on family and community, 
access to resources and opportunities, and subjective sense of well-being (Attkisson, et al.,
1991). A more detailed discussion of the construct and history of quality of life, approaches, and 
measurement, will follow.
Although some measures of quality of life assess functioning from the “outside” in an 
objective manner, a current focus in mental health has been to include the patient's perspective in 
determining relevant outcomes. This has resulted in the growth of the construct of subjective 
quality of life (Awad & Voruganti, 2000; Diener, 1984). Frisch (1994) describes subjective quality 
of life as composed of two parts, a component involving positive affect, and a cognitive 
component in which an individual judges whether needs and wishes have been fulfilled, and 
relates this to personal satisfaction.
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When assessing a patient’s functioning, as done by a medical doctor, issues related only 
to physical health are considered and those concerns related to satisfaction or subjective quality 
of life are often ignored. Quality of life assessments are helpful to the field of mental health (as 
well as to medicine in general) because they contribute information about how patients are 
functioning in various domains of their lives, which, although beyond issues of medicine 
specifically, are still affected by and can impact the individual’s physical health (Lehman, Ward, & 
Linn, 1982). This approach to measuring outcomes through quality of life also allows the 
professional to have a broader focus and directs additional attention to positive or adaptive areas 
of functioning when determining the status of the individual patient (Lehman, 1996).
Measures of quality of life are also important because some of the information gathered 
comes from the patient’s own point of view. This is especially relevant in the study of 
schizophrenia, because the disorder inherently affects the overall functioning of the patient. As a 
result, it is imperative to research the patient’s subjective evaluation of his or her own life and 
experiences. Also, in asking the patient directly, the professional is showing a respect and 
understanding that the patient does not often experience, especially when receiving medical or 
mental health services (Awad & Voruganti, 2000).
Some clinicians may express discomfort with the process of asking patients directly about 
their quality of life, because it is assumed that psychopathology would confound and interfere with 
the patient’s responses. This is especially relevant in the study of schizophrenia, where patients 
often exhibit a variety of neurocognitive deficits as well as disturbed thinking and communication 
which many clinicians assume result in unreliable reports. However, this appears to not be a 
concern for most domains assessed by quality of life measures. Lehman (1983) determined that 
psychopathology does not bias overall quality of life findings. He found that the structure of the 
assessment results was not significantly changed due to the removal of the effects of 
psychopathology in the analysis of overall quality of life ratings. Instead, the only influence of 
mental health effects was found in the assessment of patients’ self-rated (perceived) health,
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utilization of health services, and satisfaction with health care, all of which are part of only one of 
the nine subjective areas of quality of life that Lehman considers. This, as the author notes, is not 
surprising in light of the fact that the general notion of health involves both mental and physical 
health. Voruganti, Heslegrave, Awad and Seeman (1998) reported similar results and found that 
patient’s self-reports were consistent over time and evidenced significant correlations with 
objective measures completed by clinicians. This group of authors also determined that although 
patients' reports of subjective quality of life were impacted by symptom severity, side effects, 
neurocognitive functioning, clinical interventions, and medication levels, the reliability of the 
reports were not affected by these factors.
It has also been argued that professionals already make informal quality of life 
assessments during the process of “getting to know” a patient and understanding his or her 
experiences. But even such a practice is not specific enough to truly assess the patient’s quality 
of life, and formal assessments are needed. A number of domains of quality of life can be 
considered, which may include the patient’s health care, safety, security, housing, food, 
occupation, social contacts, finances, and education (Frisch, 1994; Packer, Husted, Cohen & 
Tomlinson, 1997; Skantze, Malm, Dencker, May & Corrigan, 1992). The third group of authors 
explained that quality of life is not the same concept as standard of living, which is only an 
objective assessment of the previously listed areas. Also considering the patient’s satisfaction with 
these domains constitutes quality of life. At the least, the concept of quality of life should 
emphasize the patient’s perspective on his or her sense of well-being and consider issues such 
as how the patient feels that he or she is doing, how the patient feels about what he or she has, 
and how the patient feels about his or her life situation (Frisch, 1994; Lehman, 1996). This is 
considered the patient’s subjective quality of life. In addition, researchers often do consider more 
objective areas of quality of life, including the patient’s functional status and access to resources 
and opportunities, in order to add to the patient’s own perspective. It appears that using a 
multidimensional approach to quality of life assessment rather than a global self-report rating may
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yield more reliable information. To a great extent, the concept of quality of life has come to 
represent the ultimate outcome of the interaction between the patient and the illness, its treatment, 
its psychological impact, as well as social contributions and consequences (Awad & Voruganti, 
2000).
History of quality of life assessments. The precise origins of the concept of quality of life 
are largely undetermined, but it appears that the idea developed after World War II when many of 
the population of Western societies were experiencing an increased standard of living which 
followed the economic prosperity of the times. This led to people’s expectations of greater 
satisfaction, fulfillment, and well being in their lives. This concept of satisfaction with domains of 
life was readily applied by society to areas such as physical health and job satisfaction. The term 
quality of life appears to have been first introduced to the general population by President 
Johnson in 1964 during his address on “the Great Society” (Awad & Voruganti, 2000). The 1960’s 
saw an increased focus and concern with the concept of quality of life in psychiatric patients due 
to the deinstitutionalization movement. Many chronically mentally ill patients, especially those with 
schizophrenia, were released from facilities without the necessary abilities to live independently 
and in a time in which the community was not prepared to cope with their needs. The subsequent 
deterioration of the patients' living conditions, personal safety, income, and social support resulted 
in an inferior quality of life that soon came to the notice of mental health professionals.
Thus, evaluating and improving quality of life became an emphasis in the study of 
discharged psychiatric patients. Initially, the focus was placed upon identifying patients’ needs in 
the community and drew considerable attention to the situation of the chronically mentally ill in the 
community. This attention was not maintained, however, through the late 1970’s and early 1980’s 
when the concept of quality of life was essentially discounted and ignored. It appears that the 
disinterest resulted primarily from a lack of agreement on a consistent definition of the term 
“quality of life,” a lack of adequate conceptual models pertaining to the concept, questions
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regarding the reliability of self-report measures, and a lack of standardized measures appropriate 
for patients with specific disorders, such as schizophrenia (Awad, 1997).
In the last decade, there has been a revival of interest in the concept of quality of life for 
psychiatric patients. Many factors are potentially involved in this change, one of which is the issue 
of cost of care and services for psychiatric patients in a time when resources are limited (Awad, 
1997; Frisch, 1994). Professionals are now being pressed to consider alternative outcome 
measures when evaluating services and treatments. This is as prevalent in the field of physical 
health as it is in the field of mental health. In addition, the pharmaceutical industry, while 
introducing and promoting new medications, has stressed quality of life as a significant marketing 
tool to underline differences between various medications and to emphasize a favorable health 
economic status (Awad & Voruganti, 2000).
In the age of consumerism, people are motivated to consider more personal outcomes, 
one of which has been quality of life, and cause professionals to do the same. This focus on 
quality of life has also been utilized to address the costs and benefits of various types of 
treatment. Unfortunately, most of the recent focus has been directed towards the application and 
measurement of quality of life, and little research has been completed on determining a globally 
accepted definition for quality of life, the boundaries of the concept, determinants of quality of life, 
and discovering relevant clinical correlates. It is clear that research in these areas must be 
undertaken before further advancement can be made with the issue of quality of life for the 
chronically mentally ill (Awad, 1997). Indeed, it may be that multiple definitions of the term quality 
of life are needed depending on the population under study, the progression of the illness and its 
treatment, as well as societal expectations at the particular point in time of a research study 
(Awad & Voruganti, 2000).
Quality of life and schizophrenia research. Recent studies have shown that patients with 
schizophrenia report a decreased satisfaction in particular areas of their lives such as mental 
health, inner experiences (i.e., self-fulfillment, self-reliance, freedom, joy, love), social contacts,
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and, employment (Skantze et al., 1992), as well as income level, knowledge base, education, 
general opportunities and leisure activities (Grawe & Lovaas, 1994). This has been found even in 
situations where the patient was enjoying a relatively adequate standard of living and having all 
basic needs met. Similar findings were reported in a study that compared individuals with 
schizophrenia in the United States and Italy (Warner, de Girolamo, Belelli, Bologna, Fioritti, & 
Rosini, 1998). These studies determined that the subjective quality of life reported by these 
patients was not just the absence of acute suffering and/or symptoms, nor just having some 
income and a place to live. Instead, it appears that subjective quality of life for these patients 
involved dynamics of their inner world and overall satisfaction with their experiences. This 
supports the idea that subjective quality of life is not the same as objective assessments of life 
domains.
Other research has found that seriously mentally ill patients who lived with family 
members in a very poor and rural area but reported high support from those same family 
members expressed significantly less dissatisfaction in all life domains except finances/income 
(Sullivan, Wells & Leake, 1991). It was presumed that the positive and supportive relationship with 
family members increased patient life satisfaction, even when the subject was living in adverse 
conditions. Results such as these are in direct contrast to other findings which indicate that family 
interactions can be experienced by persons with schizophrenia in very negative and critical ways 
(Hooley, 1998). Such interactions are high in expressed emotion, which is a measure of criticism, 
hostility and emotional overinvolvement within the family. Similar contrasts again support the 
notion that patient perspective is crucial in considering quality of life.
Involvement in educational groups which address issues related to schizophrenia and the 
course of the disorder was found to be related to significant gains in quality of life, even when no 
specific skills training was provided to these patients (Atkinson, Coia, Gilmour & Harper, 1996). 
Thus it appears that education, understanding, and overall insight into the disorder of 
schizophrenia provides the patient with an increased satisfaction with his or her own life. Other
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researchers have found opposite results, in that no increase in quality of life was found as the 
patient gained insight into the disorder of schizophrenia (Browne, Garavan, Gervin, Roe, Larkin & 
O’Callaghan, 1998). However, these authors do state that their population under investigation 
already maintained high levels of insight into the disorder, and a ceiling effect in gaining insight 
may have occurred.
Some researchers have undertaken to compare patient reports of quality of life with 
overall psychopathology, as well as the difference between negative and positive symptoms, and 
have found some significant results (Packer et al., 1997). The findings of this research indicate 
that level of psychopathology, as measured by the Brief Psychiatric Rating Scale total score for in­
patient schizophrenia patients, was negatively correlated with global life satisfaction and 
subjective quality of various life domains (see also Heslegrave, Awad & Voruganti, 1997; Kaiser et 
al., 1997), although not with objective evaluations of the same domains. In addition, negative 
symptoms were found to have a greater negative correlation on subjective measures of quality of 
life than positive symptoms. The impact of psychopathology on ratings of physical health, which 
are a component of quality of life, may again be implicated here. An explanation was provided for 
the finding that negative symptoms were more related to quality of life; the negative symptoms 
appear to exert a large impact on the patient and his or her experiences in part because they are 
often seen as not Treatable” and imply a more pejorative attitude towards the patient because the 
negative symptoms could be seen in some way as able to be altered. Negative symptoms also 
interfere more with basic aspects of functioning and thus potentially with satisfaction of one's life.
An extension to the concept of negative symptom presentation is that of the deficit 
symptoms or deficit syndrome which involves impairment in intrapsychic, interpersonal, and 
instrumental functioning. The deficit syndrome has been related to quality of life and is assessed 
in measures such as The Quality of Life Scale (Heinrichs, Hanlon, & Carpenter, 1984). This 
particular measure rates the person with schizophrenia on a variety of domains (i.e., sense of 
purpose, emotional interaction, social experiences, occupational role, possession of common
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
Functioning in Schizophrenia 25
objects) providing a score which reflects the individual's functioning, ranging from normal or 
unimpaired functioning to severe impairment on each of the domains in question. These authors 
assert a conceptual link between quality of life and the deficit syndrome, that they are inversely 
related. This measure is intended to be used by the clinician to make judgments about deficit 
symptoms, to register levels of change, and to describe the course of illness for the individual.
An important consideration regarding the impact of symptoms, especially the florid and 
unusual positive symptoms, on the life of a person with schizophrenia are the attributions a 
spouse makes about the etiology of the behaviors (Hooley, Richters, Weintraub, & Neale, 1987). 
When a spouse attributes the deviant behaviors as unintentional and involuntary aspects of a 
genuine illness, he or she is less likely to blame the patient for any difficulties in the relationship 
and this attribution will contribute to the marriage remaining intact. Thus it appears that not all 
symptoms are as salient or problematic for the families of individuals with schizophrenia as many 
professionals would believe.
Related to the impact of negative symptoms of the patient’s functioning and perception of 
his or her life is the effect of neuroleptic medications. Many patients report that a negative 
response to medications and a resulting “zombie-like” state leads to a perception of an inferior 
quality of life (Browne, et al., 1998), although the authors do caution that the patient's perceived 
response to the medications may actually instead be negative symptoms of schizophrenia.
In addition to the effects of psychopathology, the relationships between neurocognitive 
deficits and quality of life have been examined. Researchers have found that patients with 
schizophrenia perform poorly on tests of iconic memory via a backward-masking task, and frontal 
functioning, measured via the Wisconsin Card Sorting Task (Heslegrave, Awad & Voruganti,
1997). These same patients reported a compromised quality of life. Although both neurocognitive 
deficits and decreased quality of life were found, correlations between the two were nonsignificant 
or very weak. This led the researchers to conclude that quality of life is not related to
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neurocognitive deficits unless in extreme instances when the deficits are in basic rather than in 
higher cognitive functioning.
Issues such as symptom presentation and neurocognitive functioning appear to be 
important factors in the study of quality of life. These areas are domains of functioning that can 
often be readily assessed by clinicians and are relevant to successful community functioning. The 
present study examined these and other variables to better understand their impact on the quality 
of life of the person with schizophrenia.
Significant differences have also been found between inpatients and those living in the 
community in several areas. Patients living in the community consistently reported greater 
satisfaction in domains of general well-being, living situation, safety, mental health, and work, than 
patients who were hospitalized (Kaiser, et al., 1997). Contradictory results have been found in 
other research which determined that there were no differences in global assessments of the 
quality of life reported by these two groups, but that some differences on specific life domains 
were present (Grawe & Lovaas, 1994). These authors stated that outpatients more often report 
greatest dissatisfaction with their inner experiences and overall mental health. Inpatients tend to 
express the greatest dissatisfaction with their financial situation, low level of social contacts, and 
overall mental health. It is not surprising that both groups express dissatisfaction with their mental 
health, as this is the determining factor in much of their daily functioning and ongoing limitations.
When considering the issue of multiple respondents in the assessment of patient quality 
of life, it was found that different reports are provided by mental health professionals than those 
from patients with schizophrenia for particular life domains (Sainfort, Becker & Diamond, 1996). 
The two groups evidenced much agreement on areas of functioning, symptoms experienced by 
the patient, and overall physical health. Reports differed when considering social support and 
occupation. Providers rated the quality of each area as lower than the patients did themselves. In 
fact, the patients evaluated each of these areas as adequate in their own lives. This result raises 
the interesting question of whose point of view to consider when making these types of
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evaluations. It appears that either source will provide accurate judgments of the quality of clinical 
aspects of the patient’s life, but that the patient him or herself should be questioned regarding 
social aspects of their perceived quality of life. It was unclear to these authors why such a 
discrepancy would arise, although they did present some possibilities, including a greater patient 
knowledge of relevant factors, provider emphasis on clinical aspects of patient’s experiences, and 
patient focus on the social aspects of his or her own experiences. This relates to validity issues of 
both self-report, observer, and informant data which are always of concern in any assessment 
measure, especially those related to quality of life. This issue was addressed in the present study 
by using a measure that relies on patient report, of primary significant to ratings of satisfaction, 
and corroboration of more objective reports through an interview with a “current informant.” In 
addition, this study included the use of a “reliability” checklist for interview measures to indicate if 
particular responses were of questionable reliability.
A review of the literature has revealed that factors such as gender (Kaiser, et al., 1997; 
Lehman, Slaughter, & Myers, 1992) and levels of neuroleptic medication for those on medication 
(Kaiser, et al., 1997) apparently have no direct impact on the reported quality of life of an 
individual with schizophrenia. As noted previously, it does appear that a negative (dysphoric) 
subjective response to neuroleptic medication, rather than the actual level of the medication, is 
associated with diminished quality of life for persons with schizophrenia (Browne, et al., 1998).
Selection of quality of life assessments. Many different quality of life measures have been 
developed over the years, each with a particular focus and application to research and practice. A 
number of issues related to the selection of a specific quality of life assessment for research have 
been addressed by Lehman (1996). These are as follows:
1. The investigator must determine his or her particular purpose and needs before selecting a 
specific measure; this includes an operational definition of quality of life, means to measure 
the domains under consideration, ability to make comparisons to other relevant populations 
(other psychiatrically impaired, physically disabled, general population, economically
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disadvantaged, etc.), selection of a time frame (longitudinal or not) to study quality of life, and, 
the ability to apply quality of life results to interventions and evaluations with patients
2. The measure chosen should assess both subjective and objective domains of life
3. The assessment should be based upon a comprehensive quality of life model
4. The measure should be developed for or applicable to the population of interest
5. Training of administrators and time involved in the assessment must be considered
6. Consideration of the psychometric properties of the measure (e.g., reliability, validity, etc.) is 
important.
Another area of concern noted by the author includes the possibility of encountering floor 
effects with patients with schizophrenia, especially in role functioning domains such as spouse, 
parent, and employment roles. Researchers are also warned about the limited task perseverance 
and comprehension of psychiatric patients, recommending an interview format rather than pencil- 
and-paper measures to gather information.
Additional concerns regarding selection of a quality of life measure should also consider 
whether or not responses may be biased by patient psychopathology, whether it validly 
differentiates patients with different severity of illness (e.g., inpatient versus community living) and 
housing status (homeless versus domiciled), and whether the measure assesses symptoms that 
are nonredundant with the anhedonia common to depression (Russo et al., 1997). It was 
recommended by the authors (Lehman, 1996; Russo) that a researcher carefully select a quality 
of life assessment based upon the needs of the study and the specific characteristics of the 
measure.
Quality of life and the present study. The issue of quality of life has been demonstrated to 
be an important component in the assessment and treatment of psychiatric patients and it forms a 
central focus of the current research. This importance is especially evident in the outpatient 
treatment that many people with schizophrenia now receive and within the context of a move 
towards managed care and a greater emphasis on accountability of treatment organizations and
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agencies. With the rising cost of chronic illnesses such as schizophrenia, emphasis has shifted 
from merely prolonging life to actually enhancing the patient’s quality of life. The focus has also 
moved away from mere alleviation of symptoms. A primary emphasis of case managers and other 
outpatient treatment professionals is the quality of life of the patient and his or her ability to 
function adequately within the community. Through clinical management, quality of life 
assessments can theoretically provide information regarding a needs assessment, gaps in 
services, implementation and effectiveness of corrective measures, and focus on the patient’s 
potential return to a somewhat productive role in society (Awad & Voruganti, 2000).
Due to the importance of this potential clinical management, accompanied by the relative 
lack of comprehensive research involving quality of life assessments and their integration into 
clinical psychiatric care, quality of life has been a focus of this study. A number of other variables 
(communication, social adjustment, neurocognitive functioning, and symptom presentation) have 
been assessed to determine their relationships to both the subjective and objective quality of life 
reported by persons with schizophrenia.
The quality of life measure that was selected for inclusion in the present study is the 
Quality of Life Interview - Brief Version (QOLI; Lehman, 1988; 1996). This measure is intended to 
be used with the chronically mentally ill and assesses general quality of life rather than health 
related quality of life. The QOLI is focused predominantly on current levels of satisfaction, recent 
functional status, and access to resources. The main purpose of the QOLI is to assess life 
circumstances of patient populations both in terms of what the individuals actually do and their 
feelings about those situations. Thus it involves both an objective and a subjective assessment of 
quality of life. For the subjective assessment, patients are requested to utilize a life satisfaction 
rating scale consisting of ratings 1 = terrible through 7 = delighted. The Objective Subscales 
assess areas of living situation, daily activities, family relationships, social relations, finances, 
work-school issues, legal-safety issues, and health issues. The Subjective Subscales assess
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satisfaction with the same areas excluding daily activities, and instead include ratings of 
satisfaction with leisure activities and overall quality of life.
The effects of psychopathology and its biasing effects of self-report measures have been 
mentioned previously in this review. Conclusions have been drawn which implicate the role of 
symptom presentation and general health concerns much more than satisfaction ratings involved 
in quality of life (Lehman, 1983). In addition, Lehman’s research with the QOLI has concluded 
psychopathology does not impact quality of life ratings on this particular measure.
Initial studies on the QOLI were completed with patients in board and care homes, 
supervised community residences, and psychiatric hospitals. Research with the QOLI has shown 
differences between various groups and their quality of life. When considering community 
residents versus hospitalized patients, it was found that regardless of length of stay in the 
particular placement (community or hospital) the community residents more favorably rated their 
living conditions, had access to more financial resources, and were less likely to be assaulted in 
the past year then the hospitalized patients (Lehman, Possidente, & Hawker, 1986.) Factors that 
best predicted the quality of life of individuals with chronic psychiatric illness attending a day 
treatment program were found to be the number of admissions to the hospital in the past year, 
frequency of family contacts, satisfaction with social life, psychiatric health, and adult education 
(Levitt, Hogan, & Bucosky, 1990). In addition, of the patients in day treatment, those not of 
Caucasian race, and/or those with higher levels of anxiety and depression (as measured by the 
BPRS) rated their quality of life as significantly lower than other participants. A study discussed 
previously involving the QOLI indicated that seriously mentally ill patients who lived with family 
members in a very poor and rural area expressed significantly less dissatisfaction in all life 
domains except finances/income when they perceived high support from those family members 
(Sullivan, et al., 1991). Additional research involving the QOLI has determined that, with the 
possible exception of social relationships, there are no differences in the patient reports of quality
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of life between men and women with schizophrenia, and that this finding has proved true for 
populations in the United States, Canada, and Cuba (Vandiver, 1998).
A recent study involving the QOLI found that this measure of quality of life was less 
sensitive to change and treatment effect than other measures in patients with schizophrenia 
(Cramer, et al., 2000). The authors concluded that this could be a result of the highly symptomatic 
population under investigation and the tendency for these patients to experience extreme 
deprivation that results in a minimization of differences over time. They point out that patient 
responses to subjective questions on the QOLI might correlate poorly with rater assessments on 
other measures, which corresponds with arguments described previously made by Lehman about 
measurements of quality of life made by various sources. However, this study did determine that 
the QOLI question on global health-related quality of life was moderately to highly correlated with 
most other subjective scales, which indicates that this simple scale may be an accurate indicator 
of overall subjective quality of life. The authors concluded that the QOLI would be an appropriate 
measure for documenting either patient-rated status or objective manifestations of change in 
experiences, although it may be less likely to show significant change over time.
An alternative quality of life measure is the Quality of Life Inventory (Frisch, 1994), which 
includes a descriptive discussion of the construct of quality of life. This inventory is modeled after 
the Quality of Life Theory, which involves life satisfaction and subjective well-being and the 
integration of these factors into a theory of depression and other disorders. This self-report 
measure elicits responses from the individual regarding his or her satisfaction in sixteen areas of 
life, including love, work, and health. This measure was not chosen for inclusion in the present 
study because it does not involve both subjective and objective ratings of quality of life, the impact 
of psychopathology was unknown for this measure, and it is intended to be used more in 
evaluations of outcome and treatment response, which is not the focus of this research.
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Social Adjustment
Social adjustment and schizophrenia. Related to the interest in a patient’s quality of life is 
evaluation of the social and community functioning of that individual. Social adjustment is 
generally accepted to be the interactions between the person and his or her social environment 
and performance in social roles (Weissman, 1975). Like quality of life, the evaluation of social 
adjustment in mental health patients has developed in response to the number of patients now 
living in the community and the increased interest in the experiences and abilities of those 
individuals (Weissman, Sholomskas, & John, 1981). The consideration of social adjustment in the 
lives of patients with schizophrenia is especially relevant due to the oftentimes profound impact 
that the disease has on the social functioning of those individuals, even when they are relatively 
asymptomatic and medicated (Glazer, Aronson, Prusoff, & Williams, 1980). These individuals may 
experience difficulties with activities of daily living, social relationships, use of leisure time, 
occupational performance, and even the ability to make use of therapy and other interventions. In 
general, poor social functioning contributes to the social isolation, poor performance in social 
roles, and dissatisfaction with social interactions of individuals with schizophrenia.
Research has determined that individuals with schizophrenia are able to report their social 
adjustment accurately, as significant agreement has been found between the reports of patients 
and those of their significant others (Glazer, Sholomskas, Williams, & Weissman, 1982).
Gender differences have also consistently been reported in relation to social adjustment. 
Females tend to exhibit better premorbid social functioning and tend to survive longer in the 
community without additional relapse of symptoms. In addition, the social adjustment of males 
appears to deteriorate at a faster rate than that of females after the onset of schizophrenia 
(HSfner, et al., 1998; Moriarty, et al., 2001).
Social adjustment can be seen as measuring similar constructs to those tapped by quality 
of life measures when one considers factors such as social and family relationships, occupational 
functioning, and leisure activities. However, quality of life looks at broader areas of functioning
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than just social interactions and often includes the individual’s satisfaction with these numerous 
areas.
There has been much speculation about the interaction between symptomatology and 
social adjustment, as many have presumed that social functioning was a reflection of current 
psychopathology, especially those categorized as negative or deficit symptoms. However, 
research has revealed that social functioning is independent of severity of overall psychotic 
symptoms (Halford & Hayes, 1995) and that individuals with schizophrenia experience fairly 
significant social impairment regardless of their level of negative symptoms (Bellack, Morrison, 
Wixted & Mueser, 1990).
Social adjustment and the present study. Assessments of social adjustment are regularly 
made as part of providing services to patients with schizophrenia and is also a significant interest 
in the research of psychotic disorders. Because a measure of social adjustment was available for 
this project, social adjustment had been added as another variable of interest.
The Social Adjustment Scale II (SAS-II; Schooler, Hogarty, & Weissman, 1979) is a scale 
that was designed specifically to assess the social adjustment of patients with schizophrenia. The 
SAS-II was modified from the SAS-I (Paykel, Weissman, Prusoff, & Tonks, 1971), a scale that 
assessed the social functioning of depressed individuals, but did not take into consideration 
important concerns of those persons with schizophrenia, such as unemployment, lack of spouse 
and children, special living arrangements, and impaired skills of daily living. The time period of 
interest in assessment with this measure is the preceding two months. The SAS-II consists of 52 
questions that are asked within the context of a semi-structured interview by a trained rater. This 
measure takes 45 minutes to one hour to complete.
The SAS-II assesses the areas of work role, relationship with a principal (primary) 
household member, conjugal and nonconjugal sexual adjustment, romantic involvement, parental 
role, extended family relationships, social leisure activities, and personal well-being. Each area of 
interest includes ratings of performance at expected tasks, interpersonal relations, friction, and
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satisfaction in the roles. Ratings for these items are made on a 5-point scale, with higher numbers 
indicating greater impairment in the area being assessed. Five global ratings are also completed, 
to assess areas of work and daily responsibilities, relationship with primary household member, 
relationship with external family, social leisure activities, and general adjustment. Ratings of most 
specific items were based upon the reports of the study participants and their descriptions of their 
social roles and interactions with others. Interviewers are instructed to focus their ratings on the 
global items by comparing the participant to the adjustment of a “normal” person (i.e., one without 
mental illness) within the community and considering community norms and standards rather than 
knowledge of the individual’s adjustment or comparisons to other patients. For the purposes of 
this research study, only the global ratings will be examined.
Language Production
Language production and schizophrenia. Language errors and deviances are common in 
the speech of individuals with schizophrenia. The concept of thought disorder in schizophrenia 
was emphasized by Kraepelin’s (1919,1971) descriptions of abnormal communication, and in 
Bleuler’s (1911,1950) conceptualization of schizophrenia with his identification of “associative 
loosening” as the characteristic symptom of the disorder. Although thought disorder has continued 
to be considered pathognomic of schizophrenia, Bleuler's vague description of associative 
loosening and the more recent finding that thought disorder is present in disorders other than 
schizophrenia (Andreasen, 1979b; Harrow, Silverstein, & Marengo, 1983), has changed the 
course of research on the topic.
Some past researchers postulated that there was a “schizophrenic language” common to 
all patients, and that if one could learn this language, one would be able to communicate with 
persons with schizophrenia. This has been disputed by studies that have shown that persons with 
schizophrenia tend to respond to associations in fairly idiosyncratic ways, and that there is very 
little commonality in associations among persons with schizophrenia (Sommer, Dewar, &
Osmond, 1960)
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A significant amount of past research has focused on the attempt to identify a 
fundamental and underlying deficit for language disturbances, and when assuming that language 
reflects underlying thought patterns, for thought disturbances (Maher, 1972; McGrath, 1991).
Thus, studies have focused on specific aspects of thinking disturbances, such as concreteness 
and overinclusion in concept formation, idiosyncratic thinking and looseness of associations in 
cognitive focusing, and, overgeneralization and circumstantiality in reasoning (Johnston & 
Holzman, 1979; Maher, 1972; Pavy, 1968). However, it has become more evident over time that 
thought disorder varies across a continuum ranging from slight slippage, as sometimes seen in 
normal speech, to extremely deviant verbalizations, and that any given individual may exhibit 
varying degrees of thought disorder over time (Andreasen, 1979a; Chapman, Chapman, & Miller, 
1964)
The DSM-IV-TR (2000) characterizes the speech of patients with schizophrenia as 
disorganized via speech behavior such as frequent derailment (ideas “slip off the track” onto one 
another and appear to be unrelated or only vaguely related) or incoherence (speech that is 
incomprehensible or seemingly random). Most clinicians will agree that the communication 
disturbances observed in the speech of these individuals are an integral component in the 
identification and diagnosis of schizophrenia.
As discussed earlier, the concept of thought disorder is related to language and 
communication in schizophrenia. The idea of thought disorder has been plagued in the past with 
the absence of any agreement as to its definition, although the concept has been present in the 
literature for an extended period of time. Different conceptualizations of thought disorder have 
involved reasoning, concept formation, set maintenance, and abstraction of thought. This has 
shifted with the conceptualization of thought disorder as being composed of or at least manifested 
as an observable language disturbance that could involve any of eighteen different language 
behaviors considered to be subtypes of thought disorder (Andreasen, 1979a). These behaviors 
are poverty of speech, poverty of content of speech, pressure of speech, distractible speech,
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tangentiality, derailment, incoherence, illogicality, clanging, neologisms, word approximations, 
circumstantiality, loss of goal, perseveration, echolalia, blocking, stilted speech, self-reference, 
and paraphasias (use of wrong words or using words in wrong or senseless combinations), both 
phonemic and semantic.
A number of researchers (Barch & Berenbaum, 1996; Docherty, Hawkins, et al., 1996) 
state that multiple language production processes are associated with thought disorder and 
communication disturbances in schizophrenia. These processes include discourse planning, 
encoding of information, monitoring speech, editing own speech for errors, and articulating ones 
own speech. Barch and Berenbaum (1996) studied a variety of language production tasks and 
found that common errors in schizophrenic speech were associated with specific processes. 
Increased referential errors (vague or unclear references) were associated with impaired 
discourse planning on a story-telling task. Greater word approximations (use of an existing word in 
a new and unconventional way or development of a new word used in an understandable way) 
and neologisms (creation of a completely new word with no understandable derivation) were 
associated with decreased grammatical and phonological encoding on a speech error induction 
task. What these authors termed derailment-non sequiturs (ideas within spontaneous speech that 
are obliquely related or completely unrelated) were associated with decreased performance on a 
reality monitoring task.
The authors concluded that thought disorder is multidimensional and that the variety of 
tasks used measured different aspects of language production because they were associated with 
different speech errors. Factors such as general verbal intelligence and medication effects were 
explored and were not related to the results. The authors clarified that theirs was only a 
correlational study and did not conclude that language production deficits cause thought disorder.
An alternative theory of the communication disturbances evidenced by patients with 
schizophrenia is that the patients exhibit deficits in general cognitive processes of working 
memory and sustained attention rather than thought disorder or specific language production
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
Functioning in Schizophrenia 37
difficulties (Docherty, Hawkins, et al., 1996; see also Saykin, et al., 1994). Results supporting this 
theory have been seen in the performance of patients with schizophrenia when compared with 
those with bipolar and nonpsychiatric control subjects (Docherty, Hawkins, et al.). Tests of verbal 
fluency, concept formation, working memory, and attention were completed by these subjects. 
Results revealed that the persons with schizophrenia performed significantly worse than the 
control subjects. The mania group was no different from either the schizophrenia or the control 
groups. Specifically, reference performance was associated with general working memory and 
sustained attention, but not with concept formation or verbal fluency. Opposite results were found 
for the bipolar and normal control groups, in other words that verbal fluency and concept formation 
were associated with reference errors. Severity of illness was examined and was not related to 
the results. These researchers conclude that errors for the patients with schizophrenia are caused 
by general cognitive processes rather than specific language production processes.
The debate whether language errors are due to cognitive processes or specific language 
production processes is ongoing in the literature. It is unclear at this time which theory is correct, 
or whether both have an impact on language errors. This study will assess communication 
disturbances (which are related to discourse structure, linguistics, and specific language 
processes) and neurocognitive functioning in hopes of shedding additional light on this topic.
Language errors exhibited by patients with schizophrenia are common in the area of 
general verbal fluency, involving both letters and words, or categories. Kuperberg, McGuire and 
David (1998) presented patients with schizophrenia having thought disorder, those without 
thought disorder, and normal subjects with verbal fluency tasks to produce words beginning with a 
specific letter or to provide examples of specific categories. The results of a portion of the study 
revealed that patients with schizophrenia performed significantly worse than the normal subjects, 
and within the schizophrenia group those having thought disorder were more impaired than those 
not having thought disorder. Common errors were production of an alternative form of the same
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word, repetitions, perseverations, neologisms, and associations to other stimuli. It was noted that 
these are common errors produced by patients with schizophrenia in less formal tasks as well.
A concerted effort has been maintained in the literature to differentiate schizophrenia from 
aphasia, because at times the language productions of individuals in both groups are similar. One 
study examined both patients with schizophrenia having a formal thought disorder and those with 
aphasia (Faber, et al., 1983). The results revealed that the two groups were essentially the same 
in the frequency of neologisms and paraphasias (mispronunciation of a word because sounds 
have slipped out of sequence or substitution of an inappropriate word in an effort to say something 
specific). The patients with aphasia evidenced significantly more poverty of speech content, 
anomia (word finding problems), and decreased auditory comprehension. Those with 
schizophrenia produced significantly more word approximations, derailment, and tangentiality 
(response to a question in an oblique or even irrelevant manner). The authors reported that most 
errors in classification arose in the misidentification of aphasia patients as having schizophrenia. 
They concluded that a difference in verbal productions of individuals with schizophrenia and 
aphasia can be seen, even though a large overlap exists between the two groups.
The speech of patients with schizophrenia has been found to differ from that of other 
groups when considering syntactic properties of the speech (Fraser, King, Thomas & Kendell, 
1986). individuals with schizophrenia were found to be significantly different than those with mania 
as well as normals. The schizophrenia groups showed decreased complexity of speech, 
decreased number of well-formed sentences, increased syntactic and semantic errors, and 
increased dysfluencies. Steps were taken to control for medication effects within this study. These 
authors concluded that the psychotic illness of schizophrenia is reflected in linguistic features 
even if the disorder is not necessarily a primary language dysfunction.
Similar results were found when patients with schizophrenia are separated into those with 
chronic and those with acute forms of the disorder (Thomas, King, Fraser, & Kendell, 1990). 
Analysis of symptom measures revealed that positive symptoms predominated for patients with
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acute schizophrenia, while those in a more chronic state evidenced both positive and negative 
symptoms. Analysis of syntactic properties of schizophrenic speech revealed that the language 
productions of the chronic group were significantly worse than the other two groups, while the 
acute patients evidenced performance between the chronic and the control groups. Overall, 
individuals with chronic schizophrenia evidenced less fluency, more errors and less complexity in 
their speech. When separating hospitalized and community patients in this study, it was found that 
the performance of hospitalized patients was less complex and less fluent than those in the 
community. Symptom severity had been controlled for, and it was determined that the poorer 
performance of hospitalized patients was not due to severity of symptoms at the time of testing. A 
three year follow up to this research project (King, Fraser, Thomas & Kendell, 1990) found that the 
language of patients with schizophrenia had become more impoverished and degraded overtime 
even though the patients' symptoms were in remission. Further study showed that this 
degradation was not due to medication effects, a prolonged hospital stay, nor to patient relapse 
because patients with schizophrenia still evidenced decreased complexity and fluency over time 
when compared to previous ratings. This deterioration was not seen in persons with mania 
because at follow up they appeared essentially normal in their language productions.
Language production and the present study. The preceding review has indicated that 
language disturbances are common in persons with schizophrenia and are considered to be an 
integral component in the identification and diagnosis of schizophrenia. These language 
disturbances have included both clinical aspects of language, noted in the observations of 
Kraepelin (1919,1971) and Bleuler (1911,1950), and more technically-defined and measured 
linguistic aspects of language. Each area, clinical and linguistic, are relevant to the study and 
understanding of schizophrenia. Due to the importance and prevalence of language disturbances 
in people with schizophrenia, this construct has been included in the present study. Unclear 
references, a subtype of language disturbance and one periodically seen in the speech of non-
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patients, was considered in conjunction with the variables of quality of life, social adjustment, 
neurocognitive functioning, and general symptom presentation.
The concept of unclear references considers language disturbance with a more specific 
and scientific focus and allows the researcher to tap into the linguistic components of natural 
language within the context of the clinical aspects of the speech. The study of unclear references 
has provided valuable information about the relationships of these language disturbances with the 
other variables of interest of this study and contributed to a literature that contains relatively little 
information relating unclear references to other domains of functioning.
The Communication Disturbances Index (CDI) was developed as a measure of natural 
language that would specifically assess the level and type of communication disturbances 
evidenced in the speech of psychotic patients, even with subtle instances of communication 
failure (Docherty, DeRosa & Andreasen, 1996). The CDI focuses specifically on failures of 
communication rather than on signs of underlying thought disorder or disturbances of language 
structure. As such, it measures failures in the transmission of meaning from one person (the 
speaker) to another (the listener). Thus, vague words or incorrect usage of words are not 
measured unless they confuse or otherwise impede the meaning of the statement. The CDI 
involves a wider and more inclusive index of communication disturbance than other commonly 
used measures such as the Scale for the Assessment of Thought, Language, and Communication 
(TLC; Andreasen, 1979a, 1986) which focuses on specific examples of language behaviors that 
contribute to formal thought disorder. Docherty and her research group based the development of 
the CDI on the theory that communication disturbance, or a failure in the transmission of meaning 
from speaker to listener, is the hallmark of schizophrenia and other psychotic disorders. The idea 
of communication disturbance implies that the patient speaks and uses words or phrases in such 
a way that the meanings are not socially shared with the listener(s).
The CDI is focused on the concept of “the unclear reference” which refers to unclarity of 
meanings in speech. These unclear references are: (1) vague references, (2) confused
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references, (3) missing information references, (4) ambiguous word meanings, (5) wrong word 
references, and, (6) structural unclarities. The CDI is more inclusive than other scales because it 
includes instances of very subtle unclear meanings, considers violations of “common knowledge” 
as unclear references, takes into account unclear meanings of any word or phrase rather than 
only nominals and pronominals (as seen in other scales), and includes instances of faulty word 
usage or grammatical structure that precludes the clarity of speech meaning.
It is for these reasons that the CDI was selected for inclusion in the present study. The 
unclear reference is a construct that is periodically seen in the speech of normal subjects and is 
easily noticed by the listener in most situations. Thus, this measure tends to capture even low 
levels of communication disturbance and provide more detailed analysis when applied to the other 
variables of interest in this study (quality of life, social adjustment, neurocognitive, symptom, and 
demographic). The unclear reference language disturbance is one which affects individuals with 
schizophrenia in their daily interactions with others and can be applied through the interventions 
that are done with persons with schizophrenia via managed care and case management. All six of 
the communication failures were considered as part of the current study, specifically because 
each type of failure exhibits a different sort of unclarity in speech. A Total Communication 
Disturbance rating is also obtained by summing the six unclarities.
Initial research with the CDI has shown a number of differences between healthy persons 
and patients with mania or schizophrenia (Docherty, DeRosa, et al., 1996). It was found that the 
total number of words produced was greatest within the mania group, followed by the healthy 
group, then the schizophrenia group. Overall, the two patient groups (mania and schizophrenia) 
were equivalent and exhibited significantly more unclear references than the healthy persons in all 
areas, although the group with schizophrenia did evidence a greater frequency of vague 
references than the mania patients.
Three of the six types of disturbances (missing information references, ambiguous word 
meanings, and structural unclarities) have shown to be more prevalent in the speech of relatives
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of patients with schizophrenia and may be potential indicators of genetic vulnerability to the 
disorder (Docherty & Gottesman, 2000). In addition, these three communication disturbances 
have also been found to occur even more frequently in the speech of the patients themselves than 
in their relatives. Of these three disturbances, missing information references were found to be the 
most “schizophrenic” in quality and are speculated to be associated with specific cognitive 
weaknesses, although this connection is not well understood and needs to be studied in more 
detail.
Exploration of these communication failures exhibited by patients with schizophrenia and 
their potential cognitive origins has recently been completed. Initially, research indicated that 
patients with schizophrenia exhibited significant numbers of communication failures and that these 
were associated with both deficits in immediate auditory memory (as measured by a digit span 
task) and distractibility (involving a distracter voice) on the same task (Docherty & Gordinier,
1999). Follow up research expanded on these results (Docherty, Hall, Gordinier, & Cutting, 2000) 
when it was found that four of the communication failures (grammatical unclarities, confused 
references, missing information references, and ambiguous word meanings) were significantly 
related to conceptual sequencing as measured by a conceptualization test in which the subject is 
required to analyze a series of items and add to the series with the next sequential item. In 
addition, each of these four failures was also associated with a specific combination of other 
cognitive abilities, sustained attention (as measured by a computerized visual continuous 
performance task), immediate memory (as measured by a digit span test), and organization and 
sequencing (as measured by a trail making test). Confused references were associated only with 
deficits in immediate memory. Missing information references were associated with deficits in 
sustained attention and organization/ sequencing. Ambiguous word meanings were associated 
with deficits in sustained attention and organization/sequencing. Finally, grammatical unclarities 
were associated with deficits in immediate memory and organization/sequencing. These results
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support the theory that communication disturbances do have some connections to specific 
cognitive abilities, at least to some extent.
Additional research has been completed considering the impact of affectively positive and 
negative topics on communication disturbances utilizing the CDI. Docherty and Hebert (1997) 
found that CDI scores for patients with schizophrenia were significantly higher in the affectively 
negative than in the positive condition. When specific communication disturbances were 
considered, vague references, confused references, and ambiguous word meanings were found 
to be most affected by the affectivity of the topic. When utilizing scores from the TLC to assess for 
formal thought disorder, the authors found that there was a significant increase in positive thought 
disorder ratings in the affectively negative condition but no change in negative thought disorder. 
Patients with schizophrenia have been found to be reactive to affectively-laden material 
(Docherty, Hall, & Gordinier, 1997). Although normals did exhibit some reactivity, patients with 
schizophrenia were found to evidence much more disturbances in speech when discussing 
negative topics.
Neurocognitive Functioning
Neuropsychology and schizophrenia. Neuropsychology is generally accepted to refer to 
the study of the relation between brain function and behavior of the individual, with a specific focus 
on the behavioral expression of brain dysfunction (Keefe, 1995; Lezak, 1995). In clinical practice, 
neuropsychology has allowed professionals to determine the location of disease or damage to the 
brain as well as the abilities of the individuals in treatment. The areas of functioning traditionally 
assessed through neuropsychological assessment are: attention, higher cognitive and executive 
functioning, motor and perceptual skills, spatial abilities, affect, language, memory, and intellectual 
ability (Lezak). Such assessments are becoming much more common and this practice is no 
longer reserved only for patients with brain injury.
Benefits of neuropsychological assessment with psychiatric patients are diverse (Keefe, 
1995). An assessment can provide an objective indication or description of the patient’s mental
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functioning as well as his or her cognitive and behavioral abilities and weaknesses. The results of 
an assessment can assist in predicting the course of the illness and potentially improve diagnostic 
classification while contributing to the development of individual treatment strategies and 
interventions. The author cautions that poor performance on a single test or measure does not 
necessarily indicate a specific deficit because a number of other factors may be involved, such as 
motivation, difficulty of the task, symptoms of the illness, impaired memory, and, medication 
effects. Corroborating evidence should always be sought. One must also be aware that a specific 
deficit does not necessarily indicate dysfunction in a specific brain region because the complexity 
of the task and damage in other areas may affect the region of concern. In the study of 
schizophrenia, considering alternative applications of neuropsychological assessment such as 
those discussed above is especially important because a summary of previous research has 
determined that there is no conclusive evidence for the presence of a specific lesion indicative of 
schizophrenia (Levin, Yurgelun-Todd & Craft, 1989). In addition, a review of fifteen longitudinal 
studies (with at least follow up at one year) found that neurocognitive functioning of patients with 
schizophrenia did not decline over time (Rund, 1998).
As a result of the findings that cognitive functioning is stable over time, that no one 
specific lesion is indicative of schizophrenia, and no typical deficits are to be expected with 
schizophrenia, an understanding of the patient’s individual functioning is needed. Once this 
individual pattern of neurocognitive functioning is established, it can be applied to other areas of 
interest, such as those involved in this study (psychiatric symptoms, social adjustment, 
communication disturbances, and quality of life) to see what relationships exist and to determine 
patterns in outcome. Specific domains of neurocognitive interest for this research included 
attention and concentration, verbal fluency, verbal memory, general mental, and higher cognitive 
functioning. A review of each of these domains and research involving neurocognitive variables, 
schizophrenia, and outcome follows.
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Neurocognitive functioning and schizophrenia research. Researchers are in agreement 
that schizophrenia is associated with neurocognitive deficits in a number of areas of functioning. A 
review of the research was provided in a meta-analysis of 204 studies involving 7420 patients with 
schizophrenia assessing 22 neuropsychological test variables (Heinrichs & Zakzanis, 1998). The 
goal of the research was to estimate the consistency, strength, and selectivity of neurocognitive 
deficits in schizophrenia relating to most neurocognitive tasks in common use today. The authors 
concluded that neurocognitive impairments are a reliable finding in schizophrenia but that no one 
test and its indicated deficits are completely indicative of schizophrenia. The authors instead 
argue that neurocognitive deficits are not defining characteristics nor central to the illness, but 
rather secondary to other processes within the disease. Results are presented according to areas 
of functioning.
The authors concluded that for memory, defective total verbal learning over trials is a 
reliable finding in schizophrenia. Problems with verbal memory are related to a number of the 
language disturbances discussed in the previous section. The finding of decreased verbal learning 
was replicated with more specific indices of verbal memory such as rate of forgetting or savings 
after a delay. Nonverbal memory evidenced the same conclusions, but with more heterogeneity in 
the results. Executive functioning revealed a moderately large and reliable impairment. More 
specifically, performance on the Wisconsin Card Sorting Test (WCST) was significantly 
associated with IQ as measured by the Wechsler Adult Intelligence Scale, Revised (WAIS-R). 
Within general intellectual ability, a greater sensitivity was found with the WAIS-R than other 
measures of IQ. Impairments of intellectual functioning of patients with schizophrenia were large 
and reliable when the WAIS-R was used. A modest discrimination was found between patients 
with schizophrenia and normal controls on measures of attention. Tests such as ones like the 
continuous performance test and Trail Making Test were equally sensitive. In addition, no 
difference was found between the performance on Trails A and Trails B. Several of these domains 
were studied in the present study and relationships between the different domains were
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examined. The domains of interest included verbal memory, verbal fluency, higher cognitive 
functioning, general mental abilities, and attention.
A moderately large and reliable unilateral deficit was found with motor functioning. When 
considering tactile transfer of information a large effect was found, but the results were very 
heterogeneous across patients. A moderately large effect was found between the spatial ability of 
individuals with schizophrenia and those without. These findings were presented with caution 
because spatial ability is not often studied in schizophrenia research and only a few studies were 
considered.
The assessment of language functioning through neurocognitive measures is important in 
the understanding of how language deficits impact other neurocognitive abilities and functioning in 
various areas of their life. At a gross level, language in the context of neuropsychology refers to 
comprehension, fluency, repetition, and naming. Assessment of neurocognitive abilities in the 
domain of language functioning allows the clinician to understand the individual’s brain functioning 
as expressed by language behavior. Assessment of language functioning revealed that large 
effects in the impairment of patients with schizophrenia are found in language, as measured by 
the Controlled Oral Word Association Test, a test of verbal fluency, and the Token Test, a test 
involving oral commands to the individual to manipulate ‘‘tokens'’ of various colors and sizes. 
Moderate effects were found for a variation of vocabulary test, although there was no difference 
between the WAIS-R Vocabulary subtest and other measures of vocabulary. Medication effects 
were found with these results as a significantly larger impairment on verbal fluency is found in 
those individuals who are taking greater doses of medications. These specific deficits in language 
functioning can again be tied to the discussion in the preceding section about language 
disturbances and the communication of persons with schizophrenia. This literature in some 
aspects overlaps with that specific to language, but in no way replaces the research done 
primarily in the domain of language disturbances. The domain of verbal fluency was also under 
consideration as part of the present study.
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The authors assert between 61 and 78% of individuals with schizophrenia exhibit some 
neurocognitive deficit(s). They related that the evidence shows a number of patients with 
schizophrenia are neurocognitively normal, but that most have some deficit(s) and often they are 
more impaired than some individuals with neurological disorders. The best indicators of 
impairment in people with schizophrenia were determined to be the score of global verbal 
memory, Performance IQ and Full Scale IQ on the WAIS-R, scores from the CPT, and word 
fluency. The measures with the least ability to differentiate were the Block Design and Vocabulary 
subtest from the WAIS-R, and IQ scores derived from non-WAIS-R measures. As previously 
noted, the domains of verbal fluency and general mental ability were included in the present study.
Similar findings have been presented which reflect a generalized deficit in schizophrenia 
(Dickerson, Boronow, Ringel, & Parente, 1996; Heaton et al., 1994; Jeste, et al., 1995; Perlick, 
Mattis, Stastny, & Teresi, 1992). However, different conclusions have been drawn regarding 
specific impairments in persons with schizophrenia. Specific selective deficits for both in-patients 
and out-patients have been found to be in semantic memory, visual memory and verbal learning, 
while little if any impairment has been found in abstraction/flexibility, verbal intelligence, attention 
and motor skills (Saykin, et al., 1991). Other conclusions have indicated that out-patients with 
schizophrenia evidence impairments on tasks of efficiency, attention, auditory discrimination, 
learning, incidental memory, fine motor coordination, and sensory perceptual skill, while 
performance equivalent to normal controls is seen on tasks of forgetting, aphasia screening, 
spatial relations, and motor speed (Braff, et al., 1991).
A review of the literature that did not involve any quantitative meta-analysis of the findings 
supports these findings (Levin, et al., 1989). In general, individuals with schizophrenia were found 
to have significantly lower global performance scores than brain-damaged patients. No 
comparisons to normal controls were provided. Overall, deficits in performance were seen more 
with chronic schizophrenia than acute schizophrenia. Specific indications were provided for 
several of the separate areas of functioning. Memory was found to be especially impaired in
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severely disturbed patients with schizophrenia. Attention was found to differ across classifications 
of schizophrenia. When considering subtypes of the disorder, those with non-paranoid 
schizophrenia evidenced greater impairments in attention than those diagnosed with paranoid 
schizophrenia. Both of these areas, verbal memory and attention, are constructs of interest in the 
present study. However, no analysis of subtypes was done for the current study. Symptomatology 
also influenced attentional performance, in that patients with predominantly negative symptoms 
were more impaired than those with predominantly positive symptoms (see also Lieh-Mak & Lee, 
1997). Basic language functions such as naming and repetition were intact for patients, but 
difficulties were found in language behaviors involving semantic content, discourse, and complex 
language. This has been discussed in more detail in the language disturbances section above. 
Visual and verbal affective processing were impaired in patients with schizophrenia and those with 
predominantly negative symptoms exhibited specific deficits in conveying vocal affect to others.
Further evidence for the differentiation of neuropsychological performance in individuals 
with schizophrenia based upon symptom classification has been presented (Green & Walker, 
1985). Individuals with predominantly negative symptoms showed significant impairment on visual 
motor and visual spatial tasks, such as the Block Design subtest of the WAIS-R. Those with 
predominantly positive symptoms showed significant impairments on short-term verbal memory 
recall tasks while their performance on recognition tasks was not impaired. Exploration of the 
relationship between neurocognitive functioning and symptom presentation was undertaken as 
part of the current study.
A comprehensive review of the literature has concluded that positive symptoms tend to be 
associated with deficits in auditory information processing and self-monitoring, while negative 
symptoms tend to be associated more with deficits in visual and motor skills (Strauss, 1993). The 
author summarized recent reports that included recommendations that neurocognitive research 
focus on the analysis of individual symptoms rather than symptom dimensions (e.g., positive and 
negative symptoms). This is due to findings that individuals with hallucinations tend to have
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difficulty with discriminating the source of information and persons with delusions tend to have 
difficulty with inferential thinking and dysfunction with perceptual processes.
Some confusion between older patients with schizophrenia and individuals with 
Alzheimer's Disease (AD) arises due to impaired memory evidenced by each group. Relatively 
little is known about the interaction between the disease process of schizophrenia and the effects 
of aging. A question in the literature is whether schizophrenia continues later in development or if 
diagnoses of late-onset schizophrenia should actually be AD. A hallmark of AD is the rapid 
forgetting of recently learned information (Lezak, 1995), whereas in schizophrenia the memory 
difficulties appear to stem from inefficient learning with intact remembering of what was learned.
Heaton, et al. (1994) engaged in a project to study memory performance in AD and 
schizophrenia. Ail participants were individuals living in the community, and were classified into 
groups as normal control, AD patients, or those diagnosed with schizophrenia. The patients with 
schizophrenia were further classified as early onset-still young, early onset-older, or late onset. 
Results indicated all patient groups (schizophrenia and AD) were within the normal range on Full 
Scale IQ and the Average Impairment Rating on the Halstead-Reitan Neuropsychological Battery 
(HRB), but were significantly lower than the normal controls. AD patients exhibited significantly 
lower Global Deficit Scores on the HRB than the control group or the three schizophrenia groups. 
The four patient groups performed worse than the control group on all measures except memory 
which was calculated as percent retention of information learned. Individuals with schizophrenia 
performed equally with the control group, while the AD group had a significantly greater learning 
impairment. No significant differences were found on any measures across the three 
schizophrenia groups. The authors conclude that neuropsychological impairment in schizophrenia 
is unrelated to current age, age at onset, or duration of the illness. In addition, they state that late 
onset schizophrenia is not just AD with psychotic features because the memory impairments 
measured with rapid forgetting were seen only in the individuals with AD and the deficits 
associated with schizophrenia were nonprogressive.
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Similar results have been found in other studies of late-onset schizophrenia (Jeste, et al., 
1995). Specifically, individuals with early and late-onset schizophrenia showed essentially equal 
performance to each other and lower performance than the normal controls on most 
neuropsychological tests. No differences were found between patients and the controls on 
delayed recall or memory, perceptual motor tasks and sensory abilities. Persons with late-onset 
schizophrenia did perform better than those with early-onset on the WCST and the California 
Verbal Learning Test. The authors conclude their results support the diagnostic validity of 
schizophrenia with onset after age 45.
Neurocognitive functioning and outcome in schizophrenia. Based upon the above 
discussion, it appears no debate is necessary regarding whether people with schizophrenia suffer 
from neuropsychological and cognitive impairments. The impact of these deficits on the daily lives 
of the patients is less understood. A review of the literature relating neurocognitive measures to 
functional outcome for individuals with schizophrenia has indicated several important 
consistencies in research (Green, 1996). The goal of Green’s review was to determine which 
neurocognitive impairments may restrict the functioning of patients with schizophrenia in the 
community. Functional outcome is defined as the result of competence in a large number of tasks. 
The domains of community outcome, social problem solving, and social skill acquisition are 
considered.
Results of studying community outcome have been quite variable, but several findings 
consistently emerge (Green, 1996). Secondary verbal memory and card sorting via the WCST 
both emerged as predictors of community functioning, each of which were also examined as part 
of the current project. Secondary verbal memory refers to memory for lists of words or stories and 
is usually assessed after a delay. This is in contrast to immediate memory, which is equivalent to 
short-term memory and is often assessed with measures such as the Digit Span. No relationship 
was found between psychotic symptoms and community outcome. Social problem solving was 
best predicted by secondary verbal memory and vigilance, measured by a continuous
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performance task. A relationship between negative, but not psychotic symptoms, and social 
problem solving was found. Primary and secondary verbal memory as well as vigilance were 
determined to be the most probable predictors of social skill acquisition. No relationship between 
symptoms, negative or psychotic, was found with social problem solving.
The author concluded that the WCST performance and secondary verbal memory, as 
measured by the Rey Auditory Verbal Learning Test (AVLT), a list learning task, or the Logical 
Memory I and II subtests from the WMS-R, measuring memory for paragraph length material, are 
the best predictors of functional outcome. Primary verbal memory and vigilance were determined 
to be moderate predictors of overall outcome. The lack of a strong relationship between functional 
outcome and symptoms was attributed to a number of potential influences. Symptoms may be 
more informative across diagnostic classifications where more variability in both symptoms and 
outcome are found rather than within the single diagnosis of schizophrenia. Not all symptoms are 
equally disruptive to outcome and some may preclude individuals from community life in general.
A primary indicator of outcome is occupational status, and it is important to note that not all job 
positions would be equally affected by symptoms and symptoms may be more tolerated in some 
positions than others. Regardless of these considerations, the author points out that several 
neurocognitive measures were consistently more associated with outcome than symptoms.
Outcome as assessed by social functioning has been examined in relation to 
neurocognitive functioning. Results indicate that verbal memory, overall verbal ability, and 
cognitive flexibility are associated with social problem solving (Addington & Addington, 1999; 
Addington, McCleary, & Munroe-Blum, 1998) as measured by an individual’s ability to assess an 
interpersonal social problem, then develop and implement a solution. These authors also 
determined that neither social functioning in the community nor quality of life (both areas 
considered in this study) were associated with neurocognitive performance. Similar results have 
been found which revealed that deficits in higher cognitive functioning, although quite prevalent in 
persons with schizophrenia, were not associated with reports quality of life (Heslegrave, et al.,
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1997). These authors did postulate that deficits in more basic areas of neurocognitive functioning 
would be associated with decreased quality of life.
The study of the relationship between occupational functioning and WCST performance of 
outpatients with schizophrenia has revealed that “task orientation” at work, better social skills, and 
higher levels of occupational functioning were significantly related to WCST trials to first category 
and total number correct (Lysaker, Bell, & Beam-Goulet, 1995). The authors present the idea that 
the WCST should continue to be used in neuropsychological studies of schizophrenia and 
focused attention should be placed upon the implications of results for vocational counselors and 
neuropsychological professionals. Contrasting results have been presented which indicate that 
the WCST was not helpful in predicting social or occupational functioning in outpatients, while 
performance on aphasia, spatial organization and visual spatial tasks were correlated with social 
functioning (Dickerson, et al., 1996).
Performance on WCST has also been associated with community tenure and avoiding 
hospitalization for individuals with schizophrenia. Poorer performance on the WCST predicted 
shorter duration of community life before a first rehospitalization better than did an individual's 
history of hospitalization (Lysaker, Bell, Bioty, & Zito, 1996). An explanation for the result posits 
that impairments in cognitive flexibility and reasoning are closely associated with difficulties in 
community life and compromise the individual's ability to function which limits adaptation to social 
situations and increases vulnerability to relapse.
Specific neuropsychological functions have been found to discriminate between 
hospitalized patients and those individuals living in the community. Although all patients overall 
evidenced mild to moderate impairment on all tasks, measures of motor coordination, initiation 
and perseveration as measured by the Dementia Rating Scale (DRS), a measure used to assess 
the changes that characterize senile dementia, and measures of memory and attention 
significantly discriminated inpatients from outpatients (Perlick, et al., 1992). Measures of 
conceptualization, language, somatosensory and oral association were not significant
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discriminators of hospitalization status. Most specifically, bilateral and nondominant hand Purdue 
Pegboard performance were the most clear discriminators, followed by the DRS initiation and 
perseveration scale and the DRS memory and attention scales.
Neurocognitive functioning and the present study. The previous section suggests that the 
study of neuropsychological abilities in persons with schizophrenia is still warranted, especially in 
considering factors such as functional outcome. The present study assessed a number of 
neurocognitive domains (attention/concentration, verbal memory, verbal fluency, higher cognitive 
functioning, and general mental ability) and examined their relationship with variables of quality of 
life, social adjustment, language production, and general symptom presentation. The 
neurocognitive domains examined by this study were ones in which individuals, such as case 
workers, are able to assess informally and are areas relative to good functioning within the 
community. This research explored the interactions between neurocognitive functioning and the 
other variables in this study, providing knowledge that will be helpful in providing improved care for 
persons with schizophrenia. Findings from recent research have revealed that neurocognitive 
deficits are more closely associated with quality of life if the deficits are in basic functioning rather 
than in higher cognitive functioning (Heslegrave, et al., 1997). A review of the literature has also 
indicated that impairments in attention (Landre & Taylor, 1995; Nuechterlein, Edell, Norn's, & 
Dawson, 1986) and reality-monitoring (Harvey & Serper, 1990) are associated with language 
disturbances. Exploration of higher cognitive abilities and attentional skills was undertaken as part 
of this study, and the relationships between neurocognitive abilities and indications of overall 
functioning, as measured by social adjustment and quality of life, were completed.
The Present Study
The constructs of quality of life and social adjustment, language production, 
neurocognitive functioning, and symptom presentation have been demonstrated to be important 
components in the assessment and treatment of psychiatric patients, yet their inter-relationships 
have not been studied extensively. A primary focus of mental health services and more
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specifically case management is the general ability of the person with schizophrenia to function 
adequately within the community. Domains such as the variables of interest to the present study 
relate to the ability of a person to interact and relate to other individuals in the community and 
otherwise function adequately.
An understanding of an individual patient’s functioning is needed in order to predict his or 
her ability to survive in the community and overall outcome. Very little research has been 
completed which considers together any of the different areas of interest for the present study. In 
particular, the study of quality of life has focused predominantly on outcome and symptom 
presentation, with little emphasis on neurocognitive functioning and no focus on language 
production. Findings from recent research have indicated that increased symptom presentation is 
associated with diminished subjective quality of life (Lehman, 1983; Packer, et al., 1997), and 
neurocognitive deficits are more closely associated with quality of life if the deficits are in basic 
functioning rather than in higher cognitive functioning (Heslegrave, et al., 1997). Some research 
has centered on the relationships between symptom presentation and neurocognitive functioning 
which have found that neurocognitive deficits are related to negative symptom presentation 
(Levin, et al., 1989; Lieh-Mak & Lee, 1997; Nuechterlein, et al., 1986). More specific evidence for 
the relationship between neurocognitive performance and symptom presentation has determined 
that negative symptoms are inversely related to visual-motor tasks, while positive symptoms are 
inversely related to verbal memory performance (Green & Walker, 1985).
The present study assessed variables of symptom presentation, quality of life (both 
subjective and objective), social adjustment, language production (specifically communication 
disturbances manifested through unclear references), and neurocognitive functioning (evaluated 
in the domains of attention/concentration, verbal memory, verbal fluency, higher cognitive 
functioning, and general mental abilities), to determine existing relationships and to discover 
patterns in outcome. The variables considered for this study are those which other individuals, 
such as clinicians and case workers, are able to assess informally and have been demonstrated
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to be areas of great importance for functioning within the community. This research examined 
relationships between each of the variables in this study which are relevant to both researchers as 
well as to professionals and case workers who provide care and intervention in hopes of 
improving community functioning for persons with schizophrenia.
Hypotheses
Based upon the research reviewed regarding each of the different variables of interest for 
the study, a number of findings were predicted. In some cases these were only speculative, as a 
number of these areas had not been studied specifically in relation to one another in the past, or 
else research had addressed them only in an oblique manner. Several preliminary hypotheses 
were omitted due to insufficient numbers of participants in some groups to make analyses. These 
include exploration of the differences in functioning between males and females, exploring 
differences between those who live in rural and urban areas, and comparisons between inpatients 
and those persons living in the community. In addition, as the measure of social adjustment 
became available for this research, global ratings of social adjustment were added as variables as 
data collection was coming to an end. General hypotheses involving the social adjustment 
variables were intended to be similar to those of the quality of life assessment, as they in some 
ways measure similar constructs and can both be used as outcome measures. Social adjustment 
was expected to correlate negatively with overall symptom presentation, correlate positively with 
neurocognitive functioning, and correlate positively with ratings of quality of life.
The specific hypotheses for this study were as follows:
1. Overall symptom presentation would be negatively correlated with the measures of 
quality of life (1a) and neurocognitive functioning (1b).
2. Overall symptom presentation would be positively correlated with communication 
disturbances.
3. Negative symptoms would have a stronger negative correlation with quality of life (3a) 
and neurocognitive functioning (3b) than positive symptoms.
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4. Quality of life (objective) would be positively correlated with measures of verbal 
memory, attention, and higher cognitive functioning within the domain of neurocognitive abilities.
5. Participants would exhibit more ambiguous word meanings than other types of unclear 
references within the area of communication disturbances. The second most common form of 
communication disturbances will be missing information references.
6. Communication disturbances (unclear references) would be negatively correlated with 
performance in the specific neurocognitive domains of memory, attention, and verbal fluency.
7. Participants would exhibit greater deficits in the areas of verbal memory, word fluency, 
attention, and higher cognitive functioning than in general mental ability, the remaining domain of 
neurocognitive functioning.
8. Individual scores on the QOLI could be predicted from the other variables of the study.
Method
Participants
Participants were 55 patients diagnosed with DSM-IV (American Psychiatric Association,
1994) schizophrenia or schizoaffective disorder. The patients were recruited from the Minneapolis 
VA Medical Center (/? = 43), Hennepin County Mental Health Center (n = 5), or other programs 
within the community (n = 7) such as the National Alliance for the Mentally III of Minnesota, or the 
Tasks Unlimited program, which facilitates employment and provides other resources to persons 
with mental illness. Potential participants were screened with a medical history questionnaire 
either by review of their medical records or interview to exclude for the following: (a) current 
alcohol abuse, (b) current or past substance dependence or current substance abuse, (c) 
neurological illness or history of a medical condition with likely central nervous system effects, (d) 
history of head injury with skull fracture or loss of consciousness of greater than 20 minutes, (e) 
significant tardive dyskinesia (DISCUS score greater than 7), (f) history of Electro-Convulsive 
Therapy, (g) adoption, (h) mental retardation or charted IQ of less than 70, (i) being a non-native
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English speaker, and (j) being younger than 18 or older than 60 years of age. See Appendix A for 
Checklist for Exclusionary Criteria form that was used for the study’s initial chart reviews.
Most patients were medicated and had been receiving the same medications and 
dosages for at least two months prior to entrance into the study. As previously noted, subtypes of 
schizophrenia were not explored as part of this research study. Daily oral doses of antipsychotic 
medications were converted to chlorpromazine equivalents according to guidelines suggested by 
Bezchlibnyk-Butler and Jeffries (2001) for descriptive purposes. Depot doses were converted to 
average daily dosages using similar guidelines set by the same authors.
Materials
Chart review. After receiving permission to access medical records, a chart review (see 
Appendix B) was completed for each participant. The chart review included information about 
medical and psychiatric conditions and treatments, current psychotropic medications and 
compliance plus recent changes to medications, and current outpatient therapy. In addition, a 
record of hospitalizations was generated which included information about length of stay, location 
of hospitalizations, presenting issues, and discharge diagnosis.
Diagnostic Interview for Genetic Studies. To establish diagnosis, the Diagnostic Interview 
for Genetic Studies (DIGS; Numberger, et al., 1994) was completed with each patient by a trained 
rater at either a pre-doctoral or doctoral level. The DIGS is a semi-structured clinical interview that 
was developed for the differential diagnosis of mood and psychotic disorders and related 
“spectrum” disorders. The DIGS incorporates items which, when answered completely with 
sufficient detail and examples, can provide diagnoses through a variety of diagnostic systems.
The individual items included on the DIGS were derived from other structured interviews in order 
to be used with the various diagnostic systems. The authors have described a number of 
additional key features of the DIGS, including the extensive coverage of the course, chronology of 
symptoms, and comorbidity with other disorders, and algorithmic scoring capability of the 
interview results. This interview collects self-reported psychiatric history data that may be
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supplemented with additional medical record and relative information prior to determining the 
diagnosis. It is intended to be used by interviewers who employ significant clinical judgment, make 
ratings on symptoms, and utilize a narrative format to indicate additional information. The DIGS is 
designed for use in research settings that require a detailed and organized history of 
symptomatology since it is an interview that is not easily administered by lay interviewers or in use 
with cognitively disorganized individuals. As reported by the authors, reliabilities for the DIGS 
using computer-generated diagnoses based on algorithms (item scores that are evaluated in pre­
determined combinations to establish for which diagnoses criteria are met) were excellent, 
ranging from .73 to .96, except for schizoaffective disorder, for which disagreement on duration of 
mood vs. psychotic symptoms reduced reliability. See procedures section for a discussion of the 
present study’s inter-rater reliability for the DIGS.
A procedure often used in conjunction with the DIGS interview involves the rating of a 
series of 90 items that have been taken from the operational criteria for major clinical syndromes. 
This procedure allows the precise recording of signs and symptoms as an accurate method to 
establish a diagnosis. These rating are then entered into a computer scoring program that 
provides a diagnosis based on computer-scored algorithms. This program, the Operational 
Criteria Checklist (OPCRIT; McGuffin, Farmer, & Harvey, 1991) system, was developed to be 
used after a comprehensive diagnostic interview was completed and detailed information was 
obtained about the individual's psychiatric history. The OPCRIT has been found to provide 
convenient, reliable, easy, and valid psychiatric diagnoses according to a variety of diagnostic 
systems.
Diagnostic reliability between raters using the OPCRIT has been found to be very good, 
with coefficients between .69 and .78 for DSM-III-R diagnoses, the most recent system when the 
measure was first developed (McGuffin, et al., 1991). Item-by-item agreement, although less 
good, still achieved reasonable reliability despite the problem of low base rates for some items, 
with coefficients ranging from .34 to 1.0. A larger multicenter assessment found that the OPCRIT
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provided good reliability across a variety of geographical and theoretical backgrounds, with an 
inter-rater reliability coefficient of .73 for DSM-III-R diagnoses (Williams, et al., 1996). Concurrent 
validity was determined with comparisons between lifetime diagnoses generated by OPCRIT and 
consensus best-estimate diagnoses, with coefficients exceeding .80 for DSM-III-R diagnoses 
(Craddock, et al., 1996). Previous research on the OPCRIT has shown that independent 
clinicians having extensive experience with both the DIGS and the OPCRIT can make reliable 
diagnoses, providing a more structured procedure to establish best-estimate consensus 
diagnoses. Agreements between clinicians’ diagnoses and consensus diagnosis produced were 
excellent, with reliability coefficients ranging from 0.83 to 0.89 for DSM-III-R syndromes (Azevedo, 
et al., 1999).
Brief Psychiatric Rating Scale. To assess current symptomatology, the Expanded Version 
of the Brief Psychiatric Rating Scale (BPRS; Ventura, et al., 1993) was administered. This version 
involves the original eighteen items relating to patient symptom presentation and experiences of 
the BPRS (Overall & Gorham, 1962), plus an additional six items, all of which were rated for the 
period of one month preceding the assessment. The BPRS can be easily scored based upon 
interview information that can be gathered after engaging in any standard therapeutic session and 
possibly some direct questioning about behavior that is not elicited in the session. The BPRS 
takes only a few minutes to complete once familiarity with the items is established. Interrater 
reliabilities for the BPRS, using Cronbach's alpha, are very satisfactory, with r = .87 for the BPRS 
Total score (Bell, Milstein, Beam-Goulet, Lysaker, & Cicchetti, 1992). Specific factors for 
consideration in this study incorporated the factor structure identified by Ventura, et al., (2000) for 
the expanded BPRS. This structure incorporates symptom factors of Manic-Excitement, Negative 
Symptoms, Positive Symptoms, and Depression-Anxiety.
Global Assessment of Functioning. A judgment of each participant’s overall level of 
psychiatric functioning was made with the Global Assessment of Functioning (GAF) Scale as it is 
used with DSM-IV (1994) diagnoses. The GAF involves a clinician’s judgment of a patient's
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psychological, social, and occupational functioning at the time of the assessment. Scores range 
from 100 (superior functioning) to 1 (persistent danger of hurting self or others, inability to 
maintain minimal hygiene, or serious suicidal acts). The GAF provides detailed descriptions for 
each rating to assist in assigning a score for the individual. Reliability for the GAF has been found 
to range from .72 to .76, and it has been determined to be valid in relation to other measures of 
clinical need such as support time provided by staff and changes in neuroleptic medication 
(Jones, Thomicroft, Coffey, & Dunn, 1995).
Quality of life. The quality of life measure that was selected for inclusion in the present 
study is the Quality of Life Interview - Brief Version (QOLI; Lehman, 1988; 1996). This measure is 
intended to be used with the chronically mentally ill and assesses general quality of life rather than 
health related quality of life. The QOLI -  Long Version is a highly structured interview of 143 items 
that takes approximately 45 minutes to complete and can be administered by a trained nonclinical 
interviewer. The Brief Version takes approximately 15 minutes to complete, allows for the 
consideration of the same scales, and has psychometric properties comparable to the Long 
Version and moderate to high correlations between similar scales on each version (Lehman, 
Kernan, & Postrado, 1995). The Brief version was used in the present study. The scale is focused 
predominantly on current levels of satisfaction, recent functional status, and access to resources. 
The QOLI provides a general assessment of an individual’s life experiences in eight domains: 
living situation, daily activities and functioning, family relations, social relations, finances, work and 
school, legal and safety issues, and health. In addition, a global measure of life satisfaction is 
obtained at both the beginning and completion of the interview.
The main purpose of the QOLI is to assess life circumstances of patient populations, both 
in terms of what the individuals actually do and their feelings about those situations. Thus it 
involves both a subjective and an objective assessment of quality of life. For items which apply to 
the individual’s subjective quality of life, patients are asked to indicate their satisfaction using a life 
satisfaction rating scale consisting, as previously described, of ratings 1 = terrible through 7 =
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delighted. The Delighted-Terrible scale is presented to the patients on a continuum, with each of 
the ratings from one to seven accompanied by a computer-generated picture of a face with 
varying degrees of a smile or frown corresponding to the particular rating. Anchor-point 
descriptions for each of the ratings (1 through 7) are also provided.
Psychometric properties of the full version of the QOLI have been studied and are 
determined to be quite satisfactory with only a few ranges including statistics lower than ideal 
(Lehman, 1988). Internal consistency reliabilities reported by Cronbach's alpha range from .79 to 
.88 for the life satisfaction scales and from .44 to .82 for the objective quality of life scales. Test- 
retest reliabilities of one week have been found to range from .41 to .95 for the life satisfaction 
scales and from .29 to .98 for the objective quality of life scales. Large variations in the ranges for 
objective ratings may be a result of drastic changes in the individual’s life circumstances from one 
test session to the next, and were attributable mostly to ‘‘cohesion” and “independence” within the 
current living situation, specific areas that are assessed only by the full version of the QOLI. 
Construct and predictive validity have been deemed good by a variety of methods. The QOLI 
discriminates between patients with severe mental illness and persons in the general population, 
as well as hospitalized patients and those living in supervised community settings. These findings 
regarding the psychometric properties of the QOLI were replicated by other researchers studying 
a total of 981 acutely ill psychiatric inpatients (Russo, et al., 1997). The psychometric qualities of 
the brief version are comparable to the full version (Lehman, 1988).
Social adjustment The social adjustment measure that was available for this research 
project was the Social Adjustment Scale-ll (SAS-II; Schooler, Hogarty, & Weissman, 1979). The 
SAS-II is a semi-structured interview consisting of 52 items that takes approximately 45 minutes to 
complete. It is focused predominantly on performance at relevant tasks, interpersonal relations, 
friction with others, and satisfaction in the roles within the areas of work/daily responsibilities, 
relationship with a principal (primary) household member, conjugal and nonconjugal sexual
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adjustment, romantic involvement, parental role, extended family relationships, social leisure 
activities, and personal well-being.
The main purpose of the SAS-II is to assess the functioning of the individual within the 
given areas for the preceding two month period. Ratings for most items are made on a 5-point 
scale, with higher numbers indicating greater impairment in the area being assessed. Area means 
can be calculated from the scores on sets of individual items within each section. Five global 
ratings are also completed, to assess areas of work and daily responsibilities, relationship with 
primary household member, relationship with external family members, social leisure activities, 
and general social adjustment. Ratings on these global items are made on a 7-point scale, again 
with higher numbers indicating greater impairment. Interviewers are instructed to make these 
global ratings based upon comparison with persons generally found in the community in relation to 
community norms and standards, without regard to knowledge of the patient's earlier adjustment 
or expectations of mentally ill individuals.
Only the global ratings were used for the purposes of this study. The Work global rating 
takes into consideration the consistency and effectiveness of the individual’s work performance 
and completion of daily responsibilities in relation to his/her education, prior training, and 
experience. The Household Member global rating examines the relationship with the patient's 
primary contact within the household in terms of support, affection, and involvement with each 
other. The External Family global rating considers the relationship with family members outside of 
the home in terms of support, affection, and involvement with one another. The Social Leisure 
global rating evaluates the level and quality of social activities, and meaningfulness of interactions 
in social situations. The General Adjustment global rating takes into consideration the individual’s 
overall functioning, while considering performance in each of the social roles (work, parental, 
marital, etc.), interpersonal relationships, and personal comfort or well-being.
Psychometric properties of the SAS-II have been reported to be similar to those of the 
SAS, for which Pearson correlations were quite high, with a mean correlation of .83 (Weissman,
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Paykel, & Prusoff, 1993). The SAS-II has been found to have high agreement between patients 
and their significant others, as measured by a Spearman’s rank correlation coefficient of .98 
(Glazer, et al., 1982).
Language production. Language disturbances of each participant were assessed with the 
Communication Disturbances Index (CDI; Docherty, DeRosa, et al., 1996). This scale was 
developed with consideration of the concept of “the unclear reference” which refers to unclarity of 
meanings in speech. Definitions of each of the unclear references are provided within the scale 
along with several examples (see Appendix C). The six types of unclear meanings included in the 
CDI are Vague References, Confused References, Missing Information references, Ambiguous 
Word Meanings, Wrong Word References, and Structural Unclarities.
Speech samples for the CDI are obtained via an audiotaped semistructured interview 
lasting ten to fifteen minutes that is later transcribed for analysis. The topic(s) of this interview are 
intended to be ones unrelated to the diagnosis or treatment of the patient, but rather outside 
interests or hobbies of the individual. If a participant begins to talk about their diagnosis or 
treatment, they are redirected to discuss more neutral topics. In addition, the interviewer is 
instructed to speak as minimally as possible in order to obtain adequate speech samples from the 
participant. To control for different production rates of speech among the different experimental 
groups, the authors calculated the number of each type of communication disturbance per 100 
words of speech. Total CDI communication disturbance scores are computed by summing the 
numbers of each of the six subtypes per 100 words of speech. Thus each is a frequency rather 
than absolute score.
Initial research involving the CDI revealed that the psychometric properties are quite 
satisfactory (Docherty, Hawkins, et al., 1996). The inter-rater reliabilities for each of the six 
subscales and for the overall total communication disturbances are as follows: Vague references 
(.73), Confused references (.88), Missing information references (.89), Ambiguous word meanings 
(.88), Wrong word references (.80), Structural unclarities (.93), and Total communication
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disturbances (.94). The CDI discriminates the language of persons with schizophrenia from 
normal controls on all subtypes, and from the language of persons with mania, specifically on the 
subtypes of vague references. Considering correlations between scores on the different subtypes, 
it was found that most of the subtypes were moderately to highly correlated with each other. 
Vague references were the least related to the other subtypes, but were still correlated r  = .45 
with the total communication disturbances score. When regarding the proportions of the six 
subtypes in speech of the participants, those individuals with schizophrenia evidenced a higher 
proportion of Missing Information references compared with other groups.
Neurocognitive functioning. A variety of neurocognitive measures was employed within 
this study. These measures included: (1) Trail Making Test, parts A and B, (2) Controlled Oral 
Word Association Test, (3) Wisconsin Card Sorting Task, (4) California Verbal Learning Test, (5) 
WAIS-III Block Design, (6) WAIS-III Digit Symbol, (7) WAIS-III Digit Span, (8) WAIS-III 
Vocabulary.
The Trail Making Test (Reitan & Wolfson, 1985) from the Halstead Reitan Battery, 
employing standard scoring and norms (Heaton, Grant, & Mathews, 1991), was completed by 
each subject. Participants on the Trail Making Test must first connect consecutively numbered 
circles on a page (Part A), and then connect the same number of consecutively numbered and 
lettered circles on another page by alternating between the numbers and letters (Part B). The Trail 
Making Test is generally thought of as a measure of orientation and attention, while part A is often 
considered a measure of visual sequencing and part B is considered to tap into set-shifting and 
higher cognitive abilities. The reported reliability coefficients for the Trail Making Test vary 
between .60 and .90, although a low reliability of r=  .36 has been reported for patients with 
schizophrenia on Part A (Lezak, 1995).
The Controlled Oral Word Association Test (COWAT; Benton & Hamsher, 1989) is 
composed of three trials in which subjects are to orally produce words beginning with a 
designated letter. The letters FAS were the first to be used with this measure. Additional word sets
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have included PRW and CFL, of which the latter was used in the present study. The COWAT is a 
measure of verbal fluency and word production. Reliability of the COWAT is quite satisfactory, 
with only the letter A (of the FAS set) having a reliability coefficient below .70, and then only for 
elderly subjects (Lezak, 1995). Updated norms reflecting a more normally distributed range of 
scores was used for this measure (Ruff, Light, Parker, & Levin, 1996).
The Wisconsin Card Sorting Test (WCST; Heaton, 1981; Heaton, Chelune, Talley, Kay, & 
Curtiss, 1993) involves a pack of cards on which are printed one to four symbols, in the patterns 
of triangle, star, cross, or circle. These symbols appear in one of four colors, red, green, yellow, 
and blue. The subject’s task is to place them one by one under four stimulus cards (one red 
triangle, two green stars, three yellow crosses, or four blue circles) according to a matching 
principle that the subject must deduce from the pattern of the administrator’s responses to the 
patient’s placement of item cards under the four stimulus cards. The subject is not provided with 
any initial information about the assessment and just begins by placing cards and the 
administrator states whether the placement is correct or not. After a series of ten correct 
placements in a row, the examiner shifts the matching principle, indicating the shift to the subject 
only by the altered pattern in correct and incorrect item card placements. The matching principle 
starts with color, shifts to form, and then to number. The matching principles are then repeated for 
a maximum total of six principles. The test is discontinued after placement of 128 cards or six 
successful series of cards. Versions of the WCST are available which involve computer 
administration. The reliabilities of this procedure are comparable to the card administration. The 
WCST measures higher cognitive functioning, specifically concept formation and reasoning 
abilities. Satisfactory interrater reliabilities have been reported for the WCST; however, reliability 
coefficients are not available since success on the test depends upon discovery of the set 
principle and once determined most subjects are unlikely to exhibit impaired performance on 
future administrations of the WCST (Heaton, 1981; Lezak, 1995).
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Specific scores provided by the WCST can be evaluated in order to better understand the 
individual’s performance on the test. A Failure to Maintain Set occurs when the individual achieves 
five or more consecutive correct responses and then makes an error before eventually completing 
ten consecutive correct responses for that category. A Perseverative Error occurs after the 
individual has obtained ten consecutive correct responses and the examiner then changes the 
sorting principle without informing the individual, yet the individual continues to match on the 
previous sorting principle and does not incorporate feedback that these responses are now 
incorrect and instead persists with the previous sorting principle. The Number of Categories 
Completed refers to the number of categories (sequences often consecutive correct responses) 
that the individual successfully completed during the test. This value can range from zero to a total 
of six categories.
The California Verbal Learning Test (CVLT; Delis, Kramer, Kaplan, & Ober, 1987) is a 
measure of immediate word list recall. The administrator reads a list (A) of 16 words at the rate of 
one word per second. The subject is then asked to recall as many words from the list as possible 
while the administrator writes down the words recalled in the exact order as the subject says 
them, including repetitions and intrusions. This is repeated for a total of five trials. The 
administrator then reads a second word list (B), and writes down in exact order the subject’s recall 
of the words, again including any repetitions and intrusions. After this trial, the administrator 
returns to the first list (A), and records the number of words recalled by the subject in a “free 
recall” condition. Each of the words on List A belongs to one of four categories of shopping items, 
those being clothing, fruits, spices and herbs, and tools. Each of the words on List B also belongs 
to one of four categories, namely fish, kitchen equipment, fruits, and spices and herbs (the latter 
two which are categories that are also included on List A, but involve completely different words). 
After the free recall condition, the subject completes a “cued recall” condition, in which they are 
asked to recall items from each of the four individual categories. A 20-minute delay is imposed, 
and list A is again recalled by the subject, under both free and cued conditions. A recognition trial
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is included at the end of the test as 44 items are presented orally and the subject is required to 
identify whether each item was included on List A. All 16 items from List A are part of the 
recognition trial, in addition to 8 from List B. Additional non-list items come from several sources, 
including one of the four List A categories, phonetic resemblance to List A items, or other common 
shopping items.
It is assumed that the CVLT measures not only verbal memory, but also its interaction 
with conceptual ability. Test results provide information about use of learning strategies and the 
effectiveness of those strategies. Reliability of the CVLT has been studied and found to be quite 
good, with split-half reliability correlation coefficients between .77 and .86 (Delis, Kramer, Fridlund, 
& Kaplan, 1990).
The Wechsler Adult Intelligence Scale -  Third Edition (WAIS-III; Wechsler, 1997) is a 
measure for assessing the general mental or intellectual ability of an individual. It is described as 
helpful in the differential diagnosis of various neurological and psychiatric disorders that affect 
mental functioning. Determining scores for the WAIS-III involves comparing the examinee's 
performance to that of individuals of similar age. This is done to control for the differences in 
performance across age groups and to assure that the results obtained are meaningful based 
upon age-appropriate comparisons. Subtests from the WAIS-III that were used in the present 
study were the Vocabulary, Digit Symbol, Block Design, and Digit Span.
The Vocabulary subtest is a task in which the subject is verbally and visually presented 
with a series of words that must be defined orally. The test administrator records verbatim the 
subject's response and scores the response based upon specific scoring guidelines. Scores of 
two, one, or zero are assigned based upon the quality of the definition provided by the subject. All 
word meanings recognized by standard dictionaries or otherwise show good understanding of the 
word are assigned two points. Responses that are not incorrect but show a poverty of content are 
assigned a score of one. Responses that are clearly incorrect are assigned a score of zero. If a 
subject’s response if too vague or unclear to score easily, a neutral inquiry is made to determine if
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a superior response can be elicited. Only one query is allowed per word. The test continues until 
the subject has defined all of the words included in the test (a total of 33) or until six responses in 
a row are scored zero. The Vocabulary subtest is considered to be an excellent measure of 
general mental ability and intellectual capacity. Split-half reliability coefficients are extremely high, 
ranging from .90 to .95 across age groups, with the average across groups being .93. Test-retest 
reliability for the Vocabulary subtest was excellent, with a reliability coefficient of .91. Interrater 
reliability was very high, with a coefficient of .95 (Psychological Corporation, 1997).
The Digit Symbol-Coding subtest is a task of symbol substitution that consists of 133 split 
squares with a randomly assigned number from one to nine in the upper half of the square. A key 
is provided that pairs each number with a different nonsense symbol. The subject is to fill in the 
blank half of each square with the symbol that corresponds to number in the upper half of the 
square. The subject is to complete as many squares as possible in a 2-minute period. Incidental 
memory, a measure of the subject’s ability to recall the nonsense symbols from memory without 
prior knowledge that this will be requested, can be assessed by several optional procedures of the 
Digit Symbol subtest as well. Incidental Learning-Pairing is an assessment of the subject’s ability 
to recall the nonsense symbols and match them to the correct numbers from memory. The subject 
is presented with two rows of nine split squares with each of the numbers one through nine in 
random order to which the subject is requested to provide the appropriate nonsense symbol. 
Incidental Learning-Free Recall is an assessment of the subject’s ability to recall the nonsense 
symbols independent of the matching number. The subject is presented with a blank page and is 
requested to recall as many of the nonsense symbols as possible, without needing to match them 
to numbers. If these procedures are to be administered, the subject is allowed additional time, if 
needed, to complete a total of four rows during the Digit Symbol-Coding portion of the subtest. 
These optional procedures assist the administrator is determining what abilities (i.e., memory 
retention) may be deficient if the subject obtains a low score on the Digit Symbol-Coding task. The 
Digit Symbol subtest is a measure of complex attention and is considered to be one of the most
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sensitive of neurocognitive tests to brain damage (Lezak, 1995). Test-retest reliability is very 
good, with correlation coefficients ranging from .81 to .87 across age groups, with the average 
across groups being .84 (Psychological Corporation, 1997) for most individuals, but as low as .38 
for persons with schizophrenia (Lezak, 1995).
The Block Design subtest is a task in which the subject is presented with blocks which are 
to be used in the construction of a variety of designs ranging in difficulty and number of blocks 
needed (two, four, or nine). Each block has two red sides, two white sides, and two half-red and 
half-white sides divided along the diagonal. The designs to be replicated are either put together by 
the test administrator in a model to be duplicated by the subject or printed in smaller scale on 
cards that are presented to the subject. The Block Design subtest is a measure of general mental 
ability, and specifically assess visuospatial organization. Split-half reliability coefficients ranged 
from .79 to .90 across age groups in the standardization population, with the average across 
groups being .86. The test-retest reliability coefficient of .82 is very good for this subtest as well 
(Psychological Corporation, 1997).
The Digit Span subtest is composed of two different tasks, Digits Forward and Digits 
Backward. Digits Forward involves eight pairs of random number sequences of varying length that 
the administrator reads aloud at the rate of one per second. Digits Backward involves seven pairs 
of number sequences. In Digits Forward, the sequence ranges from two to nine digits, and the 
subject repeats the numbers back to the administrator in the same order as they were presented.
In Digits Backward, the sequence ranges from two to eight digits, and the subject repeats the 
numbers back in the opposite order as they were presented. The Digit Span subtest is a measure 
of attention, specifically for span of immediate verbal recall. Split-half reliabilities ranged from .87 
to .93 across age groups, with the average across the groups being .90. The stability of this 
subtest over time is quite high, with a test-retest coefficient of .83 (Psychological Corporation, 
1997).
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
Functioning in Schizophrenia 70
Procedures
Recruitment. Relevant staff at each recruitment site were requested to provide information 
regarding potential subjects who could be contacted and requested to participate in the study.
This process generally involved discussing with each clinician their patient case load and 
determining which patients were appropriate and stable enough for participation. In some cases, 
the clinician discussed possible participation with individual patients before their names were 
released to study staff. Patients were then contacted either by telephone or approached after an 
appointment at the VA Medical Center. They were provided a standardized verbal description of 
the study (See Appendix 0 ) to determine their interest in participating. If interested, they answered 
various demographic questions (See Appendix E) and scheduled to participate.
For outreach programs, recruitment information was posted at each site or included in 
newsletters, and interested participants were encouraged to contact research staff. For these 
potential participants, a more extensive telephone screening process (See Appendix F) was 
employed to assure criteria was met for inclusion in the research project. Those who met criteria 
and were interested in participating answered the same demographics questions and were 
scheduled for appointments.
Those patients who agreed to participate were asked to provide written consent after 
reading through a detailed consent form, having an opportunity to ask any questions, and 
answering several questions about their participation to assess for understanding of the study 
(Appendix G). Each participant was provided with a copy of their signed consent form.
Risks to the participants and negative effects of the research were minimized through a 
number of procedures. The informed consent and release of information documents allowed the 
participants to have complete information and accurate expectations regarding their participation 
so that they were able to make an informed decision whether or not to participate. Participants 
were provided with general information about their ongoing participation and the procedures they 
were completing. In addition, participants were encouraged to ask questions and identify any
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distress or discomfort that they were experiencing. It was explained to all participants that they 
could terminate their participation at any time. All assessment results and other information about 
the participants were identified using only a code number rather than by name or other identifying 
information. A master list matching each participant code number with the name of the subject 
was kept separately by the project coordinator in a secure location. All research personnel were 
required to complete training on issues related to confidentiality and research procedures.
A variety of additional measures were collected as part of a larger study, however this 
report will focus on the variables of symptomatology, language production, quality of life, social 
adjustment, and neurocognitive functioning.
Initial procedures. Once individuals agreed to participate in the research study, a 
comprehensive review of the medical record was completed, using the previously described chart 
review form. In addition to gathering the information on the chart review form, copies of various 
reports and current progress notes were obtained. This was to provide additional information 
about symptomatology during psychotic episodes and descriptions of current functioning and 
presentation. Medical records for patients at the Minneapolis VA Medical Center were reviewed as 
part of their participation. Subjects recruited from other sites were asked to sign release of 
information forms (See Appendix H) in order to obtain relevant psychiatric information from prior 
hospitalizations and other service providers. These forms were standard Release of Information 
forms used throughout the Department of Veteran’s Affairs.
Daily oral doses and depot doses of antipsychotic medications were converted to 
chlorpromazine equivalents according to guidelines suggested by Bezchlibnyk-Butler and Jeffries 
(2001). This process involved applying the “apparent clinical equivalence in schizophrenia” (pp 
89-91) for a specific dose of a given medication and converting it to an equivalent dosage of 
chlorpromazine. This is accomplished by dividing the individual’s medication dosage by the listed 
apparent clinical equivalence and then multiplying this by 100 (the clinical equivalence of 
chlorpromazine) to obtain the chlorpromazine equivalence for the given medication and dosage.
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Medications were broken down into two classes, novel agents and conventional agents. See 
Table 1 for a description of the medications prescribed to study participants, average daily 
dosage, class of medication, and the assigned chlorpromazine equivalence for each.
Training and reliability for clinical assessments. Clinicians for this study went through 
extensive training for the DIGS, BPRS, and GAF. Initially, all clinicians met as a group to review 
and become familiar with the DIGS. Any questions that arose were addressed to the developers 
of the interview and the responses were discussed among the clinicians and descriptive or 
explanatory notes were added to the body of the interview. Videotapes containing clinical 
interviews produced by the creators of the BPRS were reviewed and rated by each clinician.
These ratings were then compared to “gold standard” ratings provided with the videos. After 
training, reliability coefficients for the BPRS training interviews were found to range from .92 to .97 
across the different clinicians. The clinicians then alternated administering the DIGS to volunteer 
psychiatric patients from the Minneapolis VAMC with the other clinicians present and following 
along while independently rating the DIGS. These interviews were video taped for future 
reference. After the completion of the interview, the group of clinicians discussed their ratings for 
the DIGS and any significant deviations were explored and a “gold standard” for the interview was 
generated. In addition, the BPRS and the GAF were also rated. After the completion of each 
interview, the clinicians discussed their ratings for the BPRS and the GAF, and a “gold standard” 
for each according to our research group was developed. Reliability coefficients were found to 
range between .87 and .92 on the BPRS, and all ratings were within five points on the GAF, a 
standard developed by this research group. No specific reliability coefficients were calculated for 
the DIGS, as it was deemed more important to be reliable with ratings on the BPRS and GAF than 
on individual items on the DIGS.
Training on the QOLI included instructing interviewers to present questions to participants 
in a standardized format without bias. Reliability on the QOLI tends not to be undertaken, as the 
interviewer records only what ratings the participant provides (Lehman, 1983).
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Clinical assessments. All participants were administered the DIGS by a trained clinician, 
who also rated the individual on the BPRS and the GAF. The interviewing clinician used available 
chart review information, as release of information records were not always received in a timely 
manner, to inform and guide their interview with the patient. A reliability assessment was 
completed after each interview to assess the overall credibility of the data provided by the patient 
and to identify any sections of the interview that may contain information of a jumbled or 
inconsistent nature. The SAS-II and the QOLI were administered by a trained research staff. 
Again, after each interview, a reliability assessment was completed by the rater to assess the 
overall quality of the data provided by the participant and to identify any sections of the interviews, 
which may have contained information of a jumbled or inconsistent nature. These interviews were 
generally administered on one day as part of a longer session that included additional interviews 
for the larger research study.
Once the DIGS was completed with the participant, the interviewing clinician rated the 
questions needed to score the OPCRIT. The item responses were next entered into the OPCRIT 
program that then provided a diagnosis based upon the algorithmic scoring program. Although 
diagnoses that correspond to a variety of different diagnostic systems are provided, DSM-IV 
(1994) diagnoses were used for the purposes of this study.
After diagnosis had been established by the interviewing clinician and any additional 
information relevant to the participant's psychiatric history had been received, a second 
“diagnostic” clinician also reviewed all the available information and independently rated the 
OPCRIT. This diagnostic clinician was blind to the interviewing clinician's OPCRIT diagnosis. For 
all cases where there was agreement, this was the accepted diagnosis. For situations in which the 
two clinicians did not obtain the same diagnosis, they met for a “consensus meeting” in which 
items were compared and discussed so that a consensus diagnosis could be established. This 
consensus diagnosis was then used as the final diagnosis for the individual.
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As previously noted, symptomatology was rated by the BPRS, and the four factors as 
identified by Ventura et al. (2000) through a principal components analysis were examined. A total 
score was calculated by summing the ratings from all 24 of the items. The four BPRS symptom 
factors were Positive Symptoms, Negative Symptoms, Manic-Excitement, and Depression- 
Anxiety. The Positive Symptom scale included items of suspiciousness, hallucinations, unusual 
thought content, bizarre behavior, and disorientation. The Negative Symptom scale included items 
of self-neglect, blunted affect, emotional withdrawal, and motor retardation. The Manic-Excitement 
scale included hostility, elevated mood, grandiosity, excitement, distractibility, and motor 
hyperactivity. The Depression-Anxiety scale included anxiety, depressed mood, suicidality, and 
guilt feelings. The other five items on the BPRS (somatic concern, conceptual disorganization, 
tension, uncooperativeness, and mannerisms/posturing) did not load onto any of these factors. A 
score for each of the four scales was calculated by taking the mean of the individual items that 
loaded on the factor.
Neurocognitive assessment. The neurocognitive assessment was completed by trained 
research staff on a different day than the clinical interviews, usually within a few days, but always 
within a two week time period. All measures were administered according to established standard 
procedures. The administration order of the tests varied across participants due to the fact that 
this study was part of a larger project in which the tests were not administered in a fixed order and 
other procedures were also completed during the testing session. Participants were also allowed 
breaks when requested or when it appeared to the tester that the participant was fatigued. 
Behavioral observations were made of each assessment to identify any procedures that may not 
have reflected accurate performance by the subject. All measures were scored based upon 
standardized norms provided with the tests, unless otherwise specified above.
Impairment index. Impairment scores for the neurocognitive test scores were calculated 
by identifying each of the test scores as impaired if it was more than one standard deviation below 
the mean of the published norm. One standard deviation below the mean is equivalent to a
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percentile score of less than 16%, a T  score under 40, or lower than an age-scaled score of 7. 
This level was selected to assure that even more subtle incidences of impaired performance for 
these individuals were identified. The practice of determining “impairment” as below one standard 
deviation is quite common in the field and is recommended by experienced clinicians (Heaton, 
Grant & Matthews, 1991). According to these authors, using a cut-off of one standard deviation 
results in a false positive rate of up to about 15%, an acceptable level of specificity. An 
Impairment Index score for each participant was calculated by summing the total number of test 
scores that fell below the cutoff of one standard deviation and dividing this by the total number of 
test scores that were obtained from the participant. Thus a frequency score was obtained, rather 
than an absolute score. This means of generating the Impairment Index was established to 
accurately reflect level of overall impairment when participants were missing scores on one or 
more tests. The Impairment Index is a global measure of the overall neurocognitive impairment as 
exhibited by the participant.
Neurocognitive domain summary scores. Domain summary scores for the neurocognitive 
test results were calculated in two different ways, depending on the type of analysis that was to be 
completed. For analyses involving correlations, raw scores on each test were converted to z 
scores (resulting in a mean of 0 and a standard deviation of 1) and averaged across the 
measures included in the domain. For analyses involving within subject comparisons across 
domains, appropriately-corrected (for age, gender, and education when available) scores were 
converted to percentiles and averaged across the measures included in the domain. General 
Mental Ability was comprised of the Vocabulary and Block Design subtests of the WAIS-III. The 
Attention summary score was made up of the Digit Span subtest of the WAIS-III and Trail Making 
Test part A. The Verbal Fluency domain reflected the COWAT score. Verbal Memory included 
scores from the CVLT, specifically total score, first presentation recall, fifth presentation recall, 
short delay recall, long delay recall, and recognition. The domain of Higher Cognitive Ability was 
comprised of the Perseverative Errors, Failure to Maintain Set, and Categories Completed scores
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on the WCST, and the Trail Making Test, part B, for the domain scores that averaged z-scores. 
For the domain score that averaged percentiles, the scores of Failure to Maintain Set and 
Categories Completed were not included because these two scores are not assigned discrete 
percentile scores, but rather performance is reported as a percentile range (i.e., < 1%, 2-5%, 6- 
10%, 11-16%, or >16%). Scores in this format could not be included in the average performance 
score for the Higher Cognitive Ability domain.
Speech samples and communication disturbance ratings. A ten-minute speech sample 
was also obtained during the testing session. The participant was described the speech sample 
procedure and then signed an audio taping consent form (See Appendix I). All speech samples 
were identified only by subject number without any other personal information. Participants were 
instructed to discuss neutral topics of their choice, such as their daily activities, and were provided 
with additional topics for discussion as needed to complete the ten minutes. In addition, 
participants were asked not to provide any identifying information and avoid discussing their 
mental illness during the collection of the speech sample.
Each speech sample was transcribed by one of several trained research assistants. 
Training initially included an explanation of the interview procedure and instructions on how to 
transcribe verbatim the person’s speech. Several practice cases (either real cases from the study 
or “artificial” sample cases) were transcribed and discussed with the research assistant. 
Throughout the transcription phase of the study, research assistants were encouraged to discuss 
with the primary researcher and other transcriptionists any difficulties they may have encountered 
and questions they had regarding their tapes. The accuracy of the transcriptions were assessed 
by a different research assistant who again listened to the speech sample and made any changes 
or additions to the transcript to assure the accurate reflection of all of the content of the 
participant’s speech sample.
Speech sample ratings using the CDI were made by trained research assistants. Training 
materials were provided to this research group by the author of the CDI who indicated that
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achieving reliability within our research group should be the primary objective for the training, with 
a secondary goal of establishing CDI levels close to those of her group’s published research. In 
addition, the author made herself available for consultation regarding use of the CDI and accurate 
rating procedures. Training was composed of several different components recommended by the 
author of the measure. The first stage involved didactic presentations on the CDI and the six 
subtypes of unclear references. The second stage involved reviewing practice speech samples 
and making ratings as a group. The third stage involved research assistants making independent 
ratings on speech samples. The fourth stage involved group comparisons of the independent 
ratings and discussions of any differences.
As previously noted, the author of the CDI recommended that we strive to achieve similar 
means for ratings as those in her published articles. This was attempted and our means were 
found to be fairly similar to those of the Docherty group (Docherty et al., 1996; Docherty, Hall, et 
al., 1998; Docherty, et al., 1999; Docherty & Gottesman, 2000; Docherty et al., 2000; Gordinier & 
Docherty, 2001), although our participants exhibited somewhat more Vague References and 
slightly fewer Structural Unclarities than found in those previous studies.
Once training was completed, research assistants were assigned a randomly selected 
16% of the speech samples from the present study to rate independently. Interrater reliabilities for 
each of the six types of disturbance and total communication disturbance, reported by intraclass 
correlation coefficients, are reported in Table 2. Overall, adequate reliability was achieved, 
especially for Total Communication Disturbances, although less agreement was established for 
Confused References and Wrong Word References. Cicchetti and Sparrow (1981) have 
established guidelines for interpreting interrater reliability coefficients. They indicate that less than 
.40 is “poor," that .40 to .59 is “fair,” .60 to .74 is “good,” and greater than .75 is “excellent.” Based 
on these guidelines, the interrater reliability across the three raters in this study was found to be 
fair for Confused References, good for Wrong Word References, and excellent for the remaining 
scales.
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Scores for each of the six CDI unclear references were calculated as instances of the 
specific disturbance per every hundred words of speech. Total CDI ratings were calculated as 
instances of the total sum of all six unclarities per every hundred words of speech.
Data entry. Data entry was completed primarily by research assistants. Measures such as 
the BPRS and GAF were filled out on scannable forms. These forms were scanned and double­
checked for accuracy using the TELEform scanning system. Other measures were hand-entered 
onto templates corresponding to the data collection sheets through the File Maker Pro 4.0 
program. These measures were then double-checked for accuracy by a different research 
assistant. Both the TELEform and File Maker Pro programs allow exportation of the data to other 
programs in a spreadsheet format.
Power Analysis
A power analysis was completed in order to determine sample size needed to detect 
significant correlations between variables. As most of the hypotheses specified directionality for 
correlations, determination of significance for one-tailed tests was completed. An analysis using 
the nQuery Advisor 3.0 program setting alpha to .05 and requiring the power to be at least .67 to 
detect a correlation of .3 was found to require at least 46 subjects. A sample size of 55 was used 
for the present study. An additional analysis determined that when the sample size is 55 and 
alpha is set to .05 for a one-tailed test, a normally distributed covariate would have 74% power to 
detect a correlation of .03.
Statistical Analyses
Frequency statistics were calculated for the demographic and clinical variables of gender, 
race, diagnosis, recruitment source, marital status, current living arrangements, employment 
status, income level, current medications, and current therapy. Descriptive statistics were 
calculated for the demographic and clinical variables of age, years of education, GAF scores, age 
at onset of symptoms, age at first hospitalization, number of previous hospitalizations, and 
chlorpromazine equivalents for medications.
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To evaluate the effects of selected demographic and clinical variables on the constructs 
on interest in the study, a multivariate analysis of variance (MANOVA) was completed with each 
factor variable of gender (male/female), race (Caucasian/other), marital status (mamed/other), 
work status (working at least part-time/no work), and living arrangements (living with others/living 
alone). A separate MANOVA was completed for each of the previously factors on each of the 
following dependent variables which were grouped into theoretically meaningful constructs, such 
as satisfaction (subjective) ratings on the QOLI, objective scales on the QOLI, SAS global ratings, 
BPRS and GAF scores, and neurocognitive measures. If any of the dependent variable groupings 
were found to be significantly related to the factor variable (based upon Wilks’ Lambda), a test of 
between-subjects effects was completed to determine which of the dependent variables 
contributed to the significance. This procedure allowed fewer comparisons to be made initially, 
which was deemed appropriate based on the number of comparisons being made as part of this 
study. For those comparisons that were significant, the results from both the original multivariate 
test and then the follow-up between-subjects tests are reported. For analyses involving Pearson 
product moment correlations, no specific correction for multiple comparisons was applied, 
however, as the number of comparisons was quite large, caution should be taken when 
considering the results.
In addition, specific analyses for each of the hypotheses were as follows:
1. Pearson product-moment correlation coefficients were used to determine the 
correlations between overall symptom presentation and the measures of quality of life and 
neurocognitive functioning (using z scores that had been converted from raw scores).
2. Pearson product-moment correlation coefficients were used to determine the 
correlation between overall symptom presentation and communication disturbances.
3. Pearson product-moment correlation coefficients (compared using Fisher’s z 
transformation) were used to determine the correlations between both negative and positive
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symptoms and each of the measures of quality of life and neurocognitive functioning (using z 
scores that had been converted from raw scores).
4. Pearson product-moment correlation coefficients were used to determine the 
correlations between quality of life (subjective) and measures of verbal memory, attention, and 
higher cognitive functioning within the domain of neurocognitive abilities. Domain scores were 
calculated from averages of z scores (that were converted from raw scores) for each measure 
included in the domain.
5. A paired sample f-test was used to compare the numbers of ambiguous word meanings 
with the other types of unclear references, and then again to compare missing information 
references with the remaining four unclear references, within the area of communication 
disturbances.
6. Pearson product-moment correlation coefficients were used to determine the 
correlations between communication disturbances (unclear references) and performance in the 
specific neurocognitive domains of memory, attention, and verbal fluency. Domain scores were 
calculated from averages of z scores (that were converted from raw scores) for each measure 
included in the domain.
7. Paired samples f-tests were used to determine the relationships between areas of 
verbal memory, word fluency, attention, and higher cognitive functioning and the other domain of 
neurocognitive functioning (general mental ability) using domain scores that were calculated from 
averages of percentile scores for each measure included in the domain.
8. Multiple regression was used to predict individual scores on the QOLI from the other 
variables of the study.
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Results
The results will be presented in several steps. General findings for each of the measures 
used in the study will be described. Then individual hypotheses (identified by number and a brief 
description) will be reported. At the end of the results section, each hypothesis is listed and a 
notation is provided to indicate whether each was completely or partially confirmed, or went 
unsupported.
Demographic and Clinical Characteristics of Participants
Tables 3 and 4 describe the relevant demographic characteristics of the participants in 
this study. The average age of participants was about 47 years (ranging from 24 to 59), and 
85.5% of the participants were male. The ethnic/racial distribution of the participants was 87.3% 
Caucasian, and the remaining 12.7% African-American, Native American, Asian, or Hispanic. 
Educational levels for the participants averaged 14 years (ranging from 8 to 19), and about 42% of 
the participants were currently employed in some capacity or attending school. Annual income for 
study participants averaged between $10,000 and $20,000. In terms of marital status, only 18% 
were married, the remaining 82% were single (never married, or separated, divorced, or 
widowed). Forty-two percent of the patients were involved in some shared living arrangements 
(either partner/spouse, other family member or roommate), 9% lived in a residential treatment 
facility, and the remaining 49% lived alone.
Tables 3 and 4 also show selected clinical characteristics of the participants. These tables 
indicate that participants experienced persistent mental illness evidenced by early age of onset, 
duration of illness, and number of hospitalizations. Schizophrenia was the diagnosis of 45 
participants, and the other 10 were diagnosed with Schizoaffective Disorder. The average age for 
onset of psychiatric symptoms was between 23 and 24 years old (ranging from 13 to 47), and 
average age for first hospitalization was between 25 and 26 years old (ranging from 13 to 50), for 
the 53 participants who had been previously hospitalized. The average age of the 53 previously 
hospitalized participants did not differ from that of the entire sample. Status of chronic mental
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illness was also revealed by an average of more than six psychiatric hospitalizations per patient 
(ranging from 0 to 32) and average current Global Assessment of Functioning (GAF) score of 
48.07 (ranging from 25 to 68). This average GAF score corresponds to a rating of “Any serious 
symptomatology or impairment in functioning that most clinicians would think obviously requires 
treatment or attention.” Current treatment included medication focused (96.4% of participants), 
therapy or supportive counseling (34.4%), group therapy (21.8%), and other treatment (9.1 %) 
such as case management. Numerous participants were involved in multiple forms of treatment; 
thus percentages total greater than 100%.
Current medications of the study participants were as follows; 54.5% were prescribed 
antidepressants, 29.1% mood stabilizers, and 27.3% antiparkinsonians. Of the participants, 96.4% 
were currently prescribed at least one antipsychotic medication, with an average chlorpromazine 
equivalence of 416.5 mg/day (ranging from 16.6 to 1825 mg/day). Novel antipsychotics only were 
prescribed to 69.1% of the sample, averaging 323.9 chlorpromazine equivalents per day while the 
other 27.3% were receiving conventional antipsychotics, with an average chlorpromazine 
equivalence of 500 mg/day. See Table 1 for a description of medications that are included in each 
of the novel and conventional categories and average daily dosages for study participants. Steps 
taken to calculate these equivalents are presented in the Initial Procedures portion of the 
Procedures section of the paper. Of those receiving conventional antipsychotic medications, six 
individuals were prescribed an additional chlorpromazine equivalence of 400 mg/day of novel 
antipsychotics. Antipsychotic medication level, as measured by total chlorpromazine equivalence, 
was not correlated with any other demographic variable other than with age (r = -.363, p = .01). 
These results indicate that the older participants tended to be prescribed lower dosages of 
antipsychotic medications.
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Symptom Presentation
Additional clinical characteristics involving psychopathology, measured by the Brief 
Psychiatric Rating Scale (BPRS), are described in Table 5. The BPRS factor scores revealed that 
these patients with schizophrenia exhibited very mild to mild positive symptoms (Mean = 2.37,
SD = .96), very mild negative symptoms (1.95, SD = .83), none to very mild manic-excitement 
symptoms (1.54, SD = .77), very mild depression-anxiety symptoms (1.80, SD = .85), and very 
mild average overall symptoms (1.83, SD = .53).
Correlations of symptom presentation and demographic and clinical variables. After 
completing multivariate and correlational analyses, it was found that none of the demographic 
variables of age, gender, race, chlorpromazine equivalents for medications, marital status, years 
of education, and current living arrangements, were correlated with any scale from the BPRS or 
the GAF. Only current employment status was related to this group of scores, F  (6 ,48) = 3.60, 
p = .005, specifically BPRS Total Score, F(1, 53) = 9.59, p = .003, the BPRS Positive Symptom 
scale, F  (1, 53) = 7.77, p = .007, the BPRS Negative Symptom scale, F (1, 53) = 6.23, p = .016, 
and the GAF, F  (1,53) = 22.05, p < .001. These results indicate that individuals who are currently 
employed at least half-time experience significantly fewer total, positive, and negative symptoms, 
and exhibit better overall functioning.
Quality of Life
Results of Quality of Life Interview (QOLI) Scales. Clinical characteristics involving quality 
of life as measured by the QOLI are described in Table 6. When considering objective ratings of 
Quality of Life, the QOLI scores indicated that on average these individuals engaged in at least 
four activities outside the home during the past week (out of a possible total of 8 activities). In 
addition, they generally had contact with other people in social situations and had contact with 
family members at least once per month during the past year. The participants generally did have 
sufficient funds to cover basic expenses in the past year, and on the average had $276 
(reportedly ranging from $0 to $2500) per month to spend on themselves. Of these persons with
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schizophrenia, 30 (54.5%) were currently working or had worked in the past year, while the 
remainder had not worked at all in the past year. In regards to legal and safety issues, 4 (7.3%) of 
the participants reported that they had been the victim of a violent crime (e.g., assault, mugging) 
in the past year, 12 (21.8%) had been the victim of a nonviolent crime (e.g., theft, being cheated) 
in the past year, and 4 (7.2%) indicated that they had been arrested at least once during the past 
year.
When considering subjective ratings of Quality of Life, all means for the participants in this 
study are at least slightly above the midpoint of the scale. These individuals reported feeling 
mixed to mostly satisfied with their general life circumstances. The participants also reported 
feeling mixed to mostly satisfied with their daily activities, family relations, social relations, overall 
finances, and health. In addition, they indicated feeling mostly satisfied with their living situations. 
Finally, the study participants indicated they were mostly satisfied to pleased with their legal/safety 
circumstances and employment, at least for those currently working.
Correlations of QOLI scales with demographic and clinical variables. After completing 
multivariate and correlational tests, it was found that none of the demographic variables of age, 
gender, chlorpromazine equivalents for medications, marital status, employment status, and years 
of education, was correlated with any objective scales from the QOLI. Race was related to this 
group of scores, F  (5 ,49) = 2.90, p = .023, specifically to number of daily activities, F  (1, 53) = 
4.43, p = .040, and number of family contacts, F(1, 53) = 4.12, p = .047. These results indicate 
that the Caucasian participants tended to engage in more activities outside of the home and had 
more contact with their family members. Age was found to be negatively correlated with money 
available to spend on self (r = -.274, p < .05) and years of education was found to be negatively 
correlated with number of contacts with family members (r=  -.317, p < .05). These results indicate 
that older participants tended to have less discretionary funds and those who had more years of 
education tended to have less contact with their family members.
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Correlations between QOLI global life satisfaction and other QOLI scales. One significant 
correlation was observed between the Global Life Satisfaction rating and the objective scales on 
the QOLI. Having more social contacts on a regular basis related to a greater overall life 
satisfaction (r = .340, p < .01). Subjective scales on the QOLI were found to correlate more 
strongly with Global Life Satisfaction than the objective scales. Table 7 shows that the highest 
correlations (p < .01) to Global Life Satisfaction were in the areas of satisfaction with daily 
activities (r = .627), health (r=  .582), finances (r=  .508), living situation (r=  .438), and social 
relations (r = .349). Other areas that were also related (p < .05) to the Global Life Satisfaction 
rating were satisfaction with family relations (r = .272), and legal and safety (r= .258). These 
results indicate that for these participants, greater satisfaction in these specific areas of their lives 
is associated with increased in satisfaction in their overall life situation.
Social Adjustment
Results of Social Adjustment Scale -  II (SAS-II) ratings. Clinical characteristics involving 
social adjustment and functioning as measured by the SAS-II are presented in Table 8. Ratings 
were made on a scale of 0 = excellent adjustment, to 6 = severe maladjustment. Global ratings 
revealed that the participating individuals exhibited a mostly poor (Mean = 3.74, SO = 1.68) 
adjustment to their work role, whether it was employment, household responsibilities, or 
educational activities. For those subjects who were living with other people (n = 28), there was 
evidence of mainly good (2.18, SD = 1.09) adjustment with regard to the mutual relationship with 
the other primary person in their household. Participants also reported mostly fair (2.78,
SD = 1.31) adjustment in their relationships with family members outside of the household. Social 
leisure adjustment was found to be mostly fair (3.22, SD = 1.06) when considering outside 
activities and interactions with others. General adjustment was determined to be mostly fair (3.11, 
SD = .79) for these individuals.
Correlations of SAS-II ratings with demographic and clinical variables. After completing 
multivariate and correlational tests, it was found that none of the demographic variables of age,
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race, chlorpromazine equivalents for medications, marital status, and years of education, were 
correlated with any global ratings from the SAS. The relationship between household member 
global rating and current living arrangement (alone or with someone else) was not specifically 
analyzed as this item is only rated for those who are not living alone. Gender was related to this 
group of scores, F (4,49) = 3.19, p = .021, specifically to the ratings of relationships with 
household member, F (1,25) = 4.82, p = .038, and external family, F (1, 52) = 7.35, p = .009. 
These results indicate that females tend to have poorer adjustment in their relationships with the 
people who they live with and their extended families. Current employment status was also related 
to this group of scores, F  (4,49) = 4.61, p = .003, specifically the ratings for work and daily 
responsibilities, F (1, 52) = 18.97, p < .001, and global adjustment, F (1, 52) = 7.75, p = .007. 
These results indicate that individuals who are working at least part-time have better adjustment in 
engaging in their daily responsibilities and with their overall social functioning.
Correlations of SAS-II ratings with symptom presentation. After completing correlational 
analyses, several social adjustment global ratings were found to be significantly correlated with 
overall symptom presentation as measured by the BPRS. These areas were relationship with 
external family (r=  .315, p = .01), social leisure activities (r=  .377, p < .01), and general social 
adjustment (r = .413, p = .001). These results indicate that as participants were rated as more 
impaired in their social interactions with external family members, pursuit of social leisure 
activities, and general social interactions, they also experienced higher levels of current 
symptomatology.
Correlations of SAS-II ratings with neurocognitive functioning. After completing 
correlational analyses, several neurocognitive domains were found to be significantly related to 
several of the social adjustment global ratings. The neurocognitive domain of Verbal Memory was 
correlated with social adjustment in work and daily responsibilities (r= -.439, p < .001) and 
general adjustment (r= -.258, p < .05). The domain of Attention was correlated with adjustment in 
social and leisure activities (r = -.287, p < .05), while General Mental ability was correlated with
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adjustment with primary household member (r = -.391, p < .05). These correlations are actually in 
the positive direction, as lower scores on the SAS-II indicate better social adjustment. These 
results indicate that participants who perform better on abilities of verbal memory also experience 
better adjustment at work and completing daily activities, as well as in their overall social 
interactions. Also, as these persons with schizophrenia experience higher levels of attentional 
skills, they also pursued more social and leisure activities. Lastly, participants with stronger 
abilities of general mental ability tended to have more positive interactions with their primary 
household member.
Communication Disturbances Index (CDI) Scores
Amounts of speech gathered during the collection of the speech sample varied across 
participants; overall they produced a mean of 1222.2 (SO = 371.9) words, ranging from 453 to 
2230 words. Means and standard deviations for each of the communication disturbances are 
presented in Table 9. The Total Communication Disturbance score was 2.88 (SO = 1.24), which 
corresponds to number of disturbances per 100 words of speech. These scores are fairly similar 
to those previously published by Docherty’s research group (Docherty et al., 1996; Docherty, Hall, 
et al., 1998; Docherty, et al., 1999; Docherty & Gottesman, 2000; Docherty et al., 2000; Gordinier 
& Docherty, 2001), although it appears that participants in the present study exhibited more 
Vague References and fewer Structural Unclarities than those in Docherty's studies. However, the 
total number of communication disturbances were found to be in the same range as those 
reported by the Docherty group.
Correlations among CDI scores. Correlations were computed among the communication 
disturbance variables to assess their co-occurrence within participants. Most of the individual 
communication disturbances were significantly correlated with the others at p < .01. These results 
are presented in Table 10. Confused References was the only type of disturbance that was not 
correlated with the other types of failure, other than with the total CDI score (r  = .270, p < .05). 
These findings indicate that, for the most part, as patients exhibit frequent communication
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disturbances of one type, they generally exhibit other disturbances as well. This is consistent with 
the results reported by Docherty, et al. (1996). In addition, to determine the internal consistency of 
the scales on the CDI, a Cronbach’s alpha was calculated and found to be .74, which is generally 
considered to be an adequate level of internal consistency.
Correlations of CDI ratings with demographic and clinical variables. After completing 
multivariate and correlational analyses, it was found that demographic and clinical variables such 
as age, gender, race, chlorpromazine equivalents for medication, years of education, living 
situation, employment status, and marital status were not correlated with any of the ratings from 
the CDI.
Relationships among Communication Disturbances (Hypothesis 5). A paired samples 
f-test was computed to compare the frequency of Ambiguous Word Meanings to the other 
communication disturbances. The Ambiguous Word meanings were found to occur much more 
frequently than Vague References, t (52) = 6.59, p < .001, Confused References, t (52) = 5.92, 
p < .001, Missing Information References, t (52) = 3.53, p = .001, Wrong Word References, 
t (52) = 7.84, p < .001, and Structural Unclarities, t (52) = 7.60, p < .001. This is consistent with 
results published by the author of the measure (Docherty, et al., 1996).
A second paired samples t-test was computed to compare the frequency of Missing 
Information References to the remaining communication disturbances. The Missing Information 
References were found to occur more frequency than the remaining four deviances, Vague 
References, t (52) = 3.21, p = .002, Confused References, t (52) = 3.88, p < .001, Wrong Word 
References, t (52) = 5.25, p < .001, and Structural Unclarities, t (52) = 4.93, p < .001. Again, this is 
consistent with results published by Docherty et al. (1996).
Neurocognitive Performance
Neurocognitive test performance results will initially be presented according to the 
individual measure. Raw scores will be reported and corresponding percentiles will be provided. 
These percentiles were calculated after age, gender, and education corrections (when available)
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were applied, after which corresponding percentile scores were determined based upon the 
standardized norms provided for each measure. These percentile scores are based upon the 
assumption that the scores across populations are normally distributed. For clarification, Table 11 
lists standard scores, age scaled scores, T scores, z scores, and the corresponding percentiles. 
Table 12 presents neurocognitive performance for the participants.
WAIS-III subtests. Scores from the Wechsler Adult Intelligence Scale -  Third Edition 
(WAIS-III) are reported as raw scores and percentile scores that were converted from age scaled 
scores. Participants averaged a raw score of 43.6 on the Vocabulary subtest of WAIS-III with 
performance at 51%, which is in the average range. This percentile score indicates that the 
participants’ average performance was in the 51s1 percentile when compared to normative 
samples, not that they completed 51 % of the items correctly. Average raw score on the Block 
Design subtest was 33.85, with performance at 42%, which is also in the average range. 
Participants averaged a raw score of 15.6 on the Digit Span subtest, with performance at 41%, 
which is in the average range. Average raw score on the Digit Symbol subtest was 54.78, with the 
performance at 24%, which is in the low average range.
When considering incidental learning as measured by the Digit Symbol subtest, these 
participants recalled an average of 10.44 items (SD = 4.63) in a paired-to-symbol condition (out of 
a possible 18), and 6.56 (SD = 1.38) in a free recall condition (out of a possible 9). Percentiles 
were difficult to determine for these scores, as the standard scoring procedures (Wechsler, 1997) 
report these values as cumulative percentages associated with given raw scores, which in this 
sample range from 1% to >50%. However, the median percentile was determined to be 33.3% for 
the paired condition and 25% for the free condition. These median percentiles are both in the 
average range of performance.
COWAT. Performance on the Controlled Oral Word Association Test (COWAT) was 
found to be 31% (in the average range of performance), with an average of 32.58 (SD = 10.39) 
total words produced by participants (ranging from 12 to 58 words). For each of the letters C, F,
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and L, participants produced an average of 11.07 words (SO = 4.38; range 3 - 21), 11.16 words 
(SO = 4.09; range 3 - 21), and 11.64 words (SD = 9.84; range 1 - 21), respectively.
Trail Making Test Performance for visual sequencing abilities, as measured by the Trail 
Making Test, was found to be 33%, which is in the average range of performance, under a simple 
condition (Part A) in which participants are required to connect a series of circles with numbers in 
them. The average time to complete this condition was 34.63 seconds (SD = 11.05), with 0.40 
errors. Under a condition requiring set shifting (alternating numbers and letters; Part B), 
performance was found to be at 32% (also in the average range of performance). The average 
time to complete this condition was 94.7 seconds (SD = 41.97) with 0.81 errors.
WCST. Some scores on the Wisconsin Card Sorting Test (WCST) cannot be 
standardized to discrete percentiles due to the manner in which results are reported (Heaton, et 
al., 1993). The standardized results report the scores for Failure to Maintain Set and Categories 
Completed as falling into percentile ranges (i.e., <1%, 2-5%, 6-10%, 11-16%, and >16%), thus an 
actual percentile score cannot be determined for the performance. Average raw scores of 1.31 
(SD = 1.34) for Failure to Maintain Set, and 4.24 (SD = 1.94) for Categories Completed were 
found. For each of these scores, the median percentile range was determined to be >16% and 11- 
16%, respectively. These median percentiles both fell in the low average range of performances. 
Raw scores on the remaining variable, Perseverative Errors, were converted into T-scores and 
the average corresponding age and education corrected percentile was determined to be 23.35% 
(SD = 22.83), a value that falls in the low average range of performance. The average number of 
Perseverative Errors was found to be 22.37 (SD = 13.57).
CVLT. Participants recalled a total of 41.27 (SD = 11.67) words on the California Verbal 
Learning Test (CVLT). This level of performance averaged 13.8% (percentile score), which was 
determined by converting standard scores that had been scaled to T  scores (provided by the 
standard scoring report) into percentiles. Percentiles for other scores from the CVLT were 
converted from z scores that were provided by the scoring report. Participants recalled 5.22
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
Functioning in Schizophrenia 91
(SD = 1.65) words on the first presentation and 9.73 (SD = 2.88) by the fifth presentation of the 
word list. Performance on the first and fifth word lists fell at 17.34% and 17.75%, respectively, 
both of which are in the low average range of performance. These participants produced 8.2 
(SD = 3.11) words during the short delay recall condition, and 8.56 (SD = 3.38) words during the 
long delay condition. Performance on the short and long delay recall lists fell at 23.28% and 
24.74%, respectively, both of which are again in the low average range of performance. 
Participants correctly identified 13.4 (SD = 2.71) of the 16 words from the list during the 
recognition portion of the task. Performance on the recognition task fell at 30.76%, in the average 
range of performance.
Neurocognitive domain scores. Participants’ corrected (for age, gender, and/or education 
when available) percentile scores were collapsed into five different areas of functioning within the 
neurocognitive domain. Each of the percentile scores for tests that measure abilities of the given 
domain area was used to compute an averaged which made up the domain score. Each of the 
domain areas and the tests scores that contributed to the domain summary scores were Verbal 
Memory (CVLT total, list 1, list 5, short delay, long delay recall scores, and recognition score), 
Attention (Digit Span and Trail Making Test, Part A), Verbal Fluency (COWAT total score),
General Intellectual (Vocabulary and Block Design scores), and Higher Cognitive (WCST 
Perseverative Error score, Digit Symbol total score, and Trail Making Test, Part B). Performance 
in General Intellectual abilities fell at 46.72% (SD = 20.29). Performance for Attention (32.2%,
SD = 18.49), Verbal Fluency (31.46%, SD = 29.1), and Higher Cognitive abilities (29.25%,
SD = 18.08) were similar in score. Performance in Verbal Memory was the lowest, falling at 
21.28% (SD = 20.08).
In addition to domain averages calculated using percentile scores, neurocognitive domain 
averages were also calculated using z scores converted from raw scores on each of the 
measures. These z score converted domain scores were used for a variety of the analyses. 
Average scores for these values are not being reported here because the resulting average z
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scores are very small and contain more meaningful information when considering the individual 
rather than averaging across a group. For results reported later in this paper, descriptions are 
included to indicate whether domain summary scores were calculated using z scores or percentile 
scores.
Correlations of neurocognitive domain summary scores with demographic and clinical 
variables. After completing multivariate and correlational analyses, it was found that demographic 
and clinical variables such as age, gender, race, chlorpromazine equivalents for medication, living 
situation, employment status, and marital status were not correlated with any of the summary 
scores. The only variable to be associated with the domain summary scores was years of 
education, which was found to be related to General Mental abilities (r=  .294, p < .05). These 
results indicate that participants who had more years of education tended to perform better in the 
domain of General Mental abilities.
Relationships among different domains of neurocognitive functioning (Hypothesis 7).
Using summary scores for each of the five domains of neurocognitive functioning (calculated by 
averaging percentiles for each of the neurocognitive measures that contributed to the particular 
domain), paired samples f-tests were conducted to assess the differences between the domain of 
General Mental ability and the other four domains. An analysis of the results revealed that that the 
participants performed significantly worse in the areas of Verbal Memory, t (54) = 6.57, p < .001, 
Verbal Fluency, t (54) = 3.77, p = .001, Attention, t (54) = 3.46, p < .001, and Higher Cognitive, 
t (54) = 8.12, p < .001, than they did in the area of General Mental ability. Participants did not 
exhibit a significant difference in their performance on measures within the domain of General 
Mental ability as measured by percentile scores on the Vocabulary and Block Design subtests of 
the WAIS-III, although there was a trend that participants performed better on the Vocabulary 
subtest, t (54) = 1.970, p = .054. The only differences found among the other four domains was 
that performance in the domain of Attention was significantly better than both Verbal Memory,
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t (54) = 4.02, p < .001, and Higher Cognitive, t (54) = 3.50, p = .001. In addition, performance in 
the domain of Verbal Fluency was found to be better than Verbal Memory, t (54) = 2.14, p < .05.
Pearson product moment correlational analyses were conducted to assess the 
relationships among the five domains of neurocognitive functioning. Table 13 describes the 
findings. Attention was not significantly related to any of the other four domains, while Verbal 
Fluency was positively related to the other three domains of Higher Cognitive (r = .253, p < .05), 
General Mental (r = .393, p < .01), and Verbal Memory (r = .287, p < .05). Higher Cognitive was 
also positively associated with General Mental (r = .260, p < .05).
Neurocognitive impairment index. Impairment cut-off scores of more than one standard 
deviation below the mean are listed in Table 12 for each of the neurocognitive measures along 
with the percentage of participants who were found to be impaired on that particular measure.
This cut-off of one standard deviation below the mean is directly equivalent to a T  score of 40, a 
scaled score of 7, or a percentile score of 16%. Scores used to identify performance as impaired 
were age scaled scores for the WAIS-III, standard scores for the CVLT, or percentile scores 
corresponding to corrected raw scores (provided by test authors or available in the literature) for 
the other measures. Again, refer to Table 11 to see how these various scores are related. 
Participants as a group produced mean performance scores that were below average (i.e.,
T = 50, scaled score = 10, or percentile = 50%) on all of the measures administered except for 
the Vocabulary subtest of the WAIS-III. The percentage of participants that were identified as 
impaired on each measure ranged from 7.3% (n = 4) on the Digit Span subtest of the WAIS-III, to 
72.7% (n = 40) on the total CVLT recall score.
Because several subjects were missing one or more individual tests, a percentage of the 
total available tests that were impaired was calculated for each participant. Thus a frequency 
rather than an absolute score is obtained. The percentage of impaired scores reflects the 
Impairment Index for each person. The average Impairment Index across participants was 
36.38% (SD = 22.77), which indicates that on average, participants were impaired on more than
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one-third of the tests. This corresponds to an average of 6.55 (SD = 4.10) impaired scores per 
subject, which ranged from 0 to 16 impaired scores per participant across the sample.
Relationship Between Quality of Life and Psychiatric Status/Symptom Presentation (Hypotheses 
1a and 3a)
Pearson product moment correlational analyses were conducted to assess the 
relationships among quality of life scales and symptom presentation. Table 14 presents these 
findings. Several mental health symptom ratings were correlated with the QOLI subscales. The 
Total Score from the BPRS was significantly related to satisfaction with social interactions 
(r = -.349, p < .01). These results indicate that higher levels of psychiatric symptoms over the past 
month are associated with less satisfaction with social relations.
A significant relationship with satisfaction with social interactions as measured by the 
QOLI was found for both the BPRS scales of Positive Symptoms (r = -.256, p < .05), and Negative 
Symptoms (r=  -.371, p < .01). These results indicate that participants with higher levels of positive 
or negative symptoms also tended to experience less satisfaction with their social contacts. An 
analysis comparing the magnitude of the correlations between each of the symptom factors and 
the satisfaction with social interactions was computed using a test of significant differences 
between correlated correlations based on a corrected Fisher’s z statistic (Meng, Rosenthal, & 
Rubin, 1992). Results indicated that there was not a significant difference between the two 
correlations (z = -.788, p = .215).
Additional analyses revealed that the Depressive Symptom scale from the BPRS was 
correlated with Global Life Satisfaction (r=  -.554, p < .001), satisfaction with living situation 
(r = -.254, p < .05), satisfaction with daily activities (r = -.422, p < .01), satisfaction with family
contacts (r = -.246, p < .05), satisfaction with finances (r = -.226, p < .05), and satisfaction with 
overall health (r = -.428, p < .01). These results indicate that for these participants, higher levels of 
depressive-anxiety symptoms are associated with decreased satisfaction in each of these areas 
of their lives. The Manic Symptom scale was related only to victimization within the past year
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(r = .321, p < .01) and arrests within the past year (r = .411, p < .01). These results indicate that 
participants who exhibited greater levels of manic-excitement symptoms, also tended to have 
greater safety concerns and victimization, and more contacts with the law resulting in arrest.
Also, GAF scores were positively correlated with satisfaction with both family (r = .313, 
p < .05) and social (r=  .416, p < .01) relations, as well as satisfaction with their safety (r=  .241, 
p < .05) and number of social contacts (r = .237, p < .01). These results indicate that better overall 
psychiatric functioning is associated with higher satisfaction with both social interactions and 
safety issues, an increase in the number of social contacts, and greater satisfaction with those 
contacts.
Relationship Between Communication Disturbances and Psychiatric Status/Symptom 
Presentation (Hypothesis 2)
Pearson product moment correlational analyses were conducted to assess the 
relationships between communication disturbances on the CDI and symptom presentation as 
measured by the BPRS. Table 15 presents these correlations. None of the communication 
disturbances were significantly related to overall symptom presentation as measured by the total 
score on the BPRS, or to the specific BPRS scales of Negative Symptoms or Manic-Excitement. 
Missing Information References were related to the factor of Positive Symptoms (r = .261, p < .05) 
and Ambiguous Word Meanings were related to the factor of Depression-Anxiety (r = .242, 
p < .05). These results indicate that participants with more positive symptoms also exhibited more 
missing information references in their speech, while greater levels of depressive-anxiety 
symptoms are related to a greater number of ambiguous word meanings in their speech. 
Relationship between Neurocognitive Abilities and Psychiatric Status/Symptom Presentation 
(Hypotheses 1b and 3b)
Pearson product moment correlational analyses were conducted to assess the 
relationships among overall symptom presentation and neurocognitive functioning. Table 16 
presents these correlations. Only performance on the Digit Symbol -  Coding subtest of the WAIS-
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III was related to the Total Score on the BPRS (r=  -.228, p < .05). This result indicates that more 
psychiatric symptoms are related to a decline in symbol coding task performance.
Pearson product moment correlational analyses were conducted to assess the 
relationships between the Positive and Negative Symptom scales on the BPRS, and measures of 
neurocognitive functioning. Table 16 also presents these correlations. Several neurocognitive 
measures were related to the Negative Symptom scale on the BPRS. These include Digit Symbol
-  Coding (r = -.329, p <.01), Digit Symbol -  Pairing (r=  -.243, p < .05), Trail Making Test -  Part A 
(r=  .360, p < .01). Only Digit Span performance was related to the Positive Symptom scale on the 
BPRS (r = .243, p < .05). These results indicate that higher levels of negative symptoms are 
associated with fewer correctly coded symbols and greater time to complete the Trail Making Test
-  Part A. And, participants with more positive symptom presentation also tended to perform better 
when repeating lists of numbers.
Pearson product moment correlational analyses were conducted to determine the 
relationship between Total Score on the BPRS, as well as both the Positive and Negative 
Symptom scales, with the neurocognitive domain summary scores. Table 17 presents these 
findings. There were no significant relationships between BPRS Total Score and any of the five 
neurocognitive domains. These domain summary scores were calculated by averaging across z 
scores converted from raw scores for each of the neurocognitive measures that contributed to the 
particular. The domain of Attention was related to the Negative Symptom score (r = .252, p < .05) 
and Verbal Fluency was related to the Depressive-Anxiety Symptom scale (r = .230, p < .05). 
These results indicate that within this group greater negative symptom presentation is related to 
better performance on measures of attention and concentration. In addition, within the sample 
more depressive-anxiety symptomatology is associated with better performance on tasks of 
verbal fluency.
Also, when assessing current functioning, it was found that scores on the GAF 
significantly correlated with the domains of Verbal Memory (r = .335, p < .01) and Higher Cognitive
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abilities (r = .244, p < .05). These results indicate that as participants were rated higher in overall 
functioning, they also exhibited better verbal memory and higher cognitive abilities.
Relationship between Quality of Life and Social Adjustment
Several significant correlations were identified between the social adjustment 
global rating scales on the SAS-II and the Global Life Satisfaction rating on the QOLI. Adjustment 
in the domain of social and leisure activities was related to the global life satisfaction (r = -.270, 
p < .05). This is actually in a positive direction, as lower scores on the SAS-II indicate better 
adjustment, while higher scores on the QOLI indicate greater satisfaction. This was also true for 
the relationships between the Global Life Satisfaction on the QOLI and both household member 
adjustment rating (r = -.485, p < .01) and the overall social adjustment rating (r = -.355, p < .01) on 
the SAS-II. The ratings of work and external family adjustment on the SAS did not relate to the 
global life satisfaction rating on the QOLI. These results indicate that participants who experience 
greater global life satisfaction also tend to experience increased social functioning in relationships 
with household members, greater involvement in social and leisure activities, and greater overall 
social adjustment. Table 18 presents correlations between the scales on the QOLI and those on 
the SAS-II.
Relationship between Quality of Life and Neurocognitive Abilities (Hypothesis 4)
Pearson product moment correlational analyses were conducted to assess the 
relationship among subjective measures of quality of life and the Verbal Memory, Attention, and 
Higher Cognitive summary score domains of cognitive functioning. These domain summary 
scores were calculated by averaging across z scores converted from raw scores for each of the 
neurocognitive measures that contributed to the particular domain. None of the summary score 
domains were found to correlate with Global Life Satisfaction as measured by the QOLI. There 
were two significant correlations between these neurocognitive domains and other subjective 
quality of life scales. There was a significant association between Attention and number of social 
contacts (r = .268, p < .05), and between Verbal Memory and both satisfaction with finances
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(r=  .250, p < .05) and satisfaction with legal and safety issues (r=  .276, p < .05). These results 
indicate that participants who exhibit better performance on tasks of attention and concentration 
also tend engage in more social contacts. Also, better performance in verbal memory is 
associated with greater satisfaction with finances and legal and safety concerns. Table 19 
presents correlations between scales on the QOLI and these three domains of cognitive 
functioning.
Relationship between Communication Disturbances and Neurocognitive Abilities (Hypothesis 6) 
Pearson product moment correlational analyses were conducted to assess the 
relationship between each of the communication disturbances and the Verbal Memory, Attention, 
and Verbal Fluency summary score domains of cognitive functioning. These domain summary 
scores were calculated by averaging across z scores converted from raw scores for each of the 
neurocognitive measures that contributed to the particular domain. Table 20 presents these 
findings. Missing Information References were related to Verbal Memory (r = -.263, p < .05) while 
Confused References were related to Attention (r = -.248, p < .05). No communication 
disturbances were related to the cognitive summary domain of Verbal Fluency. These results 
indicate that poorer performance on tasks of verbal memory is associated with greater numbers 
of missing information references in speech, and poorer performance on tasks of attention and 
concentration is associated with more confused references in the speech of participants. 
Relationship between Neurocognitive Abilities and Social Adjustment
Pearson product moment correlational analyses were conducted to assess the 
relationships among measures of social adjustment and neurocognitive functioning. Table 21 
presents these findings. Only the neurocognitive domain of Verbal Memory was found to 
significantly correlate with the overall global rating (r = -.258, p = .05) on the SAS-II. This 
relationship is actually in the positive direction, as lower scores on the SAS-II indicate better social 
adjustment. Verbal Memory was also found to be significantly associated with work adjustment 
(r = -.439, p <.001), while Attention was correlated with social and leisure adjustment (r = -.287,
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p < .05) and General Mental was related to household member adjustment (r = -.391, p < .05). 
Again, these are all in the positive direction as lower scores on the SAS-II indicate better social 
adjustment. These results indicate that participants who exhibit better performance on tasks of 
verbal memory also tend to experience better adjustment in work and daily responsibilities, as well 
as overall social functioning. In addition, better performance on tasks of attention and 
concentration was associated with better adjustment in social and leisure activities, while better 
performance on tasks of general mental abilities was associated with greater social adjustment 
with household members.
Predictors of Quality of Life - Global Life Satisfaction (Hypothesis 8)
Multiple regression analyses were conducted to determine which of the study variable 
predicted the Global Life Satisfaction score from the QOLI. Variables were initially grouped into 
predictor sets according to theoretical similarity to the construct measured (e.g., social adjustment 
scores, cognitive domains, etc). Using a stepwise regression analysis, only the variables 
predicting variance from within each predictor set were retained. Because depressive 
symptomatology has been found to be strongly associated with, and at times indistinguishable 
from, subjective ratings of quality of life (Lehman, 1983; Lehman, 1996; Packer, et al., 1997), and 
as a result of the high correlation between depressive symptomatology as measured by the BPRS 
and Global Life Satisfaction (r=  -.554, p < .001) in the present study, controlling for this factor 
became an issue. Lehman (1988) recommends interpreting results from the QOLI with caution 
when considering the issue of depression, and in his own research has factored out the effects of 
depression (Lehman, 1983). Thus, in the present study, the variance accounted for by depressive 
symptomatology was removed by forcing the Depressive-Anxiety Symptom score from the BPRS 
into the regression analyses as the first predictor variable for both the initial analyses and the final 
regression. In the final regression analysis the retained predictor variables were entered to 
determine the relative contribution of each in explaining the variance in Global Life Satisfaction.
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For initial analyses, the predictor sets were identified by individual scores related to social 
adjustment, communication disturbances, neurocognitive domains, symptomatology and 
psychiatric status, and demographics. The only variable retained from the social adjustment set 
was the rating of global social adjustment. The only variable retained from the communication 
disturbances set was Ambiguous Word Meanings. No variables were retained from the 
neurocognitive, symptomatology and psychiatric status, and the demographics sets.
For the final regression, depressive-anxiety symptomatology was forced into the equation 
as the first variable. Then the global social adjustment and Ambiguous Word Meanings variables 
were entered into the equation in a stepwise fashion. When entered together, and after taking into 
account the effects of depressive symptomatology, both variables still accounted for a significant 
amount of the variance in the QOLI rating of global life satisfaction. Table 22 describes these 
results.
Overview of Hypotheses: General Social Adjustment Hypotheses
A. The hypothesis that overall symptom presentation would be positively correlated with 
impairment in social interactions was confirmed.
B. The hypothesis that neurocognitive functioning would be positively related to ratings of social 
adjustment was confirmed.
C. The hypothesis that global life satisfaction on the QOLI would be related to increased social 
adjustment was confirmed.
Overview of Hypotheses: Specific Hypotheses
1a. The hypothesis that overall symptom presentation would be negatively correlated 
with quality of life was partially confirmed as total symptoms are not related to 
global life satisfaction, but are related to subjective rating of satisfaction with social 
interactions
1b. The hypothesis that overall symptom presentation would be negatively correlated 
with neurocognitive functioning was not confirmed.
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2. The hypothesis that overall symptom presentation would be positively correlated with the 
ratings of communication disturbances was not confirmed.
3a. The hypothesis that negative symptoms would have a stronger negative relationship 
with quality of life than positive symptoms was not confirmed.
3b. The hypothesis that negative symptoms would have a stronger relationship with 
neurocognitive functioning than positive symptoms was partially confirmed as 
negative symptoms are related to a few neurocognitive measures sensitive to brain 
dysfunction, and positive symptoms are related to only one measure
4. The hypothesis that specific neurocognitive domains would be positively correlated with 
quality of life was partially confirmed as the domain of Attention is related to objective rating of 
number of social contacts, while no other relationships between domains or quality of life were 
found
5. The hypothesis that participants would exhibit more Ambiguous Word Meanings than other 
communication failures, followed by Missing Information References was confirmed.
6. The hypothesis that communication failures would be negatively associated with the 
neurocognitive domains of Verbal Memory, Attention, and Verbal Fluency was partially 
confirmed as Ambiguous Word Meanings are associated with the domain of Verbal Memory, 
and Confused References are associated with Attention
7. The hypothesis that participants would have greater deficits in the areas of Verbal Memory, 
Verbal Fluency, Attention, and Higher Cognitive functioning than in the domain of General 
Mental ability was confirmed.
8. The hypothesis that the quality of life rating of global life satisfaction would be predicted from 
the other variables of the study was confirmed.
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Discussion
The objective of this study was to explore a number of variables implicated in the 
functioning of persons with schizophrenia and to determine the relationship of each of these 
variables primarily to quality of life, and secondarily to one another. The anticipated result of this 
study was to increase understanding of the factors that contribute to quality of life and to identity 
potential strategies to assist in the improvement of the quality of life of persons with 
schizophrenia. General results will be discussed first, and then each of the specific hypotheses 
will be addressed. Final concluding comments will follow.
The participants in the present study could be best described as having chronic mental 
illness, as evidenced by the early average age of onset of psychiatric symptoms (between 23 and 
24 years old), the early age of first hospitalization (between 25 and 26 years old), and the long 
duration of illness, as the average age of participants was 47 years. During their participation, 
most participants were essentially in a residual phase of their illness, or were experiencing 
baseline symptoms. However, all were documented to have had florid psychotic symptoms in the 
past. In addition, participants averaged at least six previous psychiatric hospitalizations, and 
almost 95% were currently prescribed an antipsychotic medication. Other participant 
characteristics associated with severe and persistent mental illness include decreased 
interpersonal functioning as evidenced by lack of employment, general inability to maintain a 
marital relationship, and tendency to live alone. These findings are consistent with other 
descriptions of persons with chronic schizophrenia (DSM-IV-TR; Schultz & Andreasen, 1999).
As previously noted, almost 95% of the participants in the sample were prescribed 
antipsychotic medications. The average chlorpromazine equivalence for the participants was 
416.5 mg/day, which ranged from 16.6 to a very substantial 1825 mg/day. As the typical dose for 
chlorpromazine ranges from 75 to 1000 mg/day (Bezchlibnyk-Butler & Jeffries, 2001), the 
participants in this study on average are prescribed medications well within the suggested clinical 
range. The results of initial analyses showed that age of participants negatively correlated with
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daily medication dosage in chlorpromazine equivalents. Thus, older participants tended to be 
prescribed lower doses of medications. This may be a result of pharmacokinetics, or how the 
body handles the drug. Older individuals tend to metabolize medications at a slower rate, so 
dosages need to be lower because the medication remains in the system longer. In addition, 
changing body composition with age (i.e., more fat and less muscle) also impacts how the drug is 
distributed and metabolized within the body. Differences in medication could also be due to overall 
stabilization of symptoms and the experience of fewer positive or floridly psychotic symptoms later 
in the course of the illness, as medications are traditionally prescribed more to control the positive 
symptoms of schizophrenia. This is consistent with reports that the negative syndrome is more 
prevalent in the chronic state of schizophrenia (Crow, 1987) and that a percentage of persons with 
schizophrenia improve from the effects of the disorder over time (Harding, Zubin, & Strauss,
1987). However, debate regarding the course of schizophrenia continues, as was discussed 
previously in the literature review on course of the illness.
The study found that participants were exhibiting fairly mild psychiatric symptoms as 
measured by the Brief Psychiatric Rating Scale (BPRS), which, although warranting attention by 
professionals, did not result in serious impairment in functioning, as classified by the Global 
Assessment of Functioning (GAF). This finding lends support to the notion that older persons with 
schizophrenia, such as those in the current sample, tend to exhibit fewer psychotic symptoms, 
although symptom reduction could also be a function of the effective treatment and clinical 
management of medications and other services that the participants were receiving at the time. 
Specifically, the use of novel antipsychotic medications may speak to the relatively asymptomatic 
status and high functioning of the study participants. The results of initial analyses showed that 
lack of current employment was related to higher symptom presentation, including both positive 
and negative symptoms, and decreased global functioning. This is not a surprising finding, as one 
would expect that individuals exhibiting greater psychiatric symptoms and impairment in 
functioning would not be able to maintain or have interest in obtaining employment. Alternatively, it
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may be that persons who are unable to find and maintain employment become despondent or 
unhappy with their circumstances and then begin to exhibit greater symptomatology.
Quality of Life
The present study provides evidence that despite having a chronic mental illness, 
participants report feeling “mixed” to “mostly satisfied” with their general life circumstances. This 
may be due in part to the participants’ reports, regarding objective quality of life, which indicated 
that participants did engage in a number of activities outside of the home, had at least semi­
regular social contact with relatives and friends, and tended to have sufficient funds to cover basic 
living expenses such as food, clothing, and housing. In addition, these individuals were not likely 
to have been a victim of a crime or otherwise have had contact with the legal system in the past 
year. Satisfaction with general life circumstances may also stem from the satisfaction participants 
reported in more specific areas, such as daily activities, social interactions, finances, living 
situation, safety, and employment (at least for those who were working). Overall, these individuals 
felt that their basic needs were generally addressed to a satisfactory degree, and felt content with 
most areas of their lives. These findings are similar to those in other studies using the Quality of 
Life Interview (Lehman, et al., 1986; Sullivan, et a!., 1991 ;Trauer, Duckmanton, & Chiu, 1998).
The results of the present study revealed that demographic variables such as age and 
gender did not have any association with the ratings of quality of life. This contrasts with previous 
research with the QOLI (Lehman, et al., 1992), that had found that gender and decade of life 
appear to play a role in the quality of life experiences for persons with schizophrenia and other 
severe mental illness. It was discovered by these other authors that as individuals age, their 
reports regarding objective quality of life such as number of family contacts, and social and leisure 
activities, decrease for both males and females. In addition, across the life span, females were 
found to engage in more social activities while males tended to have more spending money 
available. When considering the present study, it may be that because this was an older sample, 
and because the participants tended to be fairly close in age across the group, no effects of age
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were noted. Again, the size of the gender groups may play a part in the current lack of differences 
between males and females, as a larger sample size for females was not available.
Correlational analysis revealed several significant relationships between satisfaction 
ratings on general life circumstances and the other ratings on the QOLI. Specifically, all of the 
subjective ratings except satisfaction with work were significantly related to the overall global life 
satisfaction rating. This is to be expected, considering that satisfaction in each of the individual 
areas contributes to overall life satisfaction. The item on satisfaction with work was only rated by 
those who were currently working, and so it does not contribute to overall life satisfaction across 
the entire sample. Strong correlations among the subjective ratings have been found in previous 
research (Trauer, et al., 1998), primarily because these rate satisfaction with different areas of 
one's life, and satisfaction in one area can directly impact satisfaction in another. In the literature, 
areas of life satisfaction, as well as domains of psychiatric outcome, tend sometimes to be 
correlated, but exhibit surprising independence in other studies (Strauss & Carpenter, 1972).
Only one objective rating, having more numerous social interactions, was found to be 
associated with general life satisfaction. It is not known specifically why the other objective ratings, 
such as number of contacts with family members or amount of spending money, do not contribute, 
although this is consistent with other research on the QOLI (Trauer, et al., 1998). It may be that 
participants have adapted to their current circumstances and are satisfied with their experiences. 
Previous long-term studies of schizophrenia reveal that much of the deterioration in schizophrenia 
occurs in the early stages of the illness (Davidson & McGlashan, 1997; McGlashan, 1988). Most 
of the participants in the current study are older with a long course of illness, and it could be 
argued that they are more stable in their illness and/or have found methods to cope with, or 
become reconciled to, some of the changes in functioning or deterioration, and as a result are 
more satisfied with their life circumstances. Alternatively, the number of contacts with family 
members may not be as important to persons with schizophrenia as the quality of the contacts 
that they already have. Although having a social support network comprised of family members
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
Functioning in Schizophrenia 106
has been found to be a positive factor in the lives of some persons with schizophrenia (Sullivan, et 
al., 1991), the presence of family members can also contribute to difficulties (Hooley, 1998), or 
possibly be a mixed blessing depending on how relatives attribute the individual’s psychiatric 
symptoms (Hooley, et al., 1987). Also, having sufficient funds to meet basic needs may be more 
important than additional spending money for these individuals.
Again, the issue of current medications should be considered when evaluating the 
relatively high functioning and satisfaction that has been exhibited by this group. Not only do novel 
antipsychotic medications contribute to a decrease in both the positive and negative symptoms 
and improvement in overall functioning, but they are associated with a lower rate of side effects, 
which can also contribute to the satisfaction that these individuals report with their lives.
Another hypothesis could be that, as many of the participants were patients at a large VA 
Medical Center and a great number of these patients were receiving disability payments and other 
services or resources as part of their comprehensive care, many of their basic needs - both 
concrete and social - were addressed. Payments and additional services that VA patients obtain 
can be quite considerable in some cases, which may allow the individuals to maintain a slightly 
higher standard of living than other persons with severe and persistent mental illness. In addition, 
many patients spend considerable time at the Medical Center socializing with other veterans and 
engage in regular interactions with a variety of staff. This may translate into greater satisfaction 
with numerous areas of their lives and higher scores on the subjective ratings on the QOLI.
Alternatively, these participants may exhibit response bias in their ratings of satisfaction 
with different areas of their lives. Social desirability is a phenomenon that is commonly studied in 
the general population (Edwards, 1957). Such a response bias may be especially relevant for 
those participants who receive their ongoing care at the VA Medical Center and could be 
concerned about the opinions of research staff or the perceived possibility that information would 
be shared with their providers. These factors may have lent unanticipated demand characteristics
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to the context of this research. In addition, these participants just may not want to acknowledge 
that they are not sufficiently satisfied with the various areas of their lives.
Social Adjustment
The results indicate that social adjustment in the five areas measured (work and daily 
responsibilities, household member, external family, social and leisure, and global adjustment) 
varied in range from above average (good) to below average (poor) for these participants. This is 
similar to other findings that indicate persons with schizophrenia are able to function with varying 
degrees of social deficits depending on the specific area being assessed (Glazer, et al., 1982; 
Weissman, et al., 1978). These individuals exhibited the most impaired social functioning in 
relation to their work role, whether it was employment, household responsibilities, or educational 
activities. Average adjustment was seen in the areas of relationships with external family, social 
and leisure activities, and general social functioning. These participants reported slightly higher 
than average adjustment in their mutual relationship with the primary person in their household. 
The conclusion to be drawn here is that these persons with schizophrenia function adequately in 
their social interactions, even though definite improvements could be made.
Limitations to the use of the Social Adjustment Scale-ll (SAS-II) include the instruction to 
“skip out” of a section if it does not apply to an individual. For example, those participants who had 
no household member because they were living alone or have no children were not asked those 
particular sections of the interview. As a result, they could not be rated in those section and no 
global rating for that social domain was available. Thus, the average global ratings for the sample 
include only those individuals for whom ratings were made, and as a result, the average ratings 
may not fully address the true social impairments of the participants. For example, the fact that an 
individual does not live with others or is not a parent may reflect poor social adjustment and an 
inability to maintain relationships. Another potential drawback to this scale is that the global ratings 
are made based upon the interviewer’s comparison of the participant to their conception of a 
“normal” person in the community. This is a very subjective procedure, and as such, interviewer
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biases may enter into the rating. However, these ratings do avoid some of the problems of subject 
response bias, as they are made by an “outside observer."
As with completing the QOLI, the concern of response bias still may also arise with the 
SAS-II. Some participants may be reluctant to indicate the extent to which their social functioning 
is impaired and may instead over-report social activities and interactions or under-report 
limitations or social difficulties that they experience. This was addressed to an extent through 
completion of a “Current Informant” interview as part of the larger study from which this data was 
obtained. At times, participant reports were very consistent with those of the current informant. But 
just as often, the reports were dissimilar or the current informant did not have sufficient 
information or knowledge to address the questions. This was especially evident for those 
participants who lived alone and had limited regular social contacts with others. In those cases 
where a discrepancy was evident, efforts were taken to determine which was the more accurate 
report, based upon the amount of detail, consistency across the interviews, and recent progress 
notes that described the individual’s current functioning as observed by his or her provider. 
Although the ratings on the SAS-II and the QOLI were not altered, the more accurate report was 
taken into consideration when making diagnostic decisions and symptom ratings.
The results of initial analyses revealed that female participants exhibited significantly 
more impaired social adjustment in their relationship with their primary household member and 
external family members. Due to the vast difference in the sample size of the gender groups (47 
males, 8 females), it is difficult to determine if this is a meaningful or clinically significant 
difference. More of the female participants lived with others and so this may have put them in 
situations where strained relationships are more likely to develop. Current employment was also 
found to be significantly related to adjustment in work and daily responsibilities, as well as in 
overall social adjustment. This is not surprising, as individuals who are functioning well enough to 
maintain employment would presumably exhibit improved social skills in interactions with people 
in other areas of their lives as compared to those who do not maintain employment.
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Communication Disturbances.
Examination of the communication disturbances results suggests that the speech of ail 
persons with schizophrenia contains some level of unclear references, however no comparison to 
a control sample or other psychiatric group was done as part of this study. In addition, these 
individuals produced varying amounts of speech, as the total number of words for a 10-minute 
speech sample ranged from approximately 450 to well over 2200 words. To account for 
differences in amount of speech, this measure does provide scores based upon disturbances per 
100 words of speech, resulting in proportional frequency rather than absolute scores. All six of the 
communication failures as measured by the CDI were present in the speech of these persons with 
schizophrenia. Study participants produced more Ambiguous Word Meanings than any other type 
of communication failures. This is reflected in their frequent use of words for which the intended 
meaning is not obvious, especially in situations when a word or phrase has more than one 
possible definition and the listener is unsure as to which the speaker is referring.
Ratings of all the communication failures other than Confused References were 
correlated with one other, and all of the communication failures, including Confused References, 
were correlated with the Total Communication Disturbance score. This indicates that as 
participants exhibited frequent communication failures of one type, they generally exhibited other 
failures as well.
Limitations to this measure, as described by its author (Docherty, et al., 1996), include the 
fact that the measure does not take into consideration the complexity of the individual speech 
sample or the severity of the communication failures because only frequencies are recorded, with 
no weighting based on severity. Some communication failures can be quite subtle and the basic 
idea of the phrase can still be understood (e.g., “I would sit in the cafe and just glare out into the 
night”), while others are more extreme and the listener is unable to understand the phrase (e.g., “I 
was trying to predict them people that I need”). Each of these examples would be rated only as 
one instance of Wrong Word Reference with no impact of the severity of the failure. Generally,
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those speech samples containing severe failures also contain frequent failures. However, it is 
possible that those participants who produced little speech and exhibited only a few severe 
communication failures would appear to be exhibiting less overall communication disturbance than 
those participants who produced extensive speech and more numerous but more subtle errors. 
There is no way to control for or evaluate this possibility unless a qualitative analysis of the 
speech samples was completed. Such a procedure was not undertaken in this study. Additional 
concerns about these results include the limitations to the interrater reliability across the three 
raters, as reliability for Confused References and Wrong Word References were determined to be 
fair and good, respectively. However, all other reliability coefficients for the ratings on the CDI 
were determined to be excellent across the three raters.
Neurocognitive Performance
Findings of the current study demonstrated that participants as a group were performing 
in the average to low average range on all of the neurocognitive measures. No control group was 
used in the present study, and so comparisons of performance level cannot be made in this way. 
However, norm-based standardized scores were used as part of the examination of performance, 
and so comparisons to a normative sample can be made. For example, none of the subjects on 
any of the measures, other than the Vocabulary subtest of the Wechsler Adult Intelligence Scale -  
Third Edition (WAIS-III), demonstrated performance in greater than the 50th percentile. One would 
expect more of the scores to be closer to the mean for a normative sample; therefore the results 
for these participants as a whole can be considered lower than what would be anticipated in the 
general population. In addition, based primarily on performance on the Vocabulary subtest (one of 
the best predictors of expected level of performance) and secondarily on performance on the 
Block Design subtest (another often-used indicator of expected performance) these participants 
are exhibiting lower-than-expected performance on the other neurocognitive tasks. It can be 
concluded that these individuals are exhibiting some level of deficit on their neurocognitive 
performance. Such a conclusion is consistent with findings that the performance of persons with
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schizophrenia tends to be impaired on a wide range of measures, which indicates generalized but 
evident cognitive deficits (Chapman & Chapman, 1973; Rund, 1998).
Five domain scores were generated to assess the performance of these participants in 
particular areas of neurocognitive functioning. Percentile scores on measures that were 
hypothesized to tap into similar constructs were grouped together and combined in order to better 
examine specific areas of performance. The results provide evidence that participants as a group 
were performing in the average range in the domains of General Mental abilities, Attention, Verbal 
Fluency, and Higher Cognitive abilities, while they performed in the low average range in the 
domain of Verbal Memory. Again, as no control group was used, comparisons based on 
performance within the study cannot be made, but as none of these domains achieved a score 
greater than in the 50th percentile, the domain abilities can be considered lower than what would 
be expected in the general population. In addition, based upon comparison with the General 
Mental ability domain (composed of the Vocabulary and Block Design subtests of the WAIS-III), 
which is the best indicator of expected performance for this group, the participants are performing 
lower than expected on the other domains. (See also section regarding Hypothesis 7 for additional 
discussion on this topic).
Results of initial analyses revealed that participants’ years of education were significantly 
related to the domain of General Mental ability, as those individuals with more education tended to 
perform better in this domain. This finding is not surprising, given that the General Mental domain 
includes a measure of word knowledge, which can be strongly influenced by education. In 
addition, the two tests that contribute to the General Mental domain (the Vocabulary and Block 
Design subtests of the WAIS-III) are considered to be good indicators of premorbid functioning, a 
factor itself which can be associated with educational pursuits.
When averaging over a group, individual differences are generally minimized. Thus it is 
important to consider an individual's performance across measures, especially when considering 
that patterns in neurocognitive deficits of persons with schizophrenia exhibit considerable variation
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(Heinrichs & Zakzanis, 1998; Rund, 1998). The Impairment Index provides an estimate of the 
individual functioning of each of those who participated in the current study. Using a cut-off score 
of one standard deviation below the mean (from normative data provided by test authors or 
selected from the literature based on the measures’ psychometric properties), the Impairment 
Index reflects the percentage of measures on which the participant demonstrated impaired 
performance. Results indicate that, individually, participants were impaired on more than 36% of 
the measures that they completed. This percentage corresponds to an average of more than 6.5 
impaired measures per individual. This is fairly consistent with the finding that persons with 
schizophrenia are generally impaired on 40 to 60% of neurocognitive measures (Goldberg, et al.,
1988) and with descriptions of generalized deficits in schizophrenia discussed above. The number 
of impaired scores varied across individuals as well, ranging from a low of 0, to as many as 16. 
Such a finding speaks to the variability of functioning within persons with schizophrenia, the 
variability of functioning across persons with schizophrenia, and that no one impairment can be 
presumed to be diagnostic of the illness (Heinrichs & Zakzanis).
A limitation to the neurocognitive performance results is that many of the correlations 
between neurocognitive performance and other variables were made using neurocognitive 
domain scores calculated from z scores that were obtained from raw scores on each of the 
measures. As a result, these z scores represent each participant’s performance relative to the 
total group of participants, rather than compared to normative data. As a result, many of the 
scores may be in the average range as compared to the performance of the group as whole, 
when in fact the scores would be otherwise considered impaired if they had been compared to a 
normative sample. Thus, only the most impaired of individuals as compared to the other 
participants obtained z scores in the impaired range. As a result, the performance of these 
participants has been artificially elevated and not all impairments are evident in the data.
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Hypotheses Related to Social Adjustment
The current study hypothesized that overall symptom presentation would be positively 
correlated with impairment in social interactions. The results support this hypothesis, as higher 
levels of current symptomatology were associated with difficulty in relationships with external 
family members, a decrease in pursuits of social and leisure activities, and impaired overall social 
functioning. This is not surprising, as one would expect those persons with schizophrenia who are 
experiencing more symptomatology to have difficulty in their interactions with others and social 
pursuits. Psychiatric symptoms can have a detrimental effect on the interpersonally relevant 
behaviors of an individual, especially if they are experiencing psychotic symptoms that are not 
well understood by others, or more negative symptoms which often result in withdrawal and 
inactivity. It is for such reasons that when persons with schizophrenia begin to exhibit serious 
symptomatology, they are often hospitalized because they are unable to care for themselves and 
maintain life in the community, or lack sufficient social support.
This study speculated that better neurocognitive functioning would be positively related to 
ratings of social adjustment. A review of the current data confirms this hypothesis. Participants 
were found to experience higher levels of adjustment in work and completing daily responsibilities, 
as well as with general social interactions, as they also exhibited better performance in abilities of 
verbal memory. This is not unexpected, as such a skill facilitates the accomplishment of work and 
daily responsibilities and is strongly involved in general social interactions, whether it is in 
following instructions, engaging in conversations, or participation in activities, for example.
Attention was found to be related to adjustment in social and leisure activities. This is also not 
surprising, as attentional ability is needed in many leisure pursuits, such as reading, watching 
television or movies, or engaging in hobbies. Attention is also required for interactions with others 
in a social context, for example in following conversations and participating in activities. General 
Mental ability was found to be correlated with adjustment in relationship with primary household 
member. One explanation for this finding is that ongoing interactions with a given person may
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become strained when it appears that the person with schizophrenia does not have the ability to 
engage in routine tasks or maintain a basic skill level.
Previous research has resulted in varying conclusions regarding the relationship between 
neurocognitive functioning and social adjustment. In some cases no neurocognitive associations 
were found with social functioning as a whole (Addington, et al.t 1998), or only with certain 
aspects of social functioning, such as social problem solving (Addington & Addington, 1999). In 
other research, specific neurocognitive tasks measuring spatial organization and visual spatial 
abilities (Dickerson, et al., 1996), verbal memory and vigilance (Green, 1996), or, in the case of 
females, verbal memory alone (Mueser, et al., 1995) were related to overall social adjustment and 
competence.
The current study showed that specific areas of neurocognitive functioning are related to 
specific areas of social functioning. As persons with schizophrenia are identified as having deficits 
in one or more of these particular areas of social functioning and when it has been determined 
that their social functioning is an area for rehabilitation, steps can be taken to assist the individual 
in improving their neurocognitive abilities and developing compensatory skills that presumably will 
have a direct effect on their social functioning as well. Based on these results, developing 
rehabilitative strategies to improve verbal memory and attention may also result in better social 
functioning in work, social-leisure, and general social interactions.
However, it appears that more research into the impact of neurocognitive functioning on 
social adjustment is needed. Also, researchers need to specifically identify which aspects of social 
adjustment are to be studied and select neurocognitive measures that are theoretically related to 
the social adjustment domains under consideration.
This research hypothesized that social adjustment would be related to the quality of life 
rating of Global Life Satisfaction. This hypothesis was supported as the data reveals that 
adjustment in the areas of relationship with primary household member, social and leisure 
activities, and global social functioning were all significantly related to Global Life Satisfaction.
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Thus one can conclude that persons with schizophrenia tend to be more satisfied with their lives 
when they are also experiencing positive relationships with the primary person in their 
households, more social and leisure pursuits, and overall have better social functioning. It can be 
argued that social interactions bring meaning and pleasure into most people's lives, and it appears 
to be the case with the participants in this study.
These results are also expected when considering the individual quality of life scales that 
were associated with the Global Life Satisfaction, including satisfaction with daily activities, living 
situation, social relations, family relations, and greater number of social contacts. Having these 
similarities between scales • both in terms of content sampling and of their intercorrelations - 
indicates that there was consistency across reports for the interviews. Also, as the SAS-II is an 
interviewer-rated measure and the QOLI Is based on self-report, the convergence of ratings 
suggests that similar information was being taken into consideration for the ratings. This also 
speaks to the previously discussed issue of the reliability of persons with schizophrenia in 
reporting their satisfaction and quality of life.
Specific Hypotheses
Hypothesis 1a (Correlation between overall symptom presentation and quality of life). The 
study hypothesized that overall symptom presentation would be negatively correlated with the 
measures of quality of life. The results partially confirm this hypothesis. Although overall symptom 
presentation is not related to Global Life Satisfaction, it is significantly associated with the 
subjective measure of satisfaction with social interactions. Based on these findings, it would 
appear that in those persons with schizophrenia who experience more psychiatric symptoms, the 
quality of their social interactions is less. This may be a direct result of their exacerbating 
psychiatric status and the impact that it has on the individual’s presentation and behaviors, and 
even desire to engage in social interactions. These factors can lead to difficult or inappropriate 
interactions and behaviors, a reduction in the number of social interactions, or the avoidance of 
interactions all together. Alternatively, participants may experience reduced satisfaction with their
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social interactions, for unrelated reasons, and as a result become distressed or displeased. Such 
negative feelings could lead to depression and/or the expression of negative symptoms.
Hypothesis 3a (Correlation between symptom factors and quality of life). The present 
research hypothesized that negative symptoms would have a stronger relationship with quality of 
life than positive symptoms. Both symptom domains were found to have a significant association 
with quality of life as measured by satisfaction with social interactions. However, there was no 
difference between the magnitude of each of these correlations, therefore the hypothesis was not 
proven to be true. Instead positive and negative symptoms maintain a similar relationship with 
participants' ratings of satisfaction with social interactions. Such a finding may be a result of the 
relatively low level of symptoms displayed by the participants in the study and limited variation in 
symptom presentations.
Several additional results reveal that other BPRS factors were associated with various 
scales from the QOLI. Manic symptoms are associated with victimization and arrests within the 
last year. A possible explanation for this finding is that persons who are experiencing manic 
symptomatology may find themselves in situations which result in contact with the legal system, 
whether as a result of victimization, illegal, or inappropriate activity. Depressive-anxiety symptoms 
were strongly related to less global life satisfaction, satisfaction with daily activities, and 
satisfaction with health. The symptoms were also moderately correlated with lower satisfaction 
with living situation, family contacts, and finances. This is not surprising in light of the previous 
discussion that depressive symptomatology is often indistinguishable from global quality of life, 
and these life areas should be taken into consideration when the global life satisfaction rating is 
made by the participants. It is interesting to note that the BPRS is a clinician-rated measure, while 
the satisfaction ratings on the QOLI are provided by the person with schizophrenia. One 
conclusion to be drawn is that the clinicians and participants are exhibiting strong parallels in their 
ratings of the participants' experiences. An alternative conclusion is that the QOLI measures 
primarily the effects of depressive symptomatology on a variety of life circumstances rather than
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patient-rated quality of life. If this were the case, it may be that interventions specifically targeting 
depressive symptomatology, in addition to those psychotic symptoms typically associated with 
schizophrenia, would be warranted. Such a goal could be accomplished by antidepressant 
medications or psychotherapy targeted at the depressive process. Additional research is needed 
to fully explore the relationship between depressive symptoms and their effects on ratings of 
quality of life as measured by the QOLI.
Future research may want to consider the possibility of exploring the relationship between 
specific individual symptoms (as rated by individual BPRS items or using other instruments) and 
quality of life. It may be possible to differentiate the effects of various symptoms from one another 
and their impact on ratings of quality of life. Such knowledge may improve services that are 
provided to persons with schizophrenia as their individual symptoms can be targeted with the goal 
of improving Global Life Satisfaction and other areas of quality of life.
Hypothesis 4 (Correlation between neurocognitive domains and quality of life.) The study 
hypothesized that quality of life (objective) would be positively correlated with the neurocognitive 
domains of Verbal Memory, Attention, and Higher Cognitive functioning. This hypothesis was not 
strongly supported by the results. The only objective rating of quality of life to be related to any of 
the domain scores was the number of social contacts reported by the individual with the domain of 
Attention. The reason for this may be similar to issues discussed above in relating social 
adjustment to Attention. It may appear that persons with schizophrenia would engage in more 
social contacts (either by making plans or being asked by others) when they are better able to 
attend to interactions with others and the activities that they engage in. In addition, none of these 
neurocognitive domain scores were associated with global life satisfaction. This may indicate that 
persons with schizophrenia can be sufficiently satisfied with their overall life circumstances 
despite any neurocognitive impairments they may experience, a conclusion that other researchers 
have also drawn (Heslegrave, et al., 1997). Alternatively, it may be that although these 
participants are exhibiting some neurocognitive deficits, as can be seen by the Impairment Index
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indicating that on average participants are impaired on more than one-third of the measures, the 
impairments are not severe enough to significantly affect functioning and quality of life. It is 
possible that a less stable or more neurocognitively impaired group would have rated their Global 
Life Satisfaction lower than the group of the present study.
Hypothesis 1b (Correlation between overall symptom presentation and neurocognitive 
functioning). This research hypothesized that overall symptom presentation would be negatively 
correlated with performance on neurocognitive tasks. As a whole, this hypothesis was not 
supported. The only neurocognitive task to be significantly associated with current 
symptomatology was the Digit Symbol -  Coding subtest of the WAIS-III. This finding may again be 
a result of the limited symptomatology that was currently being exhibited by the study participants. 
However, as this particular measure is generally considered to be the most sensitive 
neurocognitive assessment to any form of brain dysfunction (Lezak, 1995), it may have been the 
only measure able to discriminate the small but significant effects of overall symptoms. Again, 
additional correlations with other measures may have been observed if the sample as a whole 
had been more symptomatic or if more sensitive measures of general brain dysfunction were 
used.
Hypothesis 3b (Correlation between symptom factors and neurocognitive functioning.)
The present study hypothesized that negative symptoms would have a stronger relationship with 
neurocognitive functioning than positive symptoms. This hypothesis was somewhat supported by 
the data. The negative symptom dimension was found to be significantly associated with poorer 
performance on the Digit Symbol -  Coding and Pairing subtests of the WAIS-III, as well as to the 
total time on the Trail Making Test -  Part A. The positive symptom dimension was found to be 
related only to performance on the Digit Span subtest of the WAIS-III. These results again speak 
to the sensitivity of the Digit Symbol subtest and its ability to discriminate the subtle effects of 
negative symptoms. Also, it has been shown in the literature that negative symptoms tend to 
impact cognitive functioning to a greater extent than positive symptoms (Paulsen, et al., 1995) and
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more so in the areas of visual-motor and visual-spatial skills (Green & Walker, 1985; Strauss, 
1993), abilities which both the Digit Symbol and Trail Making Test tap into. It is unclear why 
positive symptoms are related to improved performance on the Digit Span subtest of the WAIS-III. 
This is an unexpected finding as positive symptoms have been found to be related to deficits on 
tasks of short-term verbal memory (Green & Walker) and auditory processing (Strauss), areas 
which the Digit Span subtest taps into. It may be that the participants who were currently 
experiencing some positive symptoms, possibly on a chronic basis, have adapted to the 
occurrence and have in fact developed coping strategies to adjust for the impact of the positive 
symptoms.
Hypothesis 7 -  Relative Deficits Among the Neurocognitive Domains. The current study 
hypothesized that the participants would exhibit greater deficits in the areas of Verbal Memory, 
Verbal Fluency, Attention, and Higher Cognitive functioning than in the domain of General Mental 
ability. The results supported this hypothesis as performance in the four indicated domains was 
significantly worse than performance in the area of General Mental ability. This is consistent with 
reports that persons with schizophrenia demonstrate mild to moderate impairments on measures 
of verbal ability, learning, attention, abstraction, and flexibility of thinking (Heaton, etal., 1994; 
Heinrichs & Zakzanis, 1998). These results indicate that as a whole participants are performing 
below their expected neurocognitive level (as estimated by performance on the tasks included in 
the General Mental domain) even though their aggregated scores in these other four domains are 
still in the average to low average range. This again speaks to the variability of neurocognitive 
performance across persons with schizophrenia, and the potential effects that higher performing 
individuals can exert on group scores.
Hypothesis 2 (Correlation between symptom presentation and communication 
disturbances). This study hypothesized that overall symptom presentation would be positively 
correlated with the ratings of communication disturbances. The results did not support this 
hypothesis, as overall symptom presentation was not correlated with any other ratings of
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communication failure or with the Total Communication Disturbance rating. An explanation for this 
finding may be again that as the participants were exhibiting relatively few overall symptoms, the 
symptoms did not impact the communication disturbance ratings. In addition, much of previous 
research completed by Docherty’s group (Docherty & Gottesman, 2000; Docherty, et al., 1996, 
Docherty, et al., 1998; Docherty, et al., 2001) did not report on current symptomatology and so 
expectations for symptom effects are not clear. Several of the studies did report symptomatology, 
but only by correlating BPRS total scores with other measures after the influence of conceptual 
disorganization was removed (Docherty & Gordinier, 1999; Docherty, et al., 2000) or in relating 
patient symptomatology to the speech disturbances of relatives (Docherty, et al., 1999). No total 
scores for symptoms were reported in these studies. Thus, it is not clear what role current 
symptomatology plays in the expression of communication failures. However, as the total number 
of communication disturbances rated in the present study was similar to that found in previous 
studies, and as our population exhibited a somewhat greater number of Vague References and 
slightly fewer Structural Unclarities than found in other research using the CDI, it can be 
hypothesized that overall symptoms may influence the relative frequencies of communication 
failures that are expressed by individuals, rather than the total number of each type of 
disturbance. Additional exploration of the relationship between current symptomatology and 
expression of communication disturbances is warranted.
Hypothesis 5 -  Frequencies of Ambiguous Word Meanings and Missing Information 
References. The study hypothesized that participants would exhibit more Ambiguous Word 
Meanings than other communication failures, followed by Missing Information References. The 
results upheld this hypothesis as Ambiguous Word Meanings were found to occur much more 
frequently than other communication failures in the speech samples of the participants, and that 
Missing Information References were more prevalent than the other four communication failures. 
This is consistent with previous studies using the CDI (Docherty, DeRosa, et al., 1996; Docherty, 
Hall, et al., 1998; Docherty, et al., 1999; Docherty & Gottesman, 2000; Docherty et al., 2000;
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Gordinier & Docherty, 2001) that have found Ambiguous Word Meanings to be the most common 
communication failure in the speech of all participants, regardless of group membership or 
psychiatric status. Missing Information References have been found to best differentiate the 
speech of persons with schizophrenia from other diagnostic groups and controls (Docherty, 
DeRosa, et al., 1996), and thus has been described as the most “schizophrenic” in quality. This 
type of communication failure makes references to information that is completely unknown to the 
listener and often makes the speaker especially difficult to follow. Missing Information References 
have also been found to be more prevalent in the speech of nonpsychiatric relatives of persons 
with schizophrenia (Docherty, et al., 1998; Docherty, et al., 1999) and has been identified as a 
possible indicator of a schizophrenic genotype (Docherty & Gottesman, 2000). It is not known at 
this time how Missing Information References relate to the expression of schizophrenia. Future 
research could consider clinical factors such as severity of the illness, duration, or age of onset, to 
determine differences among subgroups of persons with schizophrenia when analyzing 
communication disturbances.
Hypothesis 6 (Correlation of communication disturbances with neurocognitive 
functioning). The current study speculated that communication failures would be negatively 
associated with the neurocognitive domains of Verbal Memory, Attention, and Verbal Fluency.
This hypothesis was partially supported by the data. Specifically, Missing Information References 
were found to be correlated with deficits in Verbal Memory, and Confused References were 
correlated with deficits in Attention. No communication failures were found to correlate with Verbal 
Fluency. Missing Information References have been noted to occur by Docherty and her 
colleagues (2000) as an inability to remember what has actually been said to the listener as 
opposed to only thought by the speaker. Thus, the relationship between Verbal Memory and 
Missing Information References is understandable. Confused References were described as an 
inability to remember discourse long enough to execute it. Again, the relationship between 
Attention and Confused References is understandable. However, in their research, Docherty and
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colleagues instead have found that Missing Information References were related to performance 
on a continuous performance task of Attention, and Confused References were related to 
immediate auditory memory as measured by a digit span task. This Confused References finding 
is consistent with the present study, as half of the Attention domain score is attributed to a digit 
span task. Docherty’s group did not administer a list learning task, and the present study did not 
include a continuous performance task. Thus, it is difficult to determine what similarity or 
differences there are in the two studies’ findings. However, based on the description of the 
process underlying Missing Information References, verbal memory could certainly be implicated. 
Additional research in this area involving a more theoretically-driven selection of neurocognitive 
measures is needed.
Hypothesis 8 (Prediction of quality of life from other variables). The study hypothesized 
that the quality of life rating of global life satisfaction could be predicted from the other variables of 
the study. This hypothesis was supported by the data. After removing the effects of depressive 
symptomatology, because certain aspects of psychopathology, especially depression and anxiety, 
correlate moderately with QOL and should be taken into consideration (Lehman, 1988), it was 
found that Ambiguous Word Meanings from the COI and the global rating of general social 
adjustment from the SAS-II best predicted global life satisfaction from the QOLI. Thus it appears 
that global life satisfaction is most closely related to fewer depressive symptoms, more frequent 
communication failures involving ambiguous word meanings, and better overall social functioning. 
Having global life satisfaction predicted by less depressive symptoms and greater social 
adjustment is expected, as improved psychiatric status and social interactions are important 
considerations for consumers of mental health services, and can contribute to a more pleasant 
and meaningful life. However, predicting global life satisfaction from a greater number of a 
particular communication failure is less expected. One potential explanation is that Ambiguous 
Word Meanings are the most frequently observed communication disturbance in the speech of 
normals. It may be that for these persons with schizophrenia, as their speech becomes more
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similar to that of normals (i.e., fewer other disturbances and more Ambiguous Word Meanings), 
their functioning is improving, which could then result in improved life satisfaction.
Limitations to the Study
Certain characteristics of the study must be kept in mind when interpreting and attempting 
to generalize from the results. In particular, the sample comprised predominantly of male veterans 
with schizophrenia or schizoaffective disorder who were receiving care at a large midwestem 
Veteran's Administration Medical Center. A smaller proportion of participants was recruited from 
other sites in the same metro area that also provide services to the mentally ill. It is not known to 
what extent the veterans may differ from the general population or to what extent their military 
experiences may impact their functioning. In addition, this study did not address the issue of 
possible heterogeneity among the study’s small subsamples. It is certainly possible that the 
results of the present study are unduly influenced by the unique experiences of the individuals 
under consideration, and as such may not be generalizable to the general population.
Another factor to consider is that this study was part of a larger more extensive project in 
which persons with schizophrenia were recruited to participate. Numerous potential subjects 
declined to participate due to the intensive nature of the larger project or due to the request that 
immediate family members be approached about possible participation as well. As a result, the 
refusal rate for participation was quite high and those who agreed to participate may be reflective 
of a higher functioning or otherwise amenable group of persons with schizophrenia. Similar 
difficulties in schizophrenia research recruitment, including refusal rates, exclusion due to 
behavioral problems, and exclusion due to medical problems, have been described elsewhere 
(Schreiber, Breier, & Pickar, 1990).
All persons approached to participate in this study already met criteria for participation 
because their medical backgrounds were reviewed for exclusionary criteria and providers were 
consulted regarding appropriateness and ability to participate in the study. Accordingly, no
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additional analyses were completed to determine if significant differences existed between the 
groups of participants, refusers, and those initially excluded or deemed unable to participate.
Although limited findings were obtained from this research regarding the present sample, 
some speculation can be made applying these results had another group been evaluated. 
Presumably, other groups of persons with schizophrenia could be more symptomatic and lower 
functioning. These persons would probably have fewer of their needs met, have less access to 
resources, and in general report lower satisfaction with their overall life circumstances. Social 
adjustment would be lower, in relationships with others, pursuit of social and leisure activities, and 
in accomplishing work and daily responsibilities. This would result in a lessened overall social 
adjustment. Neurocognitive performance would be similar to the present group, especially in light 
of the fact that cognitive abilities tend to remain stable over time and that cognitive deficits vary 
across individuals with schizophrenia. However, one would expect relationships between 
neurocognitive performance and other variables to be stronger, possibly because functioning 
would be more impaired and impacted by even relatively subtle deficits. A lower functioning group 
would probably exhibit a greater frequency of overall communication failures, specifically more 
Missing Information References, as this is deemed the most “schizophrenic" of the failures, and 
potentially those other failures that are also more related to neurocognitive impairment (Confused 
References, Ambiguous Word Meanings, and Grammatical Unclarities) as other skills may not be 
able to compensate for difficulties in cognitive functioning when more symptomatic or acutely ill. 
Conclusion
The concept of quality of life has developed into an important and popular concept in the 
field of mental health. It has increasingly been used as a means to establish new perspectives 
regarding the experiences of an individual, as well as to measure outcome of interventions. The 
concept of quality of life has contributed to a common understanding about the functioning of 
persons with schizophrenia for all involved, the individuals themselves, relatives, providers, and 
policy makers. The objective of this study was to explore a number of variables implicated in the
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functioning of persons with schizophrenia and to determine the relationship of each of these 
variables to quality of life. It is apparent that the manner in which an individual functions, whether 
exhibited through symptoms, language, or neurocognitive abilities, can greatly impact his or her 
interactions with others, general social adjustment, and overall quality of life. The results of this 
study have immediate implications for researchers and clinicians to assist in the understanding of 
the factors that contribute to quality of life and to identify potential strategies to assist in the 
improvement of the quality of life of persons with schizophrenia.
The theory prevalent in the literature is that schizophrenia is a heterogeneous disorder 
that nonetheless has a strong genetic component which may result in a vulnerability to the illness, 
manifesting through an interaction with specific environmental factors (Gottesman, McGuffin, & 
Farmer, 1987; Schultz & Andreasen, 1999). Although the exact cause of schizophrenia is 
unknown, the most likely alternative is that the individual carries a susceptibility or vulnerability to 
developing the illness from birth, and this vulnerability interacts with an environmental agonist 
which results in the expression of the illness. In relation to the results of the current study, several 
notions can be considered. The neurocognitive deficits exhibited by persons with schizophrenia 
may be both a result of a genetic or early influence on brain development as well as the ongoing 
impact of symptomatology that the individual experiences. Interventions in this area can aid in 
improving functioning, but probably would not change the overall disease process, as it is clear by 
the variation that is found among individuals with schizophrenia that cognitive impairments in and 
of themselves are not diagnostic of the illness nor presumably cause the variety of impairments in 
functioning that are experienced by those persons.
Potentially language disturbances are reflective of an overall brain dysfunction not specific 
to schizophrenia, especially as communication failures are witnessed in the speech of normals, 
other psychiatric groups, and relatives of persons with schizophrenia (Docherty, DeRosa, et al.,
1996; Docherty, et al., 1999). Thus, language production may be an accurate measure of an 
individual’s functioning rather than a specific area for intervention. Language production may be a
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reflection of the disease process and be a good indicator of current functioning, similar to the role 
that symptomatology plays in the assessment of schizophrenia. The subjective quality of life and 
social functioning of a person with schizophrenia are probably best regarded as results of the 
disease process, but are areas in which interventions can be surely be focused.
An alternative explanation is that this type of communication failure and language 
production is in some way actually representative of an adaptive process. Although the CDI does 
not purport to measure formal thought disorder, but rather measures the unclear references that 
occur even in the speech of normals, the ambiguous references may in some way indicate that 
the persons with schizophrenia are adapting to the disorder or that the communication 
disturbance may in some way be helpful for the individual. Additional research exploring the 
relationship between unclear references, specifically ambiguous word meanings, and adaptive, 
functional, or creative aspects of the disorder of schizophrenia is certainly warranted.
It may be that both communication failures and neurocognitive performance, rather than 
being diagnostic or pathognomic of the disorder, are instead more simple characteristics 
associated with the genetic liability for schizophrenia and not the full expression of the disorder, 
what has been called an “endophenotype" (see locono, 1998 for a review). These 
endophenotypes provide additional avenues for research and attempts at understanding the 
transmission and presentation of schizophrenia. These characteristics may be ones to be 
monitored to determine the stage or severity of the illness, the individual’s current functioning, and 
relationship to the genetic expression of the disorder, rather than representing areas to be 
specifically targeted for intervention.
An important question to consider concerns how different these constructs of interest for 
the present study really are. Based on the results, it is clear that Quality of Life and social 
adjustment are definitely related to one another, and that an individual’s interactions with others 
and ability to engage in social activities plays a large role in their satisfaction with different areas 
of their life. However, as social adjustment is more an assessment of a person’s functioning, and
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
Functioning in Schizophrenia 127
quality of life involves both objective ratings of life circumstances and one’s satisfaction with those 
circumstances, they should not be considered to be the same construct. However, it is not difficult 
to presume that if a person's social adjustment were to improve, satisfaction with their life situation 
would also increase.
The most important finding of this study is that quality of life can be best predicted by less 
depressive symptomatology, better overall social functioning, and observations of language 
production to identify the frequency with which persons with schizophrenia use words in such a 
way that the intended meaning is not clear. These results are relevant at least to the present 
group, although it is unclear whether they are generalizable to other populations or subgroups of 
persons with schizophrenia. Future research may want to include additional participants who 
represent a greater age range, more varied backgrounds, and who were more symptomatic than 
those in the present study. A number of the present study’s results may have been specific to the 
functioning of the current group, most of whom were quite stable at the time of participation. This 
recommendation for future research corresponds to the suggestion by Sullivan, et al. (1992), 
which indicated factors that predict greater quality of life may vary in different populations or even 
within different systems of service provision. Also, this present study was purely correlational and 
did not examine causal relationships between variables. Thus, predictions about how to improve 
the quality of life of persons with schizophrenia are only speculative at this point, for it is not 
known how changing one variable will actually alter others.
In this population, the variables of interest show an important relationship to the quality of 
life of persons with schizophrenia who continue to function in the community. After considering the 
overall results of this study, several possible interventions are apparent to assist in the 
improvement of the quality of life of persons with schizophrenia. Strategies include decreasing 
symptomatology, perhaps through medication or therapy, increasing the number of social contacts 
and leisure activities of the individual, improving social relationships with family and friends, 
possibly through increased contact, varied activities, or counseling, and developing rehabilitative
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or compensation strategies in the areas of verbal memory and attention. Although communication 
failures in the form of Ambiguous Word References are also implicated, monitoring their frequency 
may be a better indicator of an individual’s performance rather than a domain for intervention. 
However, this could be an effective focus for intervention if an individual was taught strategies to 
monitor their speech (focusing on areas of verbal memory and attention to attend to and evaluate 
what has been said) and then to clarify instances of communication failure as they arise. In 
summary, the ultimate goal for persons with schizophrenia, their relatives, and providers should 
be to increase the individual’s general ability to function adequately within the community in the 
hopes of improving their global life satisfaction.
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Appendix A
Checklist for Exclusionary Criteria Used During Initial Chart Review
Checklist for Exclusionary Criteria
Name:________________________ _ Last Four___________ Gender M F
DOB:_____________  Age:_______ Education:____________________
Ethnicity: Caucasian African-American Hispanic Asian Native American Other 
Chart Diagnosis:______________    Psychotic Features: Y N
Please note pass or fail for each criterion item based on a review of the patient's 
medical record or any additional sources of information.
Please note with date and source (progress note, discharge summary, psych 
assessment etc.) reason why patient failed a particular criteria.
P = pass Source 
F = fail
1) English is not subject's primary language _______ ______
2) Charted IQ of less than 70 or diagnosis of mental _______ ______
retardation
3) Current alcohol or drug abuse: current or past _______ ______
suostance dependence
4) Current or past central nervous system (CNS) disease _______ _______
or condition
5) Medical condition or disease with likely CNS effects _______  _______
6) History of head injury with skull fracture, or loss of _______  _______
consciousness of greater than 20 minutes
7) Physical problem that would render study measures _______ _______
difficult or impossible to administer or interpret
(e.g.. blindness, hearing impairment, paralysis 
in upper extremeties. etc.)
8) Subject is younger than 18 or older than 60______________ _______  _______
9) Significant tardive dyskinesia (i.e., DISCUS score________________  _______
greater than 7 (total) or greater than 3 in facial
areas)
10) History of electro-convulsive (shock) therapy____________ _______  _______
11) Adopted__________________________________________ _______  _______
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Explanation for failure:
If patient passes all exclusionary criteria, please note any mention of family in the 
area who may be involved with the patient.
Central nervous system and medical diseases/conditions with likely CNS system 
effects:
Cerebrovascular accident (CVA, stroke)
Transient Ischemic Attacks (TIA's)
Multi-infarct dementia 
Alzheimer's disease 
Frontal lobe dementia 
Parkinson's disease 
Huntington's disease 
Multiple sclerosis (MS)
AIDS dementia 
Brain tumor
Seizure disorder (epilepsy)
Cerebral palsy 
Thyroid disease 
Encephalitis 
Lyme disease
Learning disability, dyslexia. ADHD. ADD (if diagnosed by a professional)
Hypoxic episode (loss of blood flow to brain, related to cardiac arrest caused by heart attack, 
severe injury.e tc.)
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Appendix B 
Comprehensive Chart Review Form
CHART REVIEW
Subject number___________
Date of entry into the study____________
Date of chart review_____________
Chan reviewed by____________  (Check if review is completed ____ )
Number of chan volumes________
General Chart Review Procedures
Confirm subject's self-reported socio-demographic information 
Note any discrepancies:
Confirm subject's self-reported use of alcohol and other drugs 
Note any discrepancies:
Confirm subject's self-reported history of onset and hospitalizations 
Note any discrepancies:
Obtain copies of reports documenting symptoms of the episode leading to the first 
hospitaiization or treatment. Place these in the subject’s file. Do not rely only on the 
subject's retrospective self-report describing the first episode.
Medical and Psychiatric Conditions and Treatments
DISCUS Score:________ Date of DISCUS:__________
Medical Disorders ( See DSM-IV Appendix G for codes)
Review discharge summaries and note medical conditions from .Axis ID. Include all 
chronic, persistent conditions from discharge summaries. Do not review outpatient notes.
Medical Condition I : Current Past onlv Code
Medical Condition 2: Current Past onlv Code
Medical Condition j: Current Past onlv Code
Medical Condition 4: Current Past only Code
Medical Condition 5: Current Past onlv Code
Medical Condition 6: Current Past onlv Code
Medical Condition 7: Current Past onlv Code
Medical Condition 8: Current Past onlv Code
Medical Condition 9: Current Past onlv Code
Medical Condition 10: Current Past onlv Code
Medical Condition 11: Current Past only Code
Medical Condition 12: Current Past onlv Code
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Current Psvchotropic Medication Subject number
Decanoate medication Code:__  Dose:____  mg per injection Weeks_
Drue I Code Dose: me/dav Route:
Drue 2 Code Dose: me/dav Route:
Drug 3 Code Dose: me/dav Route:
Drue 4 Code Dose: me/dav Route:
Drue 5 Code Dose: me/dav Route:
Drue 6 Code Dose: me/dav Route:
Drue 7 Code Dose: me/dav Route:
Drue 8 Code Dose: me/dav Route:
Drue 9 Code Dose: me/dav Route:
Drue 10 Code: Dose: me/dav Route:
Drue 11 Code: Dose: me/dav Route:
Drue 12 Code: Dose: me/dav Route:
Medication Compliance: _____
Rate the subject's typical level of medication compliance for the entire six month period 
prior to entry into the study. (Use outpatient notes.)
00 = Not applicable
01 = Excellent -  Takes all psychiatric medications as prescribed and rarely, if ever,
forgets or chooses not to take medications
02 = Good -  Generally takes all psychiatric medications as prescribed, occasionally
forgets or chooses not to take medications
03 = Fair -  Although regularly takes psychiatric medications, does not take as prescribed
(i.e. alters dose or frequency), frequently forgets or chooses not to take medications. 
Rarely goes longer than a week without taking medications.
04 = Poor -  Takes medication inconsistently and not as prescribed, has prolonged periods
(2-3 weeks) when no medications are taken.
05 = Non-compliant -  Refuses to take psychiatric medications
06 = Mixed -  Has periods of compliance that would be rated at least 2 (Good) and other
periods that would be rated 4 (Poor) or lower.
09 = Unknown
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Current Outpatient Therapy
Rate period prior to entry into the study.
Therapy I: Type  Date began:___________  Frequency:
Therapy 2: Type  Date began:___________  Frequency:
Therapy 3: Type  Date began:___________  Frequency:
Therapy 4: Type  Date began:___________  Frequency:
Tvnes:
01 = Somatic: almost completely medication oriented
02 = Talk: supportive counseling, problem solving therapy, etc., where the focus is not
medication
03 = Behavioral (almost exclusively)
04 = Psychotherapy; distinguish from 2 if a specific therapeutic approach (e.g.
psychodynamic, cognitive behavioral) is noted
05 = Group therapy
06 = Case management
07 = Other
08 = IPCC
09 = Unknown
Frequency codes:
01 = once per week or more often
02 = at least once per month, but less than once per week
03 = less than once per month
History of ECT:
Use these codes for type of ECT. These are organized by courses of ECT in which an 
interruption of two weeks or more in a series of ECT divided the series into two courses.
ECT 1 Type:___ Date began:
ECT 2 Type 
ECT 3 Type 
ECT 4 Type 
ECT 5 Type 
ECT 6 Type
Date began: 
Date began: 
Date began: 
Date began: 
Date began:
Date ended:. 
Date ended:. 
Date ended:. 
Date ended: _ 
Date ended:. 
Date ended:
Number of treatments 
Number of treatments 
Number of treatments _ 
Number of treatments _ 
Number of treatments _ 
Number of treatments
Current Treatment
See attached list for drug codes.
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Has patient's treatment regimen been stable for the two months prior to entry into the 
study? Yes __  N o___
Last date when psychotropic medication was changed prior to entry into the study:__
If medication is taken more than once per day. calculate to get mg. per day.
What was changed?
From: Code: Dose: me/dav Route:
To: Code: Dose: me/day Route:
From: Code: Dose: me/dav Route:
To: Code: Dose: me/dav Route:
From: Code: Dose: me/dav Route:
To: Code: Dose: me/day Route:
From: Code: Dose: me/dav Route:
To: Code: Dose: me/dav Route:
Was a decanoate drug changed? Code in weeks.
From: Code:__  Dose: mg per injection Weeks___
To: Code:___ Dose:____  mg per injection Weeks___
Route/Interval
If NOT decanoate. enter route codes as follows
01 = Oral
02 = IV (intravenous)
03 = IM (intramuscular)
04 = Other (specify)
05 = Unknown
If coding decanoate. code the interval at which injections are received in weeks.
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Record o f Hospitalizations
! Admitted I Discharged Davs Location Presenting Issues I Diagnosis
I
T
3
4
5
6
7
8
9
10
II
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12
13
14
15
16
17
18
19
20
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Appendix C
Examples of the Six Communication Failures from the 
Communication Disturbances Index (CDI)
Examples from the Communication Disturbances Index (CDI)
Six types of communication failure were determined to exist in the speech samples of 
persons with schizophrenia. These types are described below, and examples are given. 
Unclear references are boldfaced (from Docherty. DeRosa. & Andreason (1996), pp 
359-360.)
1 Vague references are words or phrases that are unclear because they are 
ovennclusive. They are scored only if their lack of specificity is important and 
significantly diminishes the meaning communication by the utterance. They are not 
usually blatantly deviant, but they leave the listener with an amorphous and questionable 
impression rather than a clearty communicated meaning.
1.1 i'm hoping they don t get caught up in some of the ills of our life, of our 
society.
1.2 It seems so. you know, this, that, or the other.
2. Confused references are unclear because they could refer to one of at least two clear- 
cut alternative referent, and the correct choice is not obvious. Confused references are 
often but not always, pronouns.
2 1 He staPbed the dude and I kicked him. I thought he punched him. I thought 
he was an the ground just acting like he was hurt.
2.2 My son has two children and my daughter has three. The kids have counted 
on me for a lot.
3 Missing information references seem to assume that the listener has prior information 
that ne or she does not have and should not be expected to have. Unqualified 
references to persons, places, or things unknown to the listener are classified here, as 
well as comparative references for which the basis of companson is unknown.
3 1 / like to work all right. Some of those shops were filthy. I liked the bakeries, 
some of the shops are clean. (No pnor mention of any shops or bakeries.)
3.2 They let George go home, so why not me? (No prior mention of George, and 
listener does not know him.)
3 3 I love the place best in the winter It’s just a total opposite then, (missing 
information comparison; 'opposite' in what way? Listener does not know the 
basis of comparison.)
4. Ambiguous word meanings are instances in which a word or phrase is used in such a 
way that its intended definitional meaning is uncertain. This does not include instances in 
which is seems that the wrong word has been chosen, but rather the word used could 
have a number of different meanings in its current context, and the correct meaning is 
not obvious.
4 1 He was a man that was pow in a minute. ("Pow" is unclear because the 
intended definitional meaning is uncertain. Does it mean that he became violent 
easily, or he was a man of action, or...?)
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4.2 Those people don't belong on the earth. God will get them.
4.3 I had a chance to grow with him but I got a divorce because I couldnt
5. Wrong word references are unclear because of a seemingly incorrect choice of word 
or phrase. The meaning of the utterance seems dear, but doubt is case because of the 
use of an odd of apparently inappropriate word or expression.
5.1 We 've had our qualms about me bowling, but I've always won out. (Does 
she mean ‘quarrels’?)
5.2 I used to sit in the cafe, have something to eat, and just glare out into the 
night. (Does he mean “stare"?)
6. Structural unclarities are instances in which meaning is unclear due to a breakdown or 
inadequacy of grammatical structure. Incorrect grammar is not scored unless it results in 
a loss of clarity of meaning.
6.1 I got a sister in Buffalo, New York. I've been there...must have been about 
twice since I was up there.
6.2 We went to Arizona. We stopped off lots of towns between Chicago.
(Spoken by a person living in Connecticut)
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Appendix 0  
First Contact Script for Participants Known to Meet Criteria for Participation
Patient Pirst-Ccrtac; Scnot 
(by chone or ;n person!
10/25/CO
Heilc. this :s (research staff’s name) from the Minneapolis VA Meoical Center. I'm 
contacting you to invite you to particioate in a study If you choose to participate, you will 
be askeo to complete the procedures of the study ana will be oaid for vcur time. I'm 
wcncenng :f this is a gooc time for you to talk with me about it.
Cur research is acout cognition anc cram functioning. This study examines brain wave 
activity m order to determine whicn parts of the oram are affectec wnen someone has 
mental or emotional difficulties. This study may help us to better understand why some 
incivicuals develop these types of problems, and why others, even from within the same 
family oc not. As a pan of this study we will ask your permission to contact members of 
your immediate family and ask if they are willing to participate as well. We will talk to 
one of vcur family memoers about your cnildhccc and ear.y adulthood. We will also ask 
to speak with someone wno currently knows you well and can describe your social, 
wcrk. anc emotional functioning.
If you participate, you would spend about ten to twelve hours 'with us at the Minneapolis 
VA Medical Center, and some additional time talking with us on the phene. We will 
arrange days anc times for you to come to the VA based on what fits your schedule. As 
socn as you have completed the stucy. ycu will be oaid Si 20 for your time.
As part cf the stucy we will measure your brain waves while you are at rest and when 
ycu are perfcrming a numoer of tasks. Measunng brain waves involves attaching 
senscrs tc your cooy and heac. We also ask ycu tc participate in a set of interviews 
accut your mental anc emotional functioning ounng your life. These Interviews will touch 
or areas many cecole see as sensitive and personal. You will aiso complete an 
assessment cf tnmking abilities, allow us tc draw a small amount of blcod. and undergo 
a neurological exam
Because we ask ycu to do so many things. I want to emphasize that any information you 
tell us acout yourself or your family members is kept strictly confiaentiai. We assign a 
stucy number to you and use that number to identify your information rather than your 
name Also none of the information you tell us will be accessible to mecical personnel 
anc will in no way affect any benefits you may receive from the VA cr any other military 
cr governmental organization.
Do you have any questions7
I'd like tc ask you a couple questions to make sure you understand the nature of the 
stuoy
Z What is this project studying7
I Will we ask tc contact your relatives about them participating in the study?
I  Will we ask ore of your relatives about your childhood and early adulthood?
I  Will we ask tc contact someone who knows you well about your social, work, and 
emotional functioning?
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Does this sound like something you would be interested in doing?
Then let me ask you a few questions before we go on. (DEMOGRAPHICS 
QUESTIONS)
Let's schedule you to come in to begin the study. (ASK ABOUT TRANSPORTATION.) 
SCHEDULE APPOINTMENT
When you amve we will review the content of the study. You'll also have time to ask 
questions.
We’d like to get more information about getting in touch with your immediate family 
members when you come in to see us. Please bring your address book when you come 
to your appointment. Also. I would like to get the name and phone number of a person 
who knows you well nght now who would be able to tell us about you. Who would be a 
good person for us to contact (GET CURRENT INFORMANTS NAME. NUMBER, AND 
RELATIONSHIP TO PATIENT).
Before coming in we will mail you a confirmation letter and a short questionnaire for you 
to fill out. This letter will have additional information about the study schedule and the 
location of your appointments within the VA. Could I get your address so that I can send 
this letter out to you? (PUT ON FIRST PAGE) Also. I need to get your social security 
number so that we can fill out the paperwork so that you can get paid for your 
participation. (PUT ON FIRST PAGE)
Finally. I want to explain one part of the study in greater detail. For the EEG portion, you 
will be in a laboratory working on different listening and computer tasks for about 4-5 
hours. You will be given several opportunities for breaks throughout the session. While 
in the lab. you will wear an elastic cap, much like a swimming cap, that holds a set of 
sensors in place on your head while we record your brain activity. Wearing this cap may 
leave small red marks on the scalp. For most people, these marks disappear in several 
hours. W e suggest that you bnng along a hat to wear home after we are finished (like a 
baseball cap or something). Also, it can get a bit chilly in the lab. and we recommend 
that people bring a sweater or a sweatshirt in case they get cold.
Do you have any questions7 If you have any questions that come up in the meantime, 
please call me at (612)725-2000 extension 3914 ask for (name of caller) or (other 
contact person on study).
Thank you very much. We look forward to seeing you on the a t________ o
clock.
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Appendix E 
Participant Demographic Information Form
Demographic Information Form
Suoject ID ___
Sucjec: .mtiais
1. Gencer Male ’• Female
2. Birth date:_____/____ /________
3. Current Age
4 Current Marital Status (circle one):
t = Mamed, never divorced
2 = Divorced and not remarried
3 = Divorced and remained
4 = Separated
5 = Widowed
S = Never MarnecAnnulled
5. Hew many times have you been married7 _____
S. Have you ever been widowed7 Yes / No
~ Hew many chiicren do you nave"’ ___________
S. What are your current living arrangements?
' = Alone
2 = With partner, not legally married
3 = With spouse and/or chilaren
4 = With parents or adult children
5 = With siblings or other relatives 
S = With frienas / roommates
7 = In a residential treatment facility
9. Where were you born? City and Country of Birth:
10. Are you aware of any complications that occurred during your birth? Yes /  No
If yes. oesenbe:
11. Is English your primary language? Yes / No
What is the ethnic background of your biological parents? (Code up to four ethnicities if 
possible. See list on next page)
12. Father's country of birth / Ethnic background:_________________________________
13 Mother’s country of birth / Ethnic background:____________________ ____________
Interview date __
Interviewer initials
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1 = Anglo Saxon
2 = Northern European (e.g.. Norwegian)
3 = West European (e.g.. French, German)
4 = East European. Slavic
5 = Russian
6 = Mediterranean
7 = Ashkenazi Jew
8 = Sephardic Jew
9 = Hispanic (not Puerto Rican)
10 = Puerto Rican Hispanic
11 = Mexican Hispanic
12 = Asian
13 = Arab
14 = Native American /  Alaska Native
15 = African American, not of Hispanic Origin
16 = Other, Specify_______________________
99 = Unknown
14 Education: Highest completed grade/degree:
a) subject b) father c) mother d) spouse___
1 = 7th grade or less
2 = Between 7th and 9th grade
3 = Between 10th and 12th, but not graduated.
4 = High school graduate (includes GED)
5 = Partial college (includes business school, vocational/technical, RN) 
6 = 4  year college/university graduate
7 = Graduate degree (M.A., Ph.D., M.D.. J.D.. etc.)
9 = Unknown
14. Usual Work Status:
a), subject b). father. . c). mother.
1 = full time (40 hrs/week or more)
2 = half-time (approx 20 hours/week)
3 = quarter time (approx 10 hours/week)
4 = unemployed
5 = retired
6 = homemaker
7 = student
 d). spouse____
8 = volunteer work -fu ll time
9 = volunteer work -part time
10 = disabled
11 = never worked at least 30% time
12 = other (specify)
99 = unknown
15 Have you been working or going to school in the past month? Y / N
15a. (If unemployed) How long have you been unemployed?
(Code length in months. Use as anchor point either last job of at least two 
months duration or last period in school. Use age 18 if subject has never been 
employed. Do not code as unemployment scheduled vacations from school or voluntary
homemakers.)
Length of unemployment in months:_________
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16 What is your present occupation? (Code occupation using chart below.)
Record response.______________________________________
17 What is the most responsible job you have ever held? (Code occupation using chart
below i
Record response:_____________________________________
18. (IF SUBJECT IS NOT HEAD OF HOUSEHOLD:) What is/was the occupation of the 
head of household dunng most of their working career? (Code occupation using chart 
below.)
Record response:______________________________________
Managerial and Professional Specialty Occupations
1 = Executive, administrative, and managerial occupations
2 = Professional specialty occupations
3 = Writers, artists, entertainers, and athletes
Technical. Sales, and Administrative Support Occupations
4 = Technicians and related support occupations
5 = Sales occupations
6 = Administrative suoport occupations, including clerical
Service Occupations
7 = Pnvate household occupations
8 = Protective service occupations
9 = Service occupations except protective and private household
Farming. Forestry. And Fishing Occupations
10 = Farm operators and managers
11 = Other farming, forestry, and fishing occupations
Precision Production. Craft and Repair Occupations
12 = Mechanics and repairers, construction trades, extractive occupations, 
precision production occupations
Operators. Fabricators, and Laborers
13 = Machine operators, assemblers, and inspectors
14 = Transportation and material-moving occupations
15 = Handlers, equipment cleaners, helpers, and laborers
Other
16 = Armed Services
17 = Disabled
18 = Housewife / homemaker
19 = Never worked
20 = Full time student
21 = Unemployed
22 = Retired 
99 = Unknown
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13. Annual Income: Average annual household income in past 5 years. 
 (Gross income based on tax returns.)
1 = Under 510,000
2 = S10 ,0 0 0 -$ 2 0 ,0 0 0
3 = S20.000 -  530,000
4 = S30.000 -  550,000
5 = S50.000 -  595,000 
o = S95.000 and up
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Appendix F 
First Contact Script for Participants Undetermined to Meet Criteria for Participation
Unscreened Patient First-Contac: Script 
(by phone)
3/20/01
Hello, this is (research siaff s name) from the Minneapolis V.A Medical Center. I'm contacting you 
to because you expressed an interest in finding out more about our research study. If you choose to 
participate, you will be asked to complete the procedures of die study and will be paid for your 
time I'm wondering i: this is a good time for you to talk with me about it.
Our research is about cognition and brain functioning. This study examines brain wave activity in 
order to determine which parts of the brain are affected when someone has mental or emotional 
difficulties. This study may help us to better understand why some individuals develop these types 
of problems, and why others, even from within the same family. do not. As a pan of this study we 
will ask your permission to contact members of your immediate family and ask if they are willing 
to participate as well. Immediate family members include parents under the age of TO. full brothers 
and sisters or adult children. Do you nave anyone who fits that description who lives in the area?
W e will talk to one of your family members about your childhood and early adulthood. We will 
aiso ask to speak with someone who currently knows you well and can describe your social, work, 
and emotional functioning right now.
I: you participate, you would spend about twelve to fifteen hours with us at the Minneapolis VA 
Medicai Center. W'e will arrange days and times for you to come to the VA based on what fits your 
schedule. As soon as you 'nave completed the study, you will be paid SI30 for your time.
As part of the study we will measure your brain waves while you are at rest, just sitting in a chair, 
l td  when you are performing a number of tasks on a computer. Measuring brain waves involves 
attaching sensors to your body and head: it's like having an EEG. if you've had one of those done 
before. We aiso ask you to participate in a set of interviews about your mental and emotional 
functioning during your life. These interviews will touch on areas many people see as sensitive and 
personal. You will also complete an assessment of thinking abilities, allow us to draw a small 
amount of blood (less than a teaspoon), and undergo a neurological exam. That's when the doctor 
looks at your reflexes, watches the way you walk, looks to see if there's any tremor in your hands, 
and asks you to do a few simple tasks on a computer.
Because we ask you to do so many things. I want to emphasize that any information you tell us 
about yourself or your family members is kept strictly confidential, and that begins now with 
anything you say to me on the phone. We assign a study number to you and use that number to 
identify- your information rather than your name. Also, none of the information you tell us will be 
accessible to medical personnel and will in no way axfec: any benefits you may receive from the 
Y A  or a n y  other military or governmental organization.
Do you have any questions?
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I'd like to ask you a couple questions to make sure you understand the nature of the study.
What is this project studying?
6  Will we ask to contact your relatives about them participating in the study?
Si Will we ask one of your relatives about your childhood and early adulthood? 
fi Will we ask to contact someone who knows you well about your social, work, and emotional 
functioning?
Does this sound like something you would be interested in doing?
In order to determine if you would be eligible to participate in this study, [ would need to go 
through a short interview with you. I will ask you some questions about your physical health, 
background, and life experiences. Do you have time to do that now? (IF AGREES TO 
INTERVIEW NOW): At this time I would like to make sure that I have your permission to ask you 
a series of personal questions about your background over the phone today, for the purpose of 
determining if you fit our requirements for participating in this study.
(VERBAL CONSENT IS REQUIRED BEFORE PROCEEDING. ANSWER ANY QUESTIONS 
THEY HAVE.)
Do I have your permission?
(IF YES PROCEED TO “HEALTH HISTORY SCREEN" AND “DEMOGRAPHIC 
INFORMATION FORM”)
If caller is excluded at any point during screening interview, skip to excluded / wait list script 
(last page).
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ACCEPTED SUBJECTS:
Let's schedule you to come in to begin the study. (ASK ABOUT TRANSPORTATION.) 
SCHEDULE APPOINTMENT
When you arrive we will review the content of the study. You'll read and sign a consent form and 
we'll make a copy for you to take. You'll also have time to ask questions.
We'd like to get more information about getting in touch with your immediate family members 
when you come in to see us. Please bring your address book when you come to your appointment. 
Also. I would like to get the name and phone number of a person who knows you well right now 
who would be able to tell us about you. Who would be a good person for us to contact (GET 
CURRENT INFORMANT'S NAME. NUMBER, AND RELATIONSHIP TO PATIENT).
Before coming in we will mail you a confirmation letter and a short questionnaire for you to fill out. 
This letter will have additional information about the study schedule and the location of your 
appointments within the VA. Could I get your address so that I can send this letter out to you?
(PUT ON FIRST PAGE) Also. I need to get your social security number so that we can fill out the 
paperwork so that you can get paid for your participation. (PUT ON FIRST PAGE)
We would also like to have your permission to review your medical records so that we can get more 
information about your background and the treatment you have received. We will ask you to sign a 
release of information to document that it's okay with you for us to look at these records. I will put 
this in with your confirmation letter along with a return envelope. Please sign the release and send 
it back right away so that we have time to look at your records in advance, before you come in for 
the study.
Finally. I want to explain one part of the study in greater detail. For the EEG portion, you will be in 
a laboratory working on different listening and computer tasks for about 4-5 hours. You will be 
given several opportunities for breaks throughout the session. While in the lab. you will wear an 
elastic cap. much like a swimming cap. that holds a set of sensors in place on your head while we 
record your brain activity. Wearing this cap may leave small red marks on the scalp. For most 
people, these marks disappear in several hours. We also use a substance that looks like hair gel or 
vaseline so that the sensors work properly. It gets in your hair and gets a bit messy. We do have 
shampoo if you'd like to wash your hair when you're done. Otherwise, we suggest that you bring 
along a hat to wear home after we are finished (like a baseball cap or something). Also, it can get a 
bit chilly in the lab. and we recommend that people bring a sweater or a sweatshirt in case they get 
cold. Finally, we ask that the day before you come in for the lab you not drink any alcohol and that 
you do your best to get a good night's sleep so you will be well rested and not sleepy during the 
testing.
Do you have any questions? If you have any questions that come up in the meantime, please call me 
at (612)725-2000 extension 3914 ask for (name o f caller) or {other contact person on study).
Thank you very much. We look forward to seeing you on the a t_______ o clock.
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IF CALLER WAS EXCLUDED OR LIKELY TO BE EXCLUDED:
I warn to thank you for completing this interview. Unfortunately, we are looking for people with a 
slightly different background than your own to participate in the study, so we cannot schedule you 
at this time. Would you be interested in keeping your name on a waiting list in case this changes? 
(circle YES ' N'O) If we do not call you back about participating in this study, would you like us to 
keep your name and possibly contact you about other studies we may do in the future? (circle YES 
' NO) Thank you again for taking an interest in our research.
IF CALLER MIGHT BE APPROPRIATE FOR STUDY:
I want to thank you for completing this interview. I would like to double check on the backgrounds 
of the current group of people who are already in the study. If we need people with backgrounds 
like yours, we would call you back within two weeks. When would be a good time to reach you? 
May I leave a message for you? Thank you again for taking an interest in our research.
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Health History Screen
I f  English is nor the subject s primary language, they are excluded-you can ask at any point i f  vou 
suspect they are not a native English speaker
General Note: Conditions that are ALWAYS exclusions are underlined For conditions that \L4 Y 
OR .VIA Y NOT be exclusions, ask follow-up questions to get more information (use the ones 
provided plus your own i f  necessary). then go to the "Might be appropriate " wait list script. We 
will discuss these cases and call them back to let them know i f  we will include them or not.
1. How old are you? ______  Exclude i f  over 60 or under 18.
2. Are you adopted? Y / N
3. Since this is a family study, in order for you to participate you need to have fa m ily  members 
who may be willing to participate as well. Which of your family members live in the area?
4. Do you have other family members that don't live in the area but visit you on a regular basis?
(THERE MUST BE AT LEAST TWO RELATIVES WHO WOULD BE ELIGIBLE FOR THE 
STUDY WHO LIVE CLOSE ENOUGH OR VISIT REGULARLY ENOUGH TO MAKE 
PARTICIPATION POSSIBLE.)
(IF FAMILY MEMBERS .ARE AVAILABLE. NEXT VERIFY THAT PATIENT HAS 
PSYCHOTIC SYMPTOMS.)
5. Are you currently receiving treatment for mental or emotional problems?
Brief description (ensure that caller fits  one o f the patient groups):
IF PATIENT DOES NOT SPONTANEOUSLY REPORT PSYCHOTIC SYMPTOMS. ASK THE 
FOLLOWING QUESTIONS FROM THE DIGS:
I would like to read you a list of experiences that other people have reported. Tell me which ones 
you have had.
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Has there been a time when...
Vou heard voices'? For example, some people have had the experience o f hearing people's voices 
whispering or talking to them, even when no one was actually present.
You had visions or saw things that were not visible to others?
You had oeliefs or ideas that others did not share or you later found out were not true—like people 
being against you. people trying to harm you. or people talking about you?
You believed you were being given special messages (e.g. through the TV or the radio)?
You believed that you had done something terrible for which you should be punished?
You believed that you were especially important in some way. or that you had powers to do things 
that other people could not do?
You had the feeling that you were under the control of some force or power other than yourself? 
You had a change in your body or in your physical appearance that others could not see?
6. Do you currently have any medical problems or conditions? Y I N
6a. Specify_______________________________________________________________
7. .Are you currently taking any kind of medication? Y / N’
7a. Specify’_______________________________________________________________
7b. (If taking medication that may potentially cause TD, ask): What side effects are you 
experiencing?_____________________________________________________________
8. Have you ever been hospitalized for a medical problem? Y / N 
8a -  8b. What for. and how long?
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9. Have you ever had an injury to your head"? Y . N
9a. IF YES: Did you have to go to the hospital? Y ’ N
10. Have you ever been unconscious? Y ! N
10a. IF YES: For how long? _______
11. Have you ever had a seizure or convulsion? Y •' N'
12. Do you have any other kind of problem with vour brain or spinal cord? Y ' N
12a. IF YES.’ Specify________________
Exclusions: Seizure, convulsion, hospitalization overnight for head injury, any significant problems 
with brain or other part o f central nervous system.
13. Have you ever received ECT? Y / N
14. Do you have any problems with your eyes? Y /N  (Exclusion: Visual problem not correctable 
with glasses or contacts that would interfere with doing study procedures.)
15. Do you wear a hearing aid? Y /N  (Exclusion, interferes with EEG.)
16. Do you have any problems such as paralysis, serious arthritis, back pain (anything that would 
make it very difficult for them to perform tasks or tolerate sitting for long periods o f  timef!
17. What are your drinking habits like? (Frequency, amount, current problems or treatment.) 
(If you suspect current abuse or dependence, skip to SCID questions)
(Exclude for current abuse or dependence, past abuse or dependence is acceptable.)
18. .Are you currently using any street drugs? (Frequency, amount, current problems or treatment.) 
(If you suspect current abuse or dependence, skip to SCID questions)
(Exclude for current abuse and for current or past dependence. Past abuse is acceptable.)
18a. When in your life were you using drugs the most? 
(Skip to SCID questions if past dependence seems possible.)
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
Functioning in Schizophrenia 170
Let me check for some more specific medical problems:
19. Do you have any serious or chronic illnesses like cancer, diabetes, cerebral palsv. M.S. 
(Multiple Sclerosis), or HTV? Y N
19a. Specify-_____________________________________________
(If Yes lo cerebral palsy or M.S., exclude. I f  yes lo cancer, diabetes, or HIV. get more 
information,)
Follow-up questions:
For cancer, diabetes, and HIV:
19b. Have you noticed any changes in your thinking since being diagnosed? Y / N'
19c. .Any problems with memory, concentration, or attention? Y /N  
I9d. Has your doctor told you that your central nervous system (brain and spinal cord) has 
been affected in any way? Y / N 
Diabetes:
I9e. How well-controlled is it?________________________________________
19f. What complications have you experienced? ___________________________
Cancer: 19g.What kind do you have?_____________________________________________
I9h. Are you receiving treatment at the present time?_________________________
I9i. How is it affecting you physically and mentally?_________________________
HIV:
19j. What symptoms are you having?________________________________________
19k. How is it affecting you physically and mentally?___________________________
20. What about any endocrine diseases, thvroid disease, historv of encephalitis, or eoilepsv?
Y N (If Yes to encephalitis or epilepsy, exclude. Endocrine, thyroid -  more infoi 
Follow-up questions for endocrine or thyroid diseases:
20a. Which one do you have?__________________________________________________
20b. Have you noticed any changes in your thinking since being diagnosed? Y /N  
20c. .Any problems with memory, concentration, or attention? Y / N 
20d. Has your doctor told you that your central nervous system (brain and spinal cord) has 
been affected in any way? Y ' N
21. Do you have any heart or cardiovascular problems (history of heart attack, stroke, or T.I.A.l?
Y . N (Exclude for stroke. TLA. do not exclude for high blood pressure, angina, etc.)
Heart attacks may or may not be excluded-get more information.
Follow-up questions for heart attacks:
21a. When was it?___________________________________________________________
21b. How serious was it?_____________________________________________________
21c. Was blood flow to your brain interrupted at all during the attack? Y /N
2Id. IF YES, for approximately how long?_______________________
21e. Have you noticed any changes in your thinking since this happened? Y ' N 
21 f. .Any problems with memory, concentration, or attention? Y / N 
21 g. Has your doctor told you that your central nervous system (brain and spinal cord) was 
affected in any way? Y /N
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Attached questions from SCID are to be used as necessary to clarify problems. Skip if  not 
needed. I f  subject has not been excluded, proceed to Demographic Information.
SUBSTANCE USE
Alcohol Abuse Criteria (Current Only):
Have you ever missed work or school because you were intoxicated or very hung over? (How 
often?)
Did you ever drink in a situation in which it might have been dangerous to drink at all? (Did you 
ever drive while you were really too drunk to drive?)
Has your drinking ever gotten you into trouble with the law? (How often?)
Has your drinking caused problems with other people, such as your family, friends, or people at 
work?
(Have you ever gotten into physical fights or bad arguments because of your drinking? Did you 
keep drinking anyway?)
I f YES to arty one o f  the four above, this indicates alcohol abuse. Exclude i f  current ('within the 
past month) abuse or dependence.
Drug Abuse and Dependence
Have you ever used street drugs? IF YES: What. when, and how often.
Have you ever gotten "hooked" on a prescribed medication, or taken a lot more o f it than you were 
supposed to? fF YES: What. when, and how often.
For the following questions, focus on the drug used the most.
Drug Abuse Criteria (Current only):
Have you ever missed work or school because you were high or very hung over? (How often?)
Did you ever use drugs in a situation in which it might have been dangerous to use any drugs at all? 
(Did you ever drive while you were really too high to drive?)
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Has your drug use ever gotten you into trouble with the law? (How often?)
Has your drug use caused problems with other people, such as your family, (fiends, or people at 
work? (Have you ever gotten into physical fights or bad arguments because of your drug use? Did 
you keep using anyway?)
It' YES to any one o f the four above, this indicates drug abuse. Exclude i f  current (within the past 
month). I f  past history o f drug abuse, proceed to assess for dependence.
Drug Dependence Criteria (Any time in subject’s life)
Have you often found that when you started using (drug) you ended up using much more than you 
were planning to? (IF NO: What about using it for a much longer period of time than you were 
planning to?)
Have you tried to cut down or stop using (drug)? (IF NO: Did you want to stop or cut down?) 
(Evaluate whether there is a persistent desire or multiple unsuccessful attempts to reduce use.)
Have you spent a lot of time using (drug) or recovering from its effects?
Have you had times when you would drink so often that you used (drug) instead of doing other 
things, like working, spending time with family or friends, or spending time at hobbies?
Has your drug use ever caused you psychological problems like making you depressed or anxious, 
making it difficult to sleep, or causing blackouts? Has your drug use ever caused physical health 
problems, or made a physical problem worse? (IF YES TO EITHER: Did you keep using it 
anyway?)
Have you found that you needed to use a lot more of the (drug) to get the feeling you wanted than 
you did when you first started? (IF YES: How much more? IF NO: What about finding that when 
you used the same amount, it had much less effect than before?) (Indicates tolerance.)
Have you ever had any withdrawal symptoms when you cut down or stopped using (drug)? What 
about using some (drug) to keep yourself from getting sick?
(ASK IF UNKNOWN) Did these problems (review symptoms subject endorsed) all occur at the 
same time? (I f at least three o f  the above symptoms occurred within the same 12 month period, this 
indicates drug dependence, and subject is excluded.)
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Appendix G 
Participant Consent Form
Department of Veterans Affairs Va  RESEARCH CONSENT FORM
Protocol #2511 (HSC #0005M50901) (page 1 of 7)
Subject Name:________________________ Date:______________
Title of Study: Cognitive Deficits as Indicators of Genetic Liability in Schizophrenia
PATIENT
Principal Investigator Scott R. Sponheim. Ph.D. V'aMC: Minneapolis 
INTRODUCTION
It is important that you read and understand the following explanation of the proposed 
research study before you agree to participate. This consent form describes:
• The purpose.
• The description of the study.
• The benefits.
• The risks and/or discomforts /including any potential for pain).
• Steps taken to decrease or eliminate the risks, discomforts, or possible pain.
• .Any other treatments that may be available, and
• Confidentiality and use of research results.
Whether you decide to participate or not. treatment at die VA or the University of 
Minnesota for which you are eligible will not be affected.
This consent form may contain words that you do not understand. Please ask the 
study doctor or the study staff to explain any words or information that are unclear 
to you.
PURPOSE OF THE STUDY
The purpose of this study is to understand thinking functions in individuals with mental 
disorders and their relatives. By measuring your brain wave activity while you perform a 
number of tasks, this study may enhance the understanding of the brain mechanisms that 
account for mentai disorders. The results of this study may lead to wavs of treating 
problems that lead to mental disorders. You have been asked to participate in this study 
because you are a person who may suffer from a disturbance in thought processes. Your 
participation is expected to last about one month.
DESCRIPTION OF THE STUDY
If you agree to be in this study, we would ask you to do the following things:
ai Clinical Interview. You will be asked a standard set of questions regarding 
your health, emotions, personal life, and mental health treatment. These procedures 
assess the degree to which any emotional disturbance is affecting your life and how to 
classify any emotional problems you might be having. You may have already completed 
portions of the interview by telephone.
b i Questionnaires. You will complete a set of questionnaires that ask about your 
health, emotions, personal life, opinions, and experiences.
c) Neuropsychological Assessment. You will complete a 3-hour testing session
Subject's Signature________________________
Subject Social Security -  _______________________
VA Form 10-1086 Consent form as of 3/20/01
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Department of Veterans Affairs 
Protocol #2511
Subject Name:________________
VA RESEARCH CONSENT FORM
Title of Study: Cognitive Deficits as Indicators of Genetic Liability in Schizophrenia
Principal Investigator: Scott R. Sponheim. Ph.D. VAMC: Minneapolis
with a research staff member that assesses your cognitive functioning. During the session 
you will be given tests of memory, attention, problem solving, reasoning, motor skills, 
and language.
d) Application of Electrodes and Psvchophvsiological Session. You will be asked 
to sit in a comfortable chair while your head size is measured with a measuring tape and 
electrodes are applied to your body and an electrode cap is fitted to your head. The 
electrode cap is a close-fitting cloth cap. It has recording electrodes embedded in its 
surface. The first step is to simply put it on your head. Each electrode site is then rubbed 
briefly to establish a secure contact between the electrode and scalp. In addition, a small 
dab of gel, similar to Vaseline, is applied to the scalp where each electrode is located.
The gel makes it easier for the electrical signals from your brain be measured. We will 
also place electrodes behind or on each ear. near each eye. and on your arms and legs in 
order to measure your eye movements and other bodily electrical signals. The electrode 
cap is held firmly in place with a chinstrap or elastic strip that is placed around your 
chest. Once the electrodes are in place, you will complete several tasks that will be given 
by a computer. Some of these tasks may be mentally challenging and can last about 30 
minutes. Other tasks are quite simple and last only several minutes. These tasks will be 
conducted while you are wearing the electrode cap and your brain electrical activity is 
recorded. The completion of the psvchophvsiological session will take between four and 
five hours.
e) Neurological Exam. You will complete a one-hour standard neurological exam 
where a trained researcher will make notes about your bodily features, ask you to perform 
various movements while you are being observed, and test your reflexes. The researcher 
will also examine your fingers under a microscope.
f) You will be asked to provide the name of someone who can give reliable 
information to study staff regarding your emotional and social functioning, and the name 
and location of a family member who can provide reliable information regarding your 
childhood development. You may have already provided some of this information by 
telephone.
g) You will be asked to provide the names, telephone numbers, and locations of 
individuals in your immediate family and family of origin. Your relatives may be 
contacted and invited to participate in the study.
h) You will have a small sample of blood (about 1 teaspoon) drawn by a vein stick 
and stored for possible future genetic analysis. The blood sample will be stored in a 
locked cabinet that only research staff can access. The blood sample and the DN'A
Subject's Signature___________________
Subject Social Security -  _______________________
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Department of Veterans Affairs VA RESEARCH CONSENT FORM
Protocol #2511 (HSC #0005M50901) (page 3 of 7)
Subject Name:_________________________Date:_______________
Title of Study: Cognitive Deficits as Indicators of Genetic Liability in Schizophrenia
PATIENT
Principal Investigator: Scon R. Sponheim. Ph.D. VAMC: Minneapolis
obtained from the sample will be stored with a subject code for up to 20 years. Only the 
principal investigator and the project coordinator will have access to the code linking 
your name to your subject number, [f genetic analyses are carried out on the blood 
sample or DN'A. they will be done on a "research” basis. This means that the results may 
not ever be available to you. When the analyses are done the DNA sample will be 
retained by the study staff or the lab doing the tests. If for some reason you withdraw 
from the study the blood sample and DNA will be kept by the study unless you tell the 
study staff you don’t want the sample kept. There is the possibility that you will be 
approached at a later date for follow-up information or a follow-up DNA sample. If you 
are contacted at a later date you have every right to refuse participation.
The total time o f all study procedures is 10 to 15 hours.
Exclusion criteria. You are not eligible for the study if 1) English is not your or 
your family's primary language. 2) you have a measured IQ of less than 70 or a diagnosis 
of mental retardation. 3) you have a history of dependence on alcohol or drugs, or are 
currently abusing alcohol or drugs. 4) you have a history of central nervous system 
disease. 5) you have suffered a head injury with skull fracture or significant loss of 
consciousness, 6) you have a physical problem that would render study measures difficult 
or impossible to administer or interpret (e.g.. blindness), 7) you are less than 18 years of 
age or older and 60 years, or 8) a history of electro-convulsive therapy.
As part of this study you will have a 10 to 15 minute sample of your speech 
recorded for data collection purposes, and may have responses to questions recorded on 
audio or videotape for data collection and educational purposes. The tapes and other 
study data will be kept for up to 20 years, with no information that directly identifies you.
RISKS .AND/OR DISCOMFORTS
The study has several risks: First, you may become bored, tired, or uncomfortable while 
completing the computer tasks. Second, you may find the tasks mentally challenging. 
Third, use of the electrode cap requires that we rub the electrode sites once the cap is 
positioned on the head. This rubbing is scratchy which some people find uncomfortable. 
We will measure your brain waves while you are at rest and when you are performing a 
number of tasks. Although we will wash off gel from the electrode sites at the end of the 
session, you may find a small bit left in your hair when we are finished. This gel will 
wash out with shampoo. Some minor skin irritation is possible in reaction to the 
electrode cap application: however, reddening of the skin from the pressure of the cap 
typically resolves within 24 hours. Finally, as part of study interviews, questions may be
Subject’s Signature________________________
Subject Social Security -  _______________________
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Department o f  Veterans Affairs VA RESEARCH CONSENT FORM
Protocol « 5 1 1  (HSC #0005M50901) (page 4 of 7)
Subject Name:________________________ Date:
Title of Study: Cognitive Deficits as Indicators of Genetic Liability in Schizophrenia
PATIENT
Principal Investigator: Scott R. Sponheim. Ph.D. VAMC: Minneapolis
asked which touch on sensitive issues. Consequently, you may experience pleasant or 
unpleasant emotions during the interview process. You may refuse to answer any 
questions you do not wish to answer at any time: however, this may lead to the 
discontinuation of the study protocol. Finally, you may experience some pain when the 
blood draw is completed to obtain a small sample of blood from your body. Possible side 
effects from blood drawing include faintness, inflammation of the vein, bruising, or 
bleeding at the site of the puncture. There is also a slight possibility of infection.
BENEFITS
No benefit is guaranteed from your being in this study. The knowledge gained from this 
study may benefit others in the future.
COMPENSATION
.After the completion of the study, you will receive a payment of $ 130 for your 
participation. Travel reimbursement will be provided to you at 17 cents a mile if you 
have to travel more than 40 miles to the Medical Center to participate in the study. If you 
withdraw your participation before finishing the study, you will be paid for the portion of 
the study you have completed on a pro-rated hourly basis ($10 per hour).
CONFIDENTIALITY AND USE OF RESEARCH RESULTS
The results of this study may be published or presented but your identity and records will 
not be revealed unless required by Federal Law. A Federal Law allows the U.S. Food and 
Drug Administration and the Institutional Review Board to review records. Because of 
the need for these inspections, absolute confidentiality cannot be guaranteed.
COSTS TO YOU FOR PARTICIPATING
There is no cost to you for taking pan in this study. All the study costs, including any 
procedures related directly to the study, will be paid for by the VA Medical Center. 
Participants who must make a co-payment for their usual medications or treatments will 
continue to be required to make such a co-payment for non-study related drugs. There 
should be no additional medical costs to you for taking part in this study. However, study 
visits may result in transportation costs and possible wages lost due to time missed from 
work.
MEDICAL CARE IF YOU ARE INJURED
In case you are injured from this research study, treatment will be available, including 
first aid, emergency treatment and follow-up care, as needed. The VA Medical Center
Subject's Signature_______________________
Subject Social Security = _______________________
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Department of Veterans Affairs VA RESEARCH CONSENT FORM
Protocol #2511 (HSC #0005M 5090l) (page 5 o f7)
Subject Name:________________________ Date:______________
Title o f Study: Cognitive Deficits as Indicators of Genetic Liabilitv in Schizophrenia
PATIENT
Principal Investigator: Scott R. Sponheim. Ph.D. VAMC: Minneapolis
will provide necessary medical treatment for any injury or iiiness that may arise from 
your participation in this research study. The VA Medical Center will provide payment 
for necessary emergency medical treatment. However, the VA Medical Center must be 
contacted at (612) 725-2003 within 72 hours in the event of any non-VA treatment or else 
you may lose any eligibility for VA payment of emergency bills.
COMPENSATION FOR ANY INJURIES
You have not released the VA Medical Center for liability by signing this form. This 
includes but is not limited to. free medical care other than as described in this consent 
form, payment of lost wages, or compensation for pain and suffering. Compensation for 
those items from the VA may be available under applicable Federal Law. You should 
immediately report any injuries resulting from your participation in this study to Dr. 
Sponheim at (612) 725-2074 during the day during the evenings or week-ends, by calling 
the Psychiatry Fellow on call at (612) 725-2000.
NEW INFORMATION
You will be given any new significant information that is discovered during the course of 
this study that may influence your willingness to continue the study.
OTHER INFORMATION
The researcher conducting this study is Dr. Scott R. Sponheim. You may ask any 
questions you have now. If you have questions later or study-related problems arise, you 
may contact him at the Psychology Service at the VA Medical Center in Minneapolis. 
Phone:(612) 725-2074.
If you have any questions or concerns regarding the study and would like to talk to 
someone other than the researcheifs), contact Patient Relations Department, B-310 Mayo 
Memorial Building, 420 Delaware Street S.E.. Minneapolis. Minnesota 55455: telephone 
(612)273-5050.
Your decision whether or not to participate will not affect your current or future 
relationships with the University of Minnesota or the Minneapolis VA Medical Center. If 
you decide to participate, you are free to withdraw at any time without affecting those 
relationships. When in the investigator's opinion, it would be detrimental for you to 
continue, your participation in the study will be terminated.
Subject's Signature________________________
Subject Social Security e _______________________
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Department o f Veterans Affairs VA RESEARCH CONSENT FORM
Protocol #2511 (HSC #0005M5090l) (page 6 of 7)
Subject Name:________________________ Date:______________
Title of Study: Cognitive Deficits as Indicators of Genetic Liability in Schizophrenia
PATIENT
Principal Investigator: Scott R. Sponheim. Ph.D. VAMC: Minneapolis
RESEARCH SUBJECT'S RIGHTS: I have read or have had read to me all of the 
above. Dr. Sponheim or one of his research staff has explained the study to me and 
answered all of my questions. I have been told of the risks or discomforts and possible 
benefits of the study.
I understand that 1 do not have to take part in this study and my refusal to participate will 
involve no penalty or loss of rights to which I am entitled. I may withdraw- from this 
study at any time without penalty or loss of VA or other benefits to which I am entitled.
The results of possible future genetic analyses will not have an effect on my care. 
Therefore, neither my doctor nor I will receive results of this testing. No medical report 
will be added to my records. My medical records may be reviewed in the future for 
purposes of obtaining more information about my health but my name and address will 
remain confidential and will not be released.
The results of this study may be published but my identity and records will not be 
revealed unless required by law.
In case there are medical problems or questions. I have been told I can call Dr. Sponheim 
at (612) 725-2074 during the day and Psychiatry Fellow on call at (612) 725-2000 after 
hours. If any medical problems occur in connection with this study the VA will provide 
emergency care.
If I have any question about the rights of a research subject, I understand that I may 
contact the VA Patient Representative at (612) 725-2106.
My questions have been answered and I voluntarily consent to participate in this study. 
By signing this form. I have not given away any of my legal rights, which I have as a 
subject of this research study. I will receive a signed copy of this consent form.
Subject's Signature 
Signature of Investigator
Signature of Witness
Subject Social Security -  ___
VA Form 10-1086
Date
Signature of person obtaining consent 
if other than the investigator
Approved: / / ~ / ‘■’ I__
Approval expires: j ! r  '  *7 ~ 
Chnlr, ESS: C- u T -
Consent form as^of 3/20/01
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Department o f Veterans Affairs VA RESEARCH CONSENT FORM
Protocol #2511 (HSC #0005M50901) (page 7 of? )
Subject Name:________________________ Date:_______________
Title of Study: Cognitive Deficits as Indicators o f  Genetic Liability in Schizophrenia
PATIENT
Principal Investigator: Scott R. Sponheim. Ph.D. VAMC: Minneapolis
SUBJECT’S UNDERSTANDING OF THE STUDY:
Please answer each of the four questions below to confirm that you understand this study. 
As you answer these questions, you may look at other pages of this form and ask the 
research staff any questions you may have regarding the study.
1) What are two risks or discomforts involved in this research study?
A . ____________________________________________________________________
B . ____________________________________________________________________
2) Name two things you will be asked to do during this study.
A . ____________________________________________________________________
B . ____________________________________________________________________
3) What would you do if you decided that you no longer wanted to participate in the 
study?
4) What would you do if you were experiencing distress or discomfort in the study0
Subject's Signature
Signature of person obtaining consent
Subject Social Security = ________________
VA Form 10-1086
Date
Consent form as of 3/20/01
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Appendix H 
Department of Veteran’s Affairs Release of Information Form
D e p a r t m e n t  o f  V e t e r a n s  A f f a ir s
Medical Center 
One Veterans Oriue 
Minneapolis MN 55417
r*. S « 0 ‘ V * 0  1 * -»3
. • ' 2 : 1 2 : . :  . < a s e :  
S3'.:: '0 3 :
We w ould appreciate your cooperation :n forwarding medical records or in form ation to assist our medical 
start m the examination and/ o r treatment or die patient named above:
• _  Final summary o r report or hospitalization _ _ _ _ _ _ _
(Dates.
L_ Brief report o f examination o r treatment . 
_  X-ray turns and report 
O tner (specify;
(Dates.
Please use the preaddressed envelope/lace: as appropriate, tor forwarding die requester information. X-ray 
Sims anc laboratory slides w ill be returned after review.
Sincerely,
Chief, Medical Admuusrranon Service 
Ends.
?_ 2 a s 2  sa r .c  a _ _  r e c c r a a  
o r ic g a :  H eg e -a r ., M.A..
M inr.aapcli.3  VA M ed ic a l Car.ca: 
i  153
Or.e V a c a ra r .’ s D r iv e  
M ia r .a a p c l is , Mil 5 5 -1 7
I authorize you to release the medical information requested above :o the Veterans Administration.
1 understand that I mav revoke this authorization at any time except to the extent that action has already 
been taken to comply w ith it. W ithou t my express revocation, this consent w ill automatically expire after 
che requested information has been supplied to the Veterans Admuustranon.
Signature o f Patient or Authorized Representanve Date
N O T E : The information requested on this form  letter is solicited under Tide 38, U.5.C and w ill authorize 
the addressee to disclose the inform ation you specify to the Veterans Administration. The miormanon w ill 
be used to assise our medical staff in your examination and treatment. Your disclosure o f che information 
requested is voluntary. However, your failure to give your consent may result in incomplete information on 
w hich to base your treatment.
FL 1C-212 
Fro 138CIM5)
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Table 1
Description of Novel and Conventional Antipsychotic Medications, Average Daily Dosages, and 
Chlorpromazine Equivalents for Each
Medicationa 
Generic Name Trade Name
Average
Dosage
(mg/day)
Apparent 
Chlorpromazine 
Equivalence (mg)
Novel Agents
Clozapine Clozaril 468.75 100
Olanzapine Zyprexa 14.17 4
Quetiapine Seroquel 225.00 150
Risperidone Risperdal 6.27 2
Conventional Agents
Chlorpromazineb Thorazine 100
Haloperidal Haldol 19.57 4
Loxapine Loxitane 200.00 25
Perphenazine Trilafon 40.00 8
Thiothixene Navane 40.00 10
Trifluoperazine Stelazine 40.00 6
Note. Apparent Chlorpromazine equivalence corresponds to the “apparent clinical equivalence in 
schizophrenia” from Clinical Handbook of Psychotropic Drugs (p. 89 - 91), by K. Z. Bezchlibnyk- 
Butler and J. J. Jeffries, 2001, Toronto, Canada: Hogrefe & Huber Publishers. 
a The medication list refers only to those medications that were prescribed to participants in the 
current study. This is not a complete list of antipsychotic medications, b No participants were
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prescribed Chlorpromazine, however this is included in the table for comparison purposes as 
medications are reported as Chlorpromazine equivalents.
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Table 2
Interrater Reliabilities for Ratings of Communication Disturbances
CDI Communication 
Disturbance Intraclass r
Vague References .93
Confused References .58
Missing Information References .80
Ambiguous Word Meanings .92
Wrong Word References .64
Structural Unclarities .78
Total Communication Disturbances .90
Note. Intraclass correlations across three raters who independently scored a randomly selected
16% of the speech samples from the current study.
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Table 3
Selected Demographic and Clinical Characteristics: Frequency and Percentage of Participants
Characteristic
Number of 
Participants
Percentage 
of Participants
Gender
Male
Female
Race
Caucasian 
African American 
Native American 
Asian 
Hispanic 
Marital Status
Single, never married 
Married
Divorced or widowed 
Living Arrangements 
Alone
Spouse/significant other 
Other family member 
Roommate 
Residential Treatment 
Employment Status
Working full-time
47 
8
48 
3 
2 
1 
1
36
10
9
27
10
7
6
5
85.5
14.5
87.3
5.5
3.6 
1.8 
1.8
65.5
18.2
16.3
49.1
18.2 
12.7 
10.9
9.1
16.4
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Working part-time 
Unemployed 
Disability 
Student 
Retired 
Annual Income3
Under $10,000 
$ 10-20,000 
$20-30,000 
$30-50,000 
$50-95,000 
Diagnosis
Schizophrenia 
Schizoaffective Disorder 
Current Medications^ 
Antipsychotics 
Antidepressants 
Mood Stabilizers 
Antipartkinsonians 
Current Treatment0 
Medication 
Therapy/Supportive 
Group Therapy 
Other Treatment
Functioning in Schizophrenia 185
21.8
9.1 
43.6
3.6
5.5
25.5 
50.9
7.3
14.5 
1.8
81.8
18.2
96.4
54.5 
29.1
27.3
96.4
34.4 
21.8
9.1
12
5
24
2
3
14
28
4
8
1
45
10
53
30
16
15
53
19
12
5
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a Income data collected only in these ranges, so averages are not available, b Numerous 
participants were prescribed multiple medications, so totals are greater than 100%.c Numerous 
participants were involved in multiple medications, so totals are greater than 100%.
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Table 4
Selected Demographic and Clinical Characteristics: Means, Standard Deviations, and Ranges
Characteristic Mean Standard
Deviation
Range
Age 46.84 8.07 2 4 - 5 9
Years of Education 14.25 2.18 8 - 1 9
Age at Onset of Symptoms 23.76 6.04 13 -4 7
Age at First Hospitalization 25.43 7.60 1 3 - 5 0
Number of Hospitalizations 6.87 5.73 0 - 3 2
Current GAF score3 48.07 9.84 2 5 - 6 8
Chlorpromazine Equivalents^5 416.50 320.50 16.6-1825.0
Note. GAF = Global Assessment of Functioning.
3 Possible scores ranged from 0 to 100. b Measured in milligrams.
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Table 5
Means, Standard Deviations and Ranges for the 4-Factor Model of the Brief Psychiatric Rating
Scale (BPRS): Items and Scales
Standard
BPRS Scale/Item Mean Deviation Range
Positive Symptoms 2.37 0.96
Suspiciousness 2.80 2.08 1 - 7
Hallucinations 2.75 1.86 1 - 7
Unusual Thought Content 3.15 1.66 1 - 6
Bizarre Behavior 1.80 1.28 1 - 5
Disorientation 1.35 0.67 1 - 3
Negative Symptoms 1.95 0.83
Self-Neglect 1.82 1.11 1 - 5
Blunted Affect 2.47 1.37 1 - 6
Emotional Withdrawal 2.00 1.05 1 - 5
Motor Retardation 1.53 0.98 1 - 5
Manic-Excitement 1.54 0.77
Hostility 1.84 1.21 1 - 5
Elevated Mood 1.22 0.74 1 - 5
Grandiosity 2.11 2.03 1 - 7
Excitement 1.33 1.09 1 - 6
Distractibility 1.51 0.88 1 - 4
Motor Hyperactivity 1.25 0.88 1 - 5
Depression-Anxiety 1.80 0.85
Anxiety 2.07 1.32 1 - 5
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Depressed Mood 2.22 1.47 1 - 6
Suicidality 1.15 0.52 1 - 3
Guilt Feelings 1.76 1.47 1 - 6
Other Items
Somatic Concern 1.47 0.79 1 -  4
Conceptual Disorganization 2.11 1.09 1 - 5
Tension 1.62 1.03 1 - 5
Uncooperativeness 1.49 1.30 1 - 7
Mannerisms and Posturing 1.11 0.50 1 - 4
Total (average) 1.83 0.53
Note. Ratings were made on a 7-point scale (1 = Not Present, 7 = Extremely Severe).
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Table 6
Means and Standard Deviations for Quality of Life Interview (QOLI) Scales
QOLI Subscale Mean Standard Deviation
Objective Scales
Daily Activities a 4.60 1.62
Family Contact^ 3.46 1.18
Social Contact*5 3.08 0.84
Financial Adequacy0 0.89 0.18
Spending Moneyd 275.65 415.76
Subjective Scale -  Satisfaction
General Life 4.55 1.34
Living Situation 5.01 1.41
Daily Activities 4.61 1.26
Family Relations 4.66 1.46
Social Relations 4.67 1.25
Finances 4.42 1.74
Worke 5.35 0.92
Legal and Safety 5.42 1.16
Health 4.58 0.95
Note. Satisfaction ratings were made on 7-point scales (1 = terrible, 7 = delighted). 
a Out of a possible total of 8 activities, b Values range from 1 = not at all, to 5 = at least once per 
day.c Values represent percentile out of 5 costs that can be adequately covered by available
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finances. d Values represent reported spending money available. e For this group (participants 
currently working), n = 22.
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Table 7
Correlations between Subscales/Other Indicators and Global Life Satisfaction (GLS) on the 
Quality of Life Interview (QOLI)
Subscale/lndicator GLS
Objective
Daily Activities .139
Family Contact -.040
Social Contact .340**
Financial Adequacy .176
Spending Money .031
Victim of Crime .195
Arrested in Last Year .146
Subjective -  Satisfaction
Living Situation .438**
Daily Activities .627**
Family Relations .272*
Social Relations .349**
Finances cn o 00 i
Work3 .353
Legal and Safety .258*
Health .528**
a For this group (those who are currently working), n = 22. 
*p < .05. **p<.01.
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Table 8
Means, Standard Deviations, and Ranges of Social Adjustment Scale-ll (SAS-II) Global Ratings
Global Rating Mean Standard Deviation Range
Worka 3.74 1.68 0 - 6
Household Memberb 2.18 1.09 0 - 5
External Family 2.78 1.31 1 -6
Social Leisure 3.22 1.06 1 -5
General Adjustment 3.11 0.79 2 - 5
Note. Global ratings were made on a 7-point scale (0 = excellent adjustment, 6 = severe 
maladjustment), therefore, lower scores reflect higher adjustment.
a This score refers to functioning in school or accomplishing daily responsibilities if the participant 
is not currently employed, b For this group (living with others), n = 28.
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Table 9
Means and Standard Deviations of Scales on the Communication Disturbances Index (CDI)
CDI Scale Mean Standard Deviation
Vague References .42 .30
Confused References .36 .28
Missing Information References .58 .36
Ambiguous Word Meanings .86 .56
Wrong Word References .34 .20
Structural Unclarities .32 .24
Total Communication Disturbances 2.88 1.24
Note. Scores represent number of disturbances per 100 words of speech.
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Table 11
Score Conversions for Neurocognitive Measures: Standard Score, Age Scaled Score, T score, z 
score, and Percentile Equivalents
Standard
Score
Age Scaled 
Score T score z score Percentile
55 1 20 -3 .30
60 2 23 .80
65 3 26 1.00
70 4 30 -2 2.00
75 5 33 5.00
80 6 37 9.00
85 7 40 -1 16.00
90 8 43 25.00
95 9 46 37.00
100 10 50 0 50.00
105 11 53 63.00
110 12 57 75.00
115 13 60 1 84.00
120 14 63 91.00
125 15 66 95.00
130 16 70 2 98.00
135 17 73 99.00
140 18 77 99.20
145 19 80 3 99.70
150 20 83 99.93
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Table 13
Pearson Product Moment Correlations among the Five Domains of Neurocognitive Abilities
Domain 1 2 3 4 5
1. Attention - -.105 -.033 .023 .138
2. Verbal Fluency - .253* .393** .287*
3. Higher Cognitive - .260* .126
4. General Mental - .200
5. Verbal Memory -
Note. These domain summary scores were calculated by averaging across z scores converted 
from raw scores for each of the neurocognitive measures that contributed to the particular domain 
* p < .05. ** p < .01.
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Table 16
Pearson Product Moment Correlations between Neurocognitive Measures and Selected Brief 
Psychiatric Rating Scale (BPRS) Scores
BPRS Score
Neurocognitive Score3 Total Positive Negative
WAIS-III
Vocabulary 
Digit Symbol -  Coding 
Digit Symbol -  Pairing 
Digit Symbol -  Free Recall 
Block Design 
Digit Span 
COWAT
Trail Making Test -  Part A 
Trail Making Test -  Part B 
WCST
Perseverative Errors 
Failure to Maintain Set 
Categories Completed
CVLT
Recall Total 
Recall List 1 
Recall List 5 
Short Delay Recall 
Long Delay Recall
-.133 -.053 -.162
-.228* -.052 -.329**
-.186 -.145 -.243*
-.098 -.022 -.163
.024 .161 -.027
.080 .243* -.069
.050 .164 -.146
.112 -.034 .360**
-.062 -.139 .058
-.125 -.044 -.094
.030 -.095 -.046
.071 .087 .105
-.117 -.096 -.190
-.017 -.061 -.023
-.161 -.195 -.216
-.128 -.077 -.162
-.061 -.019 -.176
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Functioning in Schizophrenia 205
Recognition Total -.009 -.049 .048
Note. WAIS-III = Wechsler Adult Intelligence Scale, Third Edition. COWAT = Controlled Oral 
Word Association Test. WCST = Wisconsin Card Sorting Test. CVLT = California Verbal Memory 
Test.
a Neurocognitive scores used for these correlations were z scores converted from raw scores for 
each of the.
*p  < .05. **p < .01.
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Table 17
Pearson Product Moment Correlations between Neurocognitive Domain Summary Scores and 
Selected Psychiatric Status and Symptom Presentation Measures
Neurocognitive Domain 
Summary Score Total
BPRS Score 
Positive Negative
GAF
Score
Verbal Memory -.100 -.101 -.147 .335**
Attention .166 .181 .252* -.119
Verbal Fluency .050 .164 -.156 .213
General Mental -.070 .069 -.122 .152
Higher Cognitive -.172 -.135 -.166 .244*
Note. The domain summary scores were calculated by averaging across z-scores converted from 
raw scores for each of the neurocognitive measures that contributed to the particular domain. 
BPRS = Brief Psychiatric Rating Scale. GAF = Global Assessment of Functioning.
* p < .05. ** p < .01.
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
Functioning in Schizophrenia 207
Table 18
Pearson Product Moment Correlations between Scales on the Quality of Life Interview (QOLI) 
and Global Ratings on the Social Adjustment Scale-ll (SAS-II)
QOLI Scale Work
SAS-II Global Rating
Household External 
Membera Family
Social 
and Leisure
General
Adjustment
Subjective Scales -  Satisfaction
General Life -.143 -.485** -.063 -.270* -.355**
Living Situation -.125 -.593** -.241* -.225 -.372**
Daily Activities .018 -.411* .089 -.432** -.241*
Family Relations ( 00 o -.254 -.636** -.281* -.463**
Social Relations -.125 -.323 -.404** -.546** -.503**
Finances -.184 -.177 -.108 -.095 -.191
Workb -.152 .129 .020 -.357 -.257
Legal and Safety -.201 -.214 .060 -.181 -.230*
Health -.023 -.374* .289* -.157 -.093
Objective Scales
Daily Activities .208 -.380* .136 -.209 -.023
Family Contacts -.066 .239 -.598** -.166 -.226
Social Contacts -.186 -.289 -.110 -.463** -.365**
Financial Adequacy -.293* -.299 -.275* -.225 -.312*
Spending Money -.149 .217 -.050 -.049 -.068
a This rating was made only on those participants with lived with others, n = 27. b This rating was 
made only on those participants who were currently working, n = 22.
* p < .05.**p<.01.
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Table 19
Pearson Product Moment Correlations between Quality of Life Interview (QOLI) Scales and 
Selected Neurocognitive Domain Summary Scores
QOLI Subscale Memory
Neurocognitive Domain 
Verbal 
Attention
Higher
Cognitive
Subjective Scales -  Satisfaction
Global Life .186 .222 .059
Living Situation -.065 .197 -.114
Daily Activities .172 .158 -.059
Family Relations .065 .137 -.099
Social Relations .199 -.059 -.095
Finances .250* .114 -.002
Work3 .333 .252 -.093
Legal and Safety .276* .082 .183
Health .129 .124 -.025
Objective Scales
Daily Activities -.199 .042 -.212
Family Contacts -.040 -.013 -.054
Social Contacts .034 .268* -.056
Financial Adequacy .072 .157 .000
Spending Money .025 .113 .089
Note. Domain summary scores were calculated by averaging across z scores converted from raw 
scores for each of the neurocognitive measures that contributed to the particular domain, 
a This rating was made only for those participants who were currently working, n = 22.
* p < .05.
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Table 20
Pearson Product Moment Correlations between Scales on the Communication 
Disturbances Index (CDI) and Selected Neurocognitive Domain Summary Scores
Neurocognitive Domain 
CDI Scale Verbal Memory Attention Verbal Fluency
Vague References -.055 -.020 -.184
Confused References .117 -.248* .133
Missing Information -.263* -.013 -.163
Ambiguous Word Meanings -.114 -.050 -.097
Wrong Word References -.112 .070 -.016
Structural Unclarities .064 -.228 .190
Total Communication Disturbances -.120 -.118 -.073
Note. These domain summary scores were calculated by averaging across z scores converted 
from raw scores for each of the neurocognitive measures that contributed to the particular 
domain.
* p < .05.
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
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Table 22
Summary of Hierarchical Regression Analysis for Variables Predicting the Quality of Life Interview 
(QOLI) Rating of Global Life Satisfaction (N = 51)
Variable B SEB beta
Model 1
Depression-Anxiety -.947 .187 -.581***
Model 2
Depression-Anxiety -.975 .179 -.599***
Ambiguous Word Meanings .849 .339 .275*
Model 3
Depressive-Anxiety -.907 .171 -.557***
Ambiguous Word Meanings .857 .321 .277**
Global Social Adjustment -.470 .181 -.272*
Note. R2 = .338 for Model 1. AR2 = .075 for Model 2. AR2 = .072 for Model 3. 
* p < .05. ** p < .01 . *** p < .001
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